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SUMMARY - Mechanisms of ventricular arrhythmogenesis in 
the age dependent Pgc-1β-/- model of mitochondrial 
dysfunction. 
 
Sudden cardiac death is a leading cause of mortality worldwide. Ventricular arrhythmias, both 
ventricular tachycardia and ventricular fibrillation, are the primary arrhythmias that lead to 
sudden cardiac death. A large proportion of ventricular arrhythmias are ischaemic in origin. 
However, increasing clinical and experimental evidence links metabolic disease, mitochondrial 
dysfunction and ageing as independent risk factors for arrhythmogenesis beyond the risk they 
confer to coronary artery disease. To date, researchers have focused upon investigation of 
monogenic ion channel disorders as well circumscribed diseases to investigate the principles 
of arrhythmogenesis. This has given insight into the basic theories of arrhythmogenesis as well 
as the tools needed to dissect them. In this study, we use Pgc-1β-/- mice as a murine model of 
mitochondrial dysfunction, to further investigate the link between mitochondrial and 
energetic insufficiency and arrhythmias.  
 
The study uses electrocardiographic data to characterise the phenotype at the whole animal 
level, revealing significant age related abnormalities in ventricular activation and abnormal 
nodal tissue phenotypes. Single cell action potential characteristics in intact Langendorff 
perfused whole hearts were then used both in programmed electrical stimulation studies and 
at incrementally paced steady states to investigate the electrophysiological characteristics 
that give rise to arrhythmia. These experiments revealed a significant deficit in maximal rate 
of depolarisation and consequent effects on conduction wavelengths, accompanied by 
instabilities in activation characteristics as evidenced by the presence of electrical alternans. 
Finally, patch-clamp studies are performed to confirm the hypotheses of the earlier 
experiments and their effect on cellular currents in a physiological environment which show 
a physiological deficit in sodium current density. At all stages care was taken to perform 
experiments in the least disruptive manner, maintaining as much physiological relevance as 
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possible. The series of experiments reveal that not only is mitochondrial dysfunction related 
to arrhythmias in an age dependant manner, but that it leads to altered sodium current 
density with a plausible role of Ca2+ as a central mediator of this, allowing future studies to 
build on this. 
 
Dr Shiraz Ahmad 
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1. INTRODUCTION 
 
1.1 EPIDEMIOLOGY OF VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC 
DEATH 
 
Cardiovascular disease is the leading worldwide cause of mortality. Approximately half of such 
cases are attributable to sudden cardiac death (SCD) (Go et al., 2013). Cardiovascular disease 
is responsible for approximately for 17 million deaths per year and sudden cardiac death 
accounts for 15-25% of these deaths (Mendis SPP and B, 2011; Hayashi et al., 2015). Sudden 
cardiac death has been defined as sudden death due to a primary cardiac cause identified 
either at autopsy, or when a potentially fatal cardiac condition (congenital or acquired) was 
known to be present during life. Sudden cardiac arrest has a very high mortality, with an 
average 7% survival rate (NICE, 2014). It encompasses sudden death when no obvious extra-
cardiac causes have been found by post-mortem examination for which an arrhythmic event 
is the likely cause of death (Priori et al., n.d.; Zipes et al., 2006) . Ventricular arrhythmias are 
thus the most common precipitant of sudden cardiac death (Koplan and Stevenson, 2007) of 
which the commonest presenting rhythm to paramedical staff is ventricular fibrillation (VF). 
However this is often thought to have been preceded by ventricular tachycardia (VT) (Turakhia 
and Tseng, 2007).  
 
In most patients, cardiac arrhythmias are the result of underlying ischaemic heart disease 
(Behr et al., 2003). In a small but significant proportion (around 4%) the sudden cardiac death 
is of unknown cause (Tung et al., 1994). This proportion is higher in patients under the age of 
40, representing almost 15% of resuscitation attempts (Viskin and Belhassen, 1990). Sudden 
cardiac death and ventricular arrhythmias therefore represent important clinical problems in 
human health. 
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1.2 THE ACTION POTENTIAL AND ELECTROPHYSIOLOGICAL BASIS OF 
ARRHYTHMIAS 
 
Cardiac arrhythmias fundamentally result from disruptions in the normally coordinated 
sequence of ion channel activation and inactivation underlying cardiac action potential (AP) 
excitation and its propagation. Ion channel characteristics, their influence over AP generation 
and propagation, and related major recent discoveries of sarcolemmal, sarcoplasmic reticular, 
(SR) and cytosolic biomolecules have been described. These molecules are involved in both 
surface membrane excitation and intracellular signalling (Fig. 1-1). The latter is crucial to the 
voltage and metabolically sensitive mechanisms mediated by the surface membrane ionic 
channels. These mechanisms underlie the generation of the automaticity underlying normal 
(or abnormal) pacing of cardiac activity, the interacting sequence of membrane 
depolarisation, plateau formation, and recovery,  and the propagation of these processes in 
atrioventricular (AV) nodal and purkinje tissue, as well as ventricular (Figure 1-1C) and atrial 
cardiomyocytes (Figure 1-1D) (Huang, 2017 a).  
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Figure 1-1: The Cardiac Action Potential and Ionic Currents. Ionic currents involved in plateau 
generation (A) depolarisation and repolarisation (B) in a ventricular cardiomyocyte (C) and atrial 
cardiomyocyte (D). The phase of the action potential during which particular ionic current is flowing is 
highlighted, as well as the channel name and the gene transcript in parentheses. Adapted from (Huang, 
2017 b). 
 
 
The AP waveform characteristic of cardiac electrophysiological activity consists of a rapid 
depolarisation (phase 0), an early repolarisation (phase 1), brief atrial and prolonged 
ventricular plateau (phase 2) and late repolarisation phases (phase 3) ending in electrical 
diastole (phase 4). AP initiation depends on Na+ or Ca2+ channel activation and its propagation. 
Ca2+ channel activation also contributes to the AP plateau. AP repolarisation (thereby 
restoring the background resting potential) is driven by a range of K+ channels (Nerbonne and 
Kass, 2005; Huang, 2017 a). An effective refractory period (ERP) follows such activity. This may 
Introduction 
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be modulated either by Na+ channel inhibition delaying the point at which a critical proportion 
of Na+ channels has recovered, or by AP prolongation. The leading edge of the resulting AP 
propagation wave is followed by regions of myocardium refractory to electrical re-activation. 
This cyclical pattern of spatial and temporal electrophysiological activity forms a coherent 
wave of excitation propagating through often anisotropic electrical connections between 
successive tissues (Figure 1-2); the sino-atrial, atrial, AVN, purkinje and endocardial and 
epicardial ventricular cardiomyocytes are successively activated, with detailed AP waveforms 
varying with cell type.  
 
 
Figure 1-2: The conduction pathway. 
Pacemaker and specialized conductile regions of the mammalian heart (left) and their characteristic 
action potential and the overall electrocardiogram waveform (right). Adapted from (Cranefield and 
Hoffman, 1968).  
 
Thus atrial cells show shorter APs than ventricular cells, reflecting larger repolarising, transient 
outward voltage dependent and acetylcholine-sensitive K+ currents (Kléber and Rudy, 2004; 
Amin et al., 2010; King et al., 2013 a) 
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These voltage changes initiate mechanical contraction of the cardiomyocytes by a process 
known as excitation-contraction coupling. In turn these voltage dependent changes are 
reciprocally modified by the excitation-contraction coupling processes that they trigger. 
Excitation-contraction coupling begins with an extracellular Ca2+ influx through transverse 
tubular membrane Ca2+ channels during phase 2 of the AP plateau. The resulting local 
elevations in cytosolic [Ca2+] trigger a ryanodine receptor (RyR2) mediated SR Ca2+ release. 
The consequent elevation in cytosolic [Ca2+]i, drives the Ca2+-troponin binding that initiates 
mechanical activation. Sarcolemmal and SR Ca2+-ATPase activity as well as surface 
sarcolemmal Na+/Ca2+ exchange then restore [Ca2+]i to its ~100 nM baseline level resulting in 
contractile relaxation ending the activity cycle (Bers, 2001, 2002). Baseline surface and 
intracellular transmembrane ion gradients driving these processes are then restored by the 
Na+-K+ ATPase and Ca2+-ATPase pumps and other carriers, resetting the effects of this 
excitable and contractile activity. The overall energetic cost is defrayed by mitochondrial 
generation of cellular ATP (Brown and O’Rourke, 2010). The inward Na+ current generated at 
the outset of the action potential drives local circuit currents. These excite hitherto quiescent 
regions of membrane, resulting in propagation of the excitation through successive cardiac 
chambers and regions within these chambers. Finally, following AP recovery, an automaticity 
property mediated by a spontaneous diastolic, phase 4, depolarisation takes the membrane 
potential in SAN and AVN cells to the threshold for generation of a subsequent AP. This 
initiates the electrophysiological events underlying the subsequent heart beat (Mangoni and 
Nargeot, 2008). 
 
1.3 GENETICALLY MODIFIED MURINE MODELS 
 
The cardiac AP and its propagation is therefore intimately dependant on the array of ionic 
channels and molecules that are involved in the cardiac AP. Disruption of these molecular 
functions may lead to disordered excitation or propagation of APs. Previous studies have 
examined the roles of these individual channels in cardiac arrhythmogenesis. They have often 
employed models with monogenic modifications or pharmacological manipulations directed 
at specific channels providing valuable insights into the contributions of particular channels to 
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arrhythmic events (Huang, 2017 a). Mice provide genetic systems that are readily 
manipulated, providing a system where the cardiac effects of specific ion channel 
modifications can be studied and used to model the corresponding human conditions.  
 
Importantly, the basic structure of the heart is preserved across all mammalian species. Both 
mouse and human hearts work within a dual circulation. There are left and right circulations 
with the ventricular chambers being structurally homologous. Murine atria do not form a 
single continuous structure with the ventricles as they do in humans; rather they are 
structured as two leaflets above the ventricle. (Figure 1-3). Nevertheless, they share similar 
conduction systems particularly regarding their nodal tissues and His-Purkinje system 
(Rentschler et al., 2001).  
 
Mouse and human hearts do differ considerably in size. The small size of the murine heart 
initially led to speculation that it was incapable of sustaining and developing cardiac 
arrhythmias (Garrey, 1914). Later studies have proven this view incorrect and atrial as well as 
ventricular arrhythmias are well characterised in WT animals as well as a diverse array of 
genetically modified murine models  (Sabir et al., 2007 a; Killeen et al., 2008 a; Dautova et al., 
2009; Matthews et al., 2013 a; Salvage et al., 2015; Ning et al., 2016 a). Although, there are a 
number of important electrophysiological differences that exist between the two species, the 
major electrophysiological differences between murine and human cardiac electrophysiology 
concern the repolarisation currents (Huang, 2017 a). 
 
The cardiac action potential in the mouse lacks a well-defined plateau region and is 
consequently shorter than the human AP (Killeen et al., 2008 a). Thus the transient outward 
current, Ito, is the major repolarising current, while IKs and IKr appear to have a reduced role. 
This contrasts with the situation in human cardiomyocytes, where the slow and rapid 
components of the latter two currents are the major repolarising currents (Grant, 2009; 
Huang, 2017 a). In contrast, hearts in both species share a rapid INa-mediated depolarisation 
phase.  
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Thus, the fidelity and translation of findings from murine models to human models is 
empirically more likely in processes that affect depolarisation. Both human and mouse hearts 
are able to demonstrate AP duration heterogeneity which leads to important tissue level 
electrophysiological phenomenon such as repolarization gradients; both transmural and 
apico-basal, as well as the development of arrhythmias when these gradients are altered 
(Knollmann et al., 2001 a; Killeen et al., 2008 b). 
 
The similar electrophysiological properties has contributed to the widespread use of the 
mouse as an electrophysiological model for a myriad of different cardiac arrhythmic 
syndromes. The ease of genetic manipulation of the mouse genome and the development of 
 
 
Mouse and human 
hearts show a 
marked structural 
homology, 
although in mouse 
hearts the left 
atrium (LA) and 
right atrium (RA) 
are positioned as 
leaflets just above 
the right and left 
ventricles (RV and 
LV) (A and B). The 
main ventricular 
chambers and the 
other supporting 
structures such as 
the valves (C), 
tendons (D), 
arteries and veins 
are similar to that 
of humans 
(Wessels and 
Sedmera, 2003). 
 
Figure 1-3: Cross 
section of the 
mouse heart. 
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knock-outs and knock-ins has been used to isolate and dissect the role of particular proteins 
in arrhythmogenesis. Presently, the use of genetically modified mouse models in such cases 
has helped elucidate and provide important mechanistic insights and therapeutic strategies 
for genetically linked disorders. In cardiac arrhythmia research, genetically modified mice 
have become one of the main species studied which has helped our understanding of 
arrhythmogenesis. 
 
Studies in NaV1.5 haplo-insufficient murine Scn5a+/- hearts have implicated loss of Na+ channel 
function and accelerated age-related fibrotic changes in compromising AP conduction 
velocities. This accentuates tissue-level re-entrant circuit formation, ultimately resulting in the 
generation of the ventricular arrhythmic substrate present in the Brugada Syndrome 
(Jeevaratnam et al., 2011, 2012; Martin et al., 2012 b; Huang, 2017 b). Further studies in 
variants with abnormal Na+ or K+ channel properties have explored disruptions in the 
repolarisation process, associated with long QT syndromes. Finally, studies using variants 
involving intracellular ion channel function, particularly the RyR2-Ca2+ release channel have 
examined the relationship between alterations in Ca2+ homeostasis and the surface electrical 
changes.   
 
1.4 THE SURFACE ELECTROCARDIOGRAM 
 
The electrical activity of the heart is readily recorded from the body surface. This is now done 
using recording electrodes placed in standard positions originally defined by Einthoven in his 
work on the first clinically applicable electrocardiogram (ECG) (Einthoven W, 1903). The ECG 
is a fundamental tool in the analysis of cardiac elelctrophysiology, both in normal and diseased 
states, and still in routine use in clinical practice today. Its characteristics can give important 
information about abnormal rhythms caused by damage to the conductive tissue or by 
imbalance in the body’s electrolytes (Van Mieghem et al., 2004).  
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The normal human ECG is composed of a P wave, a QRS complex and a T wave (Figure 1-4). 
The P wave represents the depolarisation of the atria, whereas the QRS complex is generated 
by potentials when the ventricles depolarise and is seen on the ECG as the QRS complex. The 
QRS complex comprises of three deflections - the Q wave (first negative deflection preceding 
the R wave), R wave (first positive deflection) and S deflection (negative wave following an R 
wave), each corresponding to distinct electrical activity occurring in the heart at a given point 
in time. 
 
After ventricular depolarisation, the large ventricular mass undergoes repolarisation and this 
is reflected by an upright deflection on the surface ECG known as the T wave. The atria, by 
contrast, do not have sufficient mass to cause a detectable perturbation by their 
repolarisation at the sampling frequency and standard gain settings on the human surface 
ECG in clinical practice. Atrial repolarisation is also masked by the much larger depolarisation 
of the QRS complex. Left and right atrial depolarisation are not usually seen as discrete 
components in the standard clinical human ECG though they may be delineated in other ECGs 
such as stress ECGs used in clinical practice. 
 
Also notable within the surface human ECG are isoelectric periods, the most prominent of 
which is known as the PR segment. This corresponds to the time for conduction from the atria 
to the atrioventricular node (AVN) (Surawicz et al., 2008). The ST segment represents the 
phase 2 plateau  
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Figure 1-4: The human surface ECG: 
Labelled are the P wave representing atrial depolarization, the isoelectric PR segment representing time 
to AV conduction, the QRS complex representing the ventricular depolarization, the ST segment 
representing the phase 2 plateau period and the T wave representing the ventricular repolarisation.  
Displaying the major deflections of the human surface ECG and the description of the varying intervals. 
Also labelled are the PR interval and QT interval, two frequently measured intervals in clinical practice. 
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period of the human AP (Surawicz et al., 2008). Changes in the duration of the waves or the 
intervals between them often represent a pathological process in cardiac conduction. 
 
Physiological age related variations in the surface ECG are accepted in clinical practice. In 
paediatric patients, with the removal of the placental circulation leading to the functional 
closure of the foramen ovale, the paediatric heart undergoes significant change. The left 
ventricle to right ventricle ratio (LV/RV ratio), an indicator of their respective free wall 
thicknesses, has been reported to change to 1.5:1from 0.8:1 and slowly to the adult ratio of 
2.5:1 (Tipple, 1999), while there is a steady reduction in heart rate attributed to an increase 
in vagal tone (O’Connor et al., 2008). As the cardiac muscle mass is less in children than in 
adults, the AV conduction assessed by PR interval, and ventricular depolarisation duration 
assessed by QRS duration, is shorter in children (O’Connor et al., 2008). 
 
 
The murine surface ECG has a number of important homologies to the human ECG used in 
clinical practice as well as some important differences. Firstly the P wave (Figure 1-5) is bifid 
with two discernible waves present representing the left and right atrial depolarisation; this 
is something that is also seen in the normal human ECG, though not routinely in clinical 
practice due to the sampling rate employed in clinical ECGs (Surawicz et al., 2008). The QRS 
complex is conserved but instead of terminating at an isoelectric ST segment is followed 
almost immediately by two further waves representing the repolarisation phase of the 
ventricles – the R’ wave and the C wave (Figure 1-5). The definitions of the relevant intervals 
from the human surface ECG thus have direct murine correlates – the PR interval, QRS 
complex (now including up to the peak of the R’ wave) and QT interval all have homologous 
murine interval equivalents. However there is no isoelectric ST segment. Finally, the RR 
interval represents the interval from the peak of the R wave from one R wave to the peak of 
the subsequent R wave.  
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Typical physiological values for all these intervals have not been extensively investigated in 
the mouse heart, apart from the RR interval and the QT interval – these have been found to 
vary between 60-200ms for the RR interval and around 40-60ms for the QT interval 
(Jeevaratnam et al., 2010; Boukens et al., 2014). Similar studies on different mouse strains are 
consistent with this, with typical values for the QRS duration around 10-12ms and the PR 
interval between 35-60ms (Jeevaratnam et al., 2010; Boukens et al., 2014; Chadda et al., 
2017). 
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Figure 1-5: The murine ECG: 
A: Typical ECG and definition of deflections used in quantitative analysis including the P-wave; Q 
wave/start of QRS complex; R wave peak; S wave; R' deflection (not present on human ECG); C wave 
(not present on human ECG); There is no direct correspondence to an isoelectric ST segment as in a 
human ECG though the period between the QRS complex and the beginning of the ventricular 
repolarisation represents the same phases in the murine AP. The murine equivalent of the T wave 
encompasses both the R’ wave and the C wave. The corrected QT interval, QTc is taken as the interval 
from C to H and corrected for RR intervals (Mitchell et al., 1998). B: Two successive murine ECG 
complexes and the RR interval. The shorter the RR interval the greater the heart rate. 
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1.5 MITOCHONDRIAL DYSFUNCTION IS ASSOCIATED WITH AGEING, 
METABOLIC DISEASE AND CARDIAC FAILURE.  
 
Monogenic ion channel defects account for a relatively small proportion of SCD in the clinical 
setting. A growing body of epidemiological evidence links ageing and the common 
metabolic/age related conditions of obesity, diabetes mellitus and heart failure (Kucharska-
Newton et al., 2010; Hookana et al., 2011; Yeung et al., 2012) to mitochondrial dysfunction. 
Such disorders are a growing problem in human populations especially in developed nations. 
These conditions constitute risk factors for SCD independent of any underlying coronary artery 
disease (Yeung et al., 2012; Adabag et al., 2015).  
 
The link between ageing, metabolic disease and mitochondrial dysfunction is corroborated 
with evidence at the physiological level (Larsson, 2010). Ageing is associated with 
mitochondrial DNA (mtDNA) damage and respiratory chain deficiency is a consequence of 
clonal expansion of these mutations in human mitochondria (Ademowo et al., 2017; Krishnan 
et al., 2007; Trifunovic and Larsson, 2008). Human cardiomyocytes isolated at autopsy show 
defects of cytochrome-c-oxidase, the terminal enzyme of the respiratory chain which occur 
with increasing frequency with age (Muller-Hocker, 1989). Similar features are also observed 
in other mammalian species: deterioration of respiratory chain function secondary to age-
associated mtDNA damage is observed in mouse (Piko et al., 1988), rat (Wanagat et al., 2001), 
and rhesus monkey (Schwarze et al., 1995) models (Larsson, 2010). Furthermore, in a murine 
model of premature ageing, somatic mtDNA mutations were found with increasing frequency 
(Larsson, 2010; Trifunovic et al., 2004). Thus, there is a strong experimental and observational 
evidence supporting the link between increased age and mitochondrial dysfunction.  
 
A similar link also exists for metabolic dysfunction and mitochondrial deficiency at the 
physiological level, as evidenced by complex I electron transport chain (ETC) abnormalities 
and decreased state 3 respiration in cardiac mitochondria in metabolic disease states. This has 
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been shown in human tissue taken from diabetic patients during coronary artery bypass graft 
surgery (Schrauwen-Hinderling et al., 2016). Similarly, high-fat-diet fed obese mice showed 
increased mitochondrial dysfunction, also associated with a defect in complex 1 functioning 
(Wang et al., 2015). Therefore, in common with increased age, there is evidence to support a 
link between metabolic disorders and mitochondrial dysfunction.  
 
Finally, there is also a strong link between cardiac failure and mitochondrial and metabolic 
dysfunction. Indeed the paradigm of the failing heart as an energetically starved heart has 
evidence accumulated over many years of scientific study. Cardiac tissue has a high energetic 
demand, and produces more than 90% of its demand from mitochondrial respiration. The 
importance of energy sufficiency in cardiac function is evidenced by the fact that mitochondria 
occupy around 30% of cardiomyocyte volume. Mitochondria also exhibit ordered structural 
specialisations such as spatial arrangement in rows between myofilaments such that a 
constant diffusion distance exists between mitochondria and the core of myofilaments. The 
energy balance in the heart is finely tuned – during maximal exercise the organ uses more 
than 90% of its oxidative capacity, demonstrating that there is no excess energy production 
capacity (Mootha et al., 1997).  
 
It is now known that the energy metabolism in cardiomyocytes from failing hearts show 
remodelling of energetic pathways whereby key enzymes and regulators in metabolic 
pathways such as the phosphotransferase reactions, the glycolytic pathway, the 
mitochondrial Krebs cycle and the electron transport chain itself have altered expression 
levels or are dysregulated (Ingwall, 2009). This results in progressive loss of cytosolic [ATP]. In 
the failing human myocardium and in hearts of animal models of severe failure, [ATP] is ∼30% 
lower than in normal myocardium (Neubauer, 2007). Key metabolic compounds such as AMP 
and Cr serve as energy sensors, and determine the metabolic remodelling that takes place 
often through changes in phosphorylation state among other chemical modifications of 
proteins for short term preservation of ATP (Dyck and Lopaschuk, 2006). In uncompensated 
hypertrophy and in other forms of heart failure, flux through the creatinine kinase (CK) 
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pathway and oxidation of fatty acids (which occurs in mitochondria) are both lower (Osorio et 
al., 2002; Stanley et al., 2005; Sorokina et al., 2007; O’Donnell et al., 2008) and glucose 
utilisation is not sufficient to compensate for overall decreases in the capacity for ATP supply 
leading to decreased ATP availability (Luptak et al., 2005; Neglia et al., 2007). 
 
In the early stages of heart failure, human studies have shown that fatty acid oxidation is 
largely intact or even slightly increased. However in the latter stages, there is a marked 
downregulation of the fatty acid oxidation pathways in mitochondria (Sack et al., 1996; Osorio 
et al., 2002; Lei et al., 2004). Importantly, inadequate intracellular oxygen availability does not 
seem to be a limiting factor of oxygen consumption (Gong et al., 2003) implicating peak O2 
utilization being limited by maximal oxidative ATP synthetic capacity or by the maximal 
capacities of the ATPases to utilize ATP. Failing hearts also show greater inefficiency in utilising 
oxygen for ATP generation in mitochondria; decreased ADP/O ratio has been observed that is 
reflected in a 14% decrease in efficiency of the failing hearts (Murray et al., 2008). Decreased 
activity of the respiratory chain and the Krebs cycle is correlated with reduced cardiac function 
in human and experimental studies of heart failure (Jarreta et al., 2000; Ning et al., 2000).  
 
The link between metabolic and mitochondrial insufficiency and heart failure is underscored 
by the fact that inborn errors of fatty acid metabolism (such as acyl-coA dehydrogenase 
deficiency) are associated with cardiomyopathy in humans. Targeted gene knockouts in 
mouse models recapitulates these findings giving further weight to a link between metabolic 
dysfunction and heart failure (Exil et al., 2003; Abdurrachim et al., 2015). We can therefore 
see that the exploration of mitochondrial function is key to examining its role in a wide range 
of linked pathologies.  
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1.6 CARDIAC ARRHYTHMIAS ARE ASSOCIATED WITH AGEING, METABOLIC 
DISEASE, CARDIAC FAILURE  
 
Just as ageing, metabolic disease and cardiac failure are each associated with mitochondrial 
dysfunction (see section 1.4) each of these disorders are in turn linked to cardiac arrhythmia. 
There is also a more indirect link between mitochondrial dysfunction itself and cardiac 
arrhythmias at the clinical and experimental level. Mitochondria from patients with chronic 
atrial fibrillation, the most common cardiac arrhythmia, show structural abnormalities, 
increased DNA damage and impaired function (Ad et al., 2005; Bukowska et al., 2008; Lin et 
al., 2003; Tsuboi et al., 2001; Valli et al., 2017a). Additionally, fatal ventricular arrhythmias are 
a feature of inherited mitochondrial disorders such as Kearns-Sayre syndrome (Kabunga et al., 
2015; Valli et al., 2017b). Both acute and chronic mitochondrial dysfunction promote cardiac 
arrhythmogenesis in animal models (see review (Akar and O'Rourke, 2011)). Acute, ischaemic-
reperfusion-induced mitochondrial impairment results in VF in guinea pigs which can be 
abolished by pharmacological manipulations of mitochondrial membrane potential (Akar et 
al., 2005; Brown et al., 2010; Valli et al., 2017b). Furthermore, in goat and dog models of AF, 
abnormal structure and function of mitochondria have been observed (Ausma et al., 1997; 
Morillo et al., 1995; Valli et al., 2017a). Thus, mitochondrial dysfunction is an interesting 
setting in which to study arrhythmogenesis. 
 
Second, growing clinical and epidemiological evidence links these conditions (ageing, 
metabolic dysfunction and heart failure) to cardiac arrhythmias (Kucharska-Newton et al., 
2010; Hookana et al., 2011; Yeung et al., 2012). This is reflected in the increasing trend in the 
incidence and prevalence of atrial fibrillation for which 60% of the increase has been 
attributable to metabolic factors. (Miyasaka et al., 2006; Valli et al., 2017b). Diabetes mellitus, 
obesity, physical inactivity, and metabolic syndrome have all been associated with increased 
risk of developing AF (Mozaffarian et al., 2008; Nichols et al., 2009; Tedrow et al., 2010; Valli 
et al., 2017b; Watanabe et al., 2008). Metabolic disorders also predispose to ventricular 
arrhythmias, which have been identified as a common presentation in patients with inherited 
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fatty acid oxidation disorders (Bonnet et al., 1999). In middle aged individuals who do not 
smoke, obesity increases the risk of SCD. An increased risk of SCD is also seen in diabetic 
patients compared to non-diabetic patients post myocardial infarction (Yeung et al., 2012).  
 
Ageing itself is also associated with an increased incidence of cardiac rhythm disturbances 
including both pathological bradycardic rhythms as well as atrial and ventricular tachy-
arrhythmias (Go et al., 2001; Deo and Albert, 2012; Bradshaw et al., 2014), though the 
underlying mechanisms remain unclear. Thus, the risk of cardiac rhythm abnormalities 
accumulates with age. Defects of the cardiac conduction system leading to heart block are 
known to be an age related disease process  (Lenegre, 1964; Lev, 1964). Incidences of atrial 
and fatal ventricular arrhythmias increase with age over time, with the prevalence of atrial 
fibrillation rising rapidly from around 4% of individuals aged 60 to 70 years of age to nearly 
20% of individuals aged over 80 (Zoni-Berisso et al., 2014). There is a similar age dependant 
risk of ventricular arrhythmias, with the annual incidence of sudden cardiac death 8 times 
higher in 75 year olds compared to people aged 50 years (Deo and Albert, 2012). Age 
dependant trends are also seen with inherited arrhythmic syndromes; the number of 
symptomatic patients with the Brugada syndrome increases dramatically with age (Gourraud 
et al., 2017), despite the defect being present since birth.  
 
Finally, the link between heart failure syndromes and fatal and non-fatal ventricular 
arrhythmias has long been established (Chakko et al., 1989) . These are an important cause of 
mortality in heart failure. In severe congestive heart failure, ventricular arrhythmias (including 
non-sustained VT) are observed in up to 85% of patients (Singh et al., 1997). The establishment 
of implantable cardioverter defibrillators (ICDs) as a proven heart failure therapy in both 
primary and secondary prevention (Investigators, 1997; Moss et al., 2002; Bardy et al., 2005) 
emphasises the close link between heart failure and fatal ventricular arrhythmias.   
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1.7 THE PGC SYSTEM AS A REGULATOR OF MITOCHONDRIAL FUNCTION 
 
We have seen how ageing, metabolic dysfunction and cardiac failure are each associated with 
mitochondrial dysfunction and how these three disorders are also associated with cardiac 
arrhythmias. Taken together these experimental and clinical findings converge upon a central 
role for mitochondrial dysfunction in cardiac arrhythmogenesis (Figure 1-6). 
 
Mitochondria have been implicated in modulating cytosolic Ca2+ in cardiomyocytes 
(Lukyanenko et al., 2009) and so it is plausible that mitochondrial dysfunction will alter spatial 
and temporal properties of calcium handling at the cellular level, leading to the necessary ion 
concentration changes for a pro arrhythmic phenotype. In addition, the development of an 
age related pro-arrhythmic electrophysiological phenotype in various models has also been 
linked to cellular changes in calcium handling (Hatch et al., 2011; Yang et al., 2015) such as a 
decrease in the amplitude of the systolic Ca2 + transient and in some cases a decrease in peak 
L-type Ca2 + current (Feridooni et al., 2015).  
 
 
Figure 1-6: The relationship of ageing, metabolic disease and cardiac failure with mitochondrial 
dysfunction and cardiac arrhythmia based on current evidence. The dashed line represents a link 
where the evidence is less substantial. 
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With ageing, the rate of sarco/endoplasmic reticulum Ca2 +-ATPase (SERCA)-mediated Ca2 + 
removal is reduced (Jiang et al., 1993) and the properties of SR Ca2 + release in terms of Ca2 + 
sparks are altered (Jiang et al., 1993). These changes are also correlated with reductions in the 
peak tension developed in cardiac tissue with advancing age, especially at higher heart rates 
(Lim et al., 1999) Other studies showed that the maximum rate of tension development 
(+ dT/dt) and maximum rate of relaxation (− dT/dt) are slowed with age (Jiang et al., 1993; Lim 
et al., 1999). 
 
Chronic mitochondrial dysfunction in cardiomyocytes would then be expected to lead to 
cumulative, age related changes, which may be evidenced by abnormal calcium handling. 
Studies of such dysfunction have been expedited through targeting the PGC system as this is 
known to act as a central mitochondrial regulator.  This has been permitted through the use 
of genetically modified murine models. The Pgc-1 gene family consists of three members: Pgc-
1α, Pgc-1β, and Pgc-1-related coactivator (PRC) (Villena, 2015). A recent review (Villena, 2015) 
describes the mechanism of action of PGC-1 coactivators in detail. The expression patterns of 
Pgc-1α and Pgc-1β are similar. Both show high expression levels in tissues with high energy 
requirements and mitochondrial content such as the heart, skeletal muscle, kidney and brown 
adipose tissue (BAT) (Villena, 2015).  
 
The PGC-1 proteins regulate mitochondrial mass, function and cellular metabolism, 
upregulating expression of nuclear and mitochondrial genes involved in fatty acid β–oxidation, 
the tricarboxylic acid cycle and electron transport (Arany et al., 2005) (Figure 1-7). In 
particular, PGC-1α and PGC-1β are highly expressed in oxidative tissues such as the heart, 
serving to co-ordinate mitochondrial activity with upstream cellular signals (Sonoda et al., 
2007). PGC-1 family members operate to match increased energy demands during prolonged 
stimuli such as exercise or fasting, to the expression levels of catabolic enzymes. This is 
achieved by an increase in the activity of transcription factors, which themselves are regulated 
by transcriptional coactivators, of which PGC-1 coactivators are a subset (Villena, 2015). PGC-
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1 coactivators thus link cellular energy stores with external stressors, matching mitochondrial 
activity with energy demands (Figure 1-8). 
 
Thus, PGC-1 forms a nexus for a range of metabolic pathways within the cardiomyocyte, 
central to the heart’s ability to meet energetic demands. Their expression is down-regulated 
in obesity, insulin resistance, heart failure and type II diabetes mellitus and is accompanied 
with an associated mitochondrial dysfunction (Dillon et al., 2012). Mice deficient in both Pgc-
1α and Pgc-1β develop a perinatal, lethal, low cardiac output state and conduction disease 
(Lai et al., 2008). In contrast, both Pgc-1α-/- and Pgc-1β-/- hearts show normal baseline function 
(Arany et al., 2005; Lelliott et al., 2006), with Pgc-1β-/- hearts displaying abnormal 
electrophysiological responses to adrenergic challenge. Together with its normal baseline 
contractile function these features make Pgc-1β-/- models attractive to investigating pro-
arrhythmic effects of chronic mitochondrial dysfunction. 
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Figure 1-7: Control of mitochondrial biogenesis by the PGC-1 signaling. 
Interaction between PGC-1 and specific transcription factors orchestrates the major functions of 
mitochondria, including fatty acid β-oxidation, the tricarboxylic acid cycle (TCA), mtDNA replication and 
oxidative phosphorylation, and the electron transport chain (OxPhos/ETC), in addition to biogenesis of 
this organelle. PPARα interacts with its binding partner, the retinoid X receptor (RXR), to control the 
expression of many fatty acid β-oxidation enzymes. NRF-1 and NRF-2 contribute to the maintenance of 
mtDNA and the expression of multiple components of the ETC. ERR members regulate the expression 
of virtually all functions of the mitochondria including those shown here. Adapted from (Scarpulla et 
al., 2012) 
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Figure 1-8: Integration of energy-generating and antioxidant pathways by PGC-1 signalling. 
PGC-1α is activated via post-transcriptional phosphorylation by AMPK or by deacetylation via SIRT1 in 
response to nutrient deprivation. Induction or activation of the coactivator can enhance mitochondrial 
biogenesis and oxidative function through the coactivation of multiple transcription factors involved in 
respiratory gene expression. PGC-1α activation may also promote an antioxidant environment by 
coactivating ERRα to induce SIRT3, a mitochondrial sirtuin that has been implicated in reactive oxygen 
species (ROS) detoxification. In addition, AMPK promotes autophagy through direct phosphorylation of 
ULK1 or via suppression of the TORC1 kinase complex. Inhibition of the TORC1 pathway also has been 
shown to have a negative effect on senescence. Increased autophagy, enhanced ROS detoxification, 
and inhibition of TORC1, are all associated with health and longevity. Under conditions of caloric excess, 
SRC-3 induces GCN5, which inactivates PGC-1α through acetylation. Adapted from (Scarpulla et al., 
2012) 
 
Despite their similar expression patterns, the functions of Pgc-1α and Pgc-1β differ. Pgc-1α 
appears to have a more dynamic function, as its expression is upregulated by physiological 
stimuli such as fasting, exercise and cold temperatures in the liver, skeletal muscle and BAT, 
respectively. Pgc-1β expression does not appear to be altered by these stimuli. Thus, it is 
assumed that Pgc-1α works to adapt tissues to conditions of high energy demand whereas the 
role of Pgc-1β relates mainly to the maintenance of basal mitochondrial function (Villena, 
2015). 
 
Both Pgc-1α-/- and Pgc-1β-/- mice demonstrate mitochondrial dysfunction. However, Pgc-1α-/- 
mice demonstrate further cardiac phenotypes including cardiac pump failure. Pgc-1β-/- mice 
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display an electrophysiological phenotype in the absence of pump failure, and are thus an 
attractive model for the study of arrhythmias in a setting of chronic mitochondrial dysfunction 
(Lelliott et al., 2006). This model has recently been introduced to study biochemical (Gurung 
et al., 2011; Lelliott et al., 2006) and electrophysiological (Ahmad et al., 2017b; Valli et al., 
2017a; Valli et al., 2017b) sequelae of chronic mitochondrial dysfunction and energetic 
deficiency.  
 
Pgc-1β-/- mice show mitochondrial dysfunction and accompanying energetic deficiency. They 
show a reduction in cardiac mitochondrial volume fraction, along with decreased expression 
of ETC genes (Lelliott et al., 2006). Pgc-1β-/- and wild-type (WT) heart mitochondria are 
similarly packed between myofibres, and there are no changes in density of mitochondrial 
cristae within mitochondria (Lelliott et al., 2006), suggesting that the internal mitochondrial 
structure is unchanged in Pgc-1β-/- hearts (Lelliott et al., 2006). This is a plausible explanation 
of why the knockout of Pgc-1β alone causes only minor effects on the function of cardiac 
mitochondria (Lelliott et al., 2006; Sonoda et al., 2007; Villena, 2015). Indeed, defects in 
mitochondrial function seen in Pgc-1β-/- mice are partly abrogated by up-regulation of Pgc-1α 
(Lelliott et al., 2006). 
 
Electrophysiological studies on Pgc-1β knockout in murine hearts have yet to be studied in 
detail. Resting heart rate and left ventricular contractility are similar between Pgc-1β-/- and 
WT but on dobutamine injection, the chronotropic response in Pgc-1β-/- mice is blunted 
compared to WT mice (Lelliott et al., 2006). Pgc-1β-/- mice also demonstrate increased cardiac 
arrhythmogenicity during in-vivo isoprenaline challenge or programmed electrical stimulation 
(PES) in Langendorff-perfused murine hearts (Gurung et al., 2011). However, the detailed 
electrophysiological phenotype of the Pgc-1β knockout mouse and how age impacts on its 
development has thus far not been studied. 
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1.8 OBJECTIVES OF THE THESIS 
 
The present project is directed at investigating the relationship between chronic energetic 
deficiency, ageing and cardiac arrhythmias in a murine model (Figure 1-9). The study will 
accordingly focus on Pgc-1β-/- mice as the adopted model, as it does not display cardiac pump 
failure unlike other mitochondrial lesions. The hypothesis is that while ageing, metabolic 
disease and cardiac failure are linked to both cardiac arrhythmias and mitochondrial 
dysfunction (see section 1.4 and section 1.5 respectively) mitochondrial dysfunction and 
cardiac arrhythmias are themselves intimately linked (Figure 1-9). The objective of the study 
is to demonstrate whether a primary mitochondrial lesion can lead to susceptibility to 
arrhythmia and if this susceptibility is age dependent. As arrhythmias are a tissue level/whole 
organ phenomenon, the experimental design preserves cellular and tissue level architecture 
as much as possible. The study will first characterize the electrocardiographic and tissue level 
electrophysiological features of Pgc-1β ablation and the effect of age on these.  This allows 
the study to explore the study question while preserving cellular and tissue and organ level 
architecture as much as possible. The focus on electrocardiographic characteristics in the first 
part of the study allows the determination of whether there are spontaneous ventricular 
arrhythmias or not and gives indications as to cellular level changes that may be found – these 
are then explored in the subsequent experiments included in the thesis.  
 
As well as the primary objective to determine if there are statistically more arrhythmias in the 
Pgc-1β-/- mice and whether this propensity to arrhythmia (if it exists) is age dependent, the 
study aims to explore a number of other secondary objectives. Importantly, the study aims to 
explore and characterize the electrophysiological instabilities that may be present in Pgc-1β 
ablated hearts through standard electrophysiological protocols employed widely in clinical 
practice and research and analyze whether they correspond to known arrhythmic theories. 
These include S1S2 and restitution studies that, importantly, utilize a technique that allows 
for intracellular recordings. This technique is used for the first time in the literature. This again 
permits interrogation of the system to see whether it is pro-arrhythmic, as well as analysis of 
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protocols that can help elucidate the underlying arrhythmic mechanisms. The novel micro-
electrode technique also permits additional measurements of membrane potentials and 
correlates of sodium channel density that give important indications of cellular level ion 
channel changes. These are then be explored in the final phase of the study with a loose patch 
clamping technique to assess ionic currents in an intact whole tissue preparation. This gives 
further corroborating evidence to the cellular electrophysiological changes elucidated 
previously. Together, the study engages the question of the electrophysiological 
characterization of mitochondrial deficiency at the whole organ, tissue and single cell level.  
 
 
  
 
 
Figure 1-9: Postulated relationship between metabolic disorders, age, mitochondrial  
dysfunction and cardiac arrhythmias. 
Age and metabolic disorders, themselves age-dependent, lead to mitochondrial dysfunction which 
in turn predisposes to arrhythmogenesis. In the present study, the experimental model used to 
investigate the effects of mitochondrial dysfunction on arrhythmogenesis was Pgc-1β knockout 
mice. 
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2. MATERIALS AND METHODS 
 
2.1 EXPERIMENTAL ANIMALS 
 
This research has been regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of Cambridge Animal 
Welfare and Ethical Review Body (AWERB). Age-matched homozygote Pgc-1β-/- and WT inbred 
C57/B6 mice were studied. Pgc-1β-/- mice were generated using a triple LoxP targeting vector 
as previously described (Lelliott et al., 2006). Heterozygous triple LoxP mice crossed with 
ROSA26-Cre mice generated heterozygous Pgc-1β-/- mice, which were further bred to 
generate homozygous Pgc-1β−/− mice. This body of work was completed prior to the initiation 
of the study (Gurung et al., 2011 a). Mice were bred on a C57/B6 background to avoid possible 
strain-related confounds. The young WT and young Pgc-1β-/- groups consisted of mice aged 
between 3-4 months; animals aged greater than 12 months were used for the aged WT and 
aged Pgc-1β-/- groups. Mice were housed in plastic cages maintained at 21 ± 1oC, subjected to 
12 hour dark/light cycles, and had unconstrained access to water, sterile rodent chow (RM3 
Maintenance Diet, SDS, Witham, Essex, UK), bedding and environmental stimuli. 
 
2.2 ECG STUDIES 
2.2.1 ELECTROCARDIOGRAPHY 
 
Mice were anaesthetised with tribromoethanol (avertin: 2,2,2 trimethylethanol, Sigma-
Aldrich, Poole UK) administered into the intra-peritoneal space with a 27G hypodermic 
needle. Young and aged, WT (n = 5 and 8) and Pgc-1β-/- (n = 9 and 6) animals were used. They 
were then weighed, placed supine on a warmed (37°C) platform, and their limbs secured with 
adhesive tape to minimise movement artefact and enable correct lead positioning. Three 2-
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mm diameter electrodes (MLA1204; ADInstruments, Colorado Springs, CO, USA) placed in the 
right forelimb, left forelimb and left hindlimb respectively enabled lead I and lead II ECG 
recordings. The electrodes were connected to a 4-channel NL844 pre-amplifier whose outputs 
were then led through 4-channel NL820 isolator and NL135 low-pass filter units (set at a 1.0-
kHz cut-off and with a 50-Hz notch) within a NL900D chassis and power supply (Neurolog-
Digitimer, Hertfordshire, UK). To reduce electrical noise, all recordings were carried out within 
a grounded Faraday cage. Signals were sampled at 5 kHz and analogue-to-digital conversion 
employed a CED 1401c interface (Cambridge Electronic Design, Cambridge, UK). This then 
conveyed the signal to a computer for display and recording using Spike II software 
(Cambridge Electronic Design).  
 
ECG recordings commenced immediately following electrode attachment in anaesthetised 
animals. These were continued for 5 minutes to permit preparations to reach a steady state, 
and for a further 5 min to obtain traces for quantitative analysis. Dobutamine hydrochloride, 
a β1 adrenoreceptor agonist used to stimulate cardiac adrenergic responses in clinical practice, 
was then administered into the intraperitoneal space (3 mg/kg; Sigma Aldrich, Poole UK). ECG 
recording was then continued until a new steady state was reached. A further 5 min recording 
period provided traces for quantitative ECG analysis following pharmacological challenge. 
2.2.2 DIGITAL SIGNAL PROCESSING 
 
All analysis employed custom-written software in the open-source R programming language. 
Data was imported into the R program. An infinite impulse response (IIR) high pass 
Butterworth filter of order 2 was designed and the signal passed through to eliminate baseline 
drift. The signal was filtered in both forward and reverse directions to negate effects of any 
phase shift. A low-pass Savitzky-Golay algorithm was then applied. R peak fiducial points were 
identified with a peak-finding algorithm used to detect QRS complexes. An iterative process 
determined the signal envelope and an adaptive threshold was used to identify time points in 
the signal that were greater than threshold in the continuous ECG signal. QRS complex timing 
positions were determined; peaks on a more substantive upward or downward trend were 
disregarded in favour of the peak with the larger absolute value. If multiple peaks were 
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detected within 2 ms the peaks were analysed again and the larger maximum value taken as 
the correct peak, and the smaller peak discarded. In addition, all detections were visually 
verified. P waves were analyzed independently of QRS complexes by deleting the QRS 
complexes and subsequent isolation of the P wave parameters. This analysis thus made no 
assumption of QRS complexes being preceded by P waves. Analysis was performed on 300 
second periods of ECG data immediately prior to and following administration of dobutamine 
hydrochloride. The effect of dobutamine was judged from observed ECG parameter changes. 
Figure 1-5A and Figure 3-1 depict typical murine ECG recordings with parameters calculated 
based upon this archetypal signal. Intervals were corrected for heart rate using the formula 
previously described (Mitchell et al., 1998). 
 
2.3 WHOLE HEART LANGENDORFF PREPARATIONS 
 
All chemical agents were purchased from Sigma-Aldrich (Poole, UK) except where otherwise 
indicated. Mice were first anticoagulated with 200 IU heparin sodium administered into the 
intra-peritoneal space with a 27G hypodermic needle. After a 10 min interval, mice were killed 
by cervical dislocation (Schedule 1: UK Animals (Scientific Procedures) Act (1986)), a 
sternotomy performed, and the hearts were rapidly excised and submerged in ice-cold KH 
solution. No recovery, anaesthetic or surgical procedures were required. 
 
The aorta was then cannulated with a modified 21G hypodermic needle, secured with a 5-0 
braided silk suture and retrogradely perfused with Krebs-Henseleit (KH) solution warmed to 
37oC by a water jacket heat-exchange coil (model C-85A, Techne, Cambridge, UK) at a constant 
rate of 2.05 ml min−1 by a peristaltic pump (MINIPULS3, Gilson, Luton, UK) through 200 μm 
and 5 μm Millipore filters (Millipore, Watford, UK). The KH buffer was made with NaCl (119 
mM), NaHCO3 (25 mM), KCl (4 mM), MgCl2 (1 mM), KH2PO4 (1.2 mM), CaCl2 (1.8 mM), glucose 
(10 mM) and sodium pyruvate (1.8 mM), bubbled with 95% O2/5% CO2 (British Oxygen 
Company, Manchester, UK) to achieve a pH of 7.4 preventing CaCO3 precipitation and 
matching the 7.3–7.4 pH of mouse plasma. Following commencement of perfusion, 
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preparations were only further studied if they demonstrated sustained intrinsic activity with 
a basic cycle length (BCL) <200 ms and 1:1 atrioventricular conduction (AV) for 10 minutes. 
Hearts meeting these criteria were then perfused with 150 ml KH solution containing 20 µM 
blebbistatin after which perfusion with plain KH solution continued through to the conclusion 
of the experiment. The blebbistatin (20 µM, Selleckchem, Houston, USA) was used to 
electromechanically uncouple the heart during the microelectrode studies and permit stable 
cardiomyocyte impalement (Fedorov et al., 2007). 
2.3.1 ELECTROPHYSIOLOGICAL RECORDINGS 
 
Simultaneous microelectrode and electrocardiograph (ECG) studies were performed in a 
Faraday cage incorporating a modified horizontal Langendorff perfusion system, a light 
microscope (objective ×5, eyepiece ×5, W. Watson and Sons Limited, London, UK), custom-
built head stage and a warmed tissue holding chamber. All equipment was electrically 
isolated. The stimulating and recording electrodes were positioned relative to the heart using 
two precision micromanipulators (Prior Scientific Instruments, Cambs, UK).  Hearts were 
paced using a bipolar platinum-coated stimulating electrode (NuMed, New York, USA) 
positioned against the lateral surface of the right ventricle, connected to a DS2A-Mk.II 
stimulator (Digitimer, Welwyn Garden City, Herts., UK) delivering a voltage that was twice the 
diastolic excitation threshold plus 0.5 mV. 
 
Whole heart volume conducted ECGs were recorded simultaneously with intracellular 
recordings to distinguish between local cellular and generalised organ level events. Two 
unipolar ECG leads were immersed into the warmed bath and placed adjacent to the right and 
left ventricles. Signals were amplified using model NL104A amplifiers (NeuroLog; Digitimer, 
Hertfordshire, UK), filtered with model NL125/126 filters, set to a bandwidth of 5 – 500 Hz, 
and the analogue signal digitised using a model 1401 interface (Cambridge Electronic Design). 
Sharp microelectrodes for intracellular recordings were drawn from borosilicate glass pipettes 
(OD 1.2 mm, ID 0.69 mm, Harvard Apparatus, Cambridge, UK) using a homebuilt 
microelectrode puller, and filled with 3 M KCl (tip resistance 15 – 25 MΩ). The microelectrode 
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was mounted onto a right-angled microelectrode holder containing a Ag/AgCl tip and 
connected to a high-input impedance direct-current microelectrode amplifier system 
(University of Cambridge, Cambridge, UK). Measurements of intracellular voltage were made 
relative to that of the Ag/AgCl reference electrode. An impalement was accepted for further 
recording if it resulted in an abrupt appearance of a resting membrane potential (RMP) 
between -65 mV and -90 mV, with APs that were normal in waveform and had an amplitude 
>75 mV. Impalements were restricted to the proximal left ventricle to avoid confounds of 
regional differences in AP characteristics. Hearts were first studied under conditions of regular 
pacing at a frequency of 8 Hz.  
2.3.2 PACING PROTOCOLS 
 
Hearts were stimulated at two times the threshold voltage plus 0.5 mV. Hearts underwent 
two pacing protocols. The electrophysiological properties of the whole heart langendorff 
preparation were interrogated using a number of different protocols. The S1S2 protocol is a 
programmed electrical stimulation (PES) protocol consisting of drive trains of eight paced (S1) 
beats at a BCL of 125 ms followed by a single extra stimulus (S2) every ninth beat. The initial 
S1-S2 coupling interval was 89 ms, reducing by 1 ms every subsequent cycle. The protocol was 
terminated when the ventricular effective refractory period (ERP) was reached, defined as the 
final S1-S2 coupling interval at which the S2 stimulus successfully triggered an AP, or sustained 
arrhythmia was observed. Incremental pacing protocols began at a 130 ms basic cycle length 
(BCL) before being decremented by 5 ms for each subsequent cycle of 100 stimulations. This 
cycle was repeated until the heart showed entry into 2:1 block or arrhythmia.  
 
2.4 QUANTIFICATION OF AP PARAMETERS AND ARRHYTHMIC INCIDENCE 
 
AP amplitude was measured from the RMP to the peak voltage attained. The time from AP 
peak to repolarisation to 90% of baseline was taken as the action potential duration (APD90). 
AP latencies were measured as the time intervening between the stimulus delivery and the 
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AP peak. The maximum rate of depolarisation (dV/dt)max was obtained from the first 
differential of the intracellular AP waveform.  The incidence of abnormal rhythms was 
quantified from the PES protocol as follows: an isolated non-triggered AP following an S2 beat 
was termed an ectopic beat, and two successive non-triggered beats were termed a couplet. 
Episodes of ventricular tachycardia were categorised as non-sustained ventricular tachycardia 
(NSVT) if the episode consisted of ≥3 consecutive non-triggered beats but lasting <30 s; 
episodes lasting for >30 s were categorised as sustained VT. 
 
2.5 QUANTIFICATION OF CARDIAC FIBROSIS 
 
The degree of fibrotic change was assessed as previously described (Jeevaratnam et al., 2011). 
Briefly, following cardiectomy hearts were flushed with KH buffer, then perfused with 4% 
buffered formalin for 5 minutes, followed by storage in formalin overnight. After fixation, 
gross transverse sections of 7 µm thickness were cut and subjected to routine tissue 
processing, paraffin embedding and staining with picrosirius red. Sections were subsequently 
viewed, magnified and images digitally acquired using the Nano Zoomer 2.0 Digital Pathology 
system (Hamamatsu, Hertfordshire, UK). For quantification of fibrosis, a custom made 17 cm 
× 30 cm morphometric grid was superimposed on each photomicrograph, and each 
corresponding 0.2 mm × 0.2 mm area of tissue within the grid was assessed first for the 
presence or absence of cardiac tissue, and then for presence of fibrosis.  The degree of fibrosis 
was expressed as the proportion of squares containing cardiac tissue that displayed evidence 
of fibrosis. The assessment was conducted independently by two investigators who were 
blinded to the animal identification, and their results were assessed for consistency by 
applying an inter-class correlation coefficient analysis (ICC), which can be interpreted as 
follows: 0 – 0.2 indicates poor agreement; 0.3 – 0.4 indicates fair agreement; 0.5 – 0.6 
indicates moderate agreement; 0.7 – 0.8 indicates strong agreement; and >0.8 indicates 
almost perfect agreement. 
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2.6 LOOSE PATCH CLAMP EXPERIMENTS 
2.6.1 VENTRICULAR PREPARATIONS 
Hearts were excised and mounted on the Langendorff perfusion system as described 
previously. Hearts were then perfused with 75 ml of a KH solution to which 10 mM 2,3-
butanedione monoxime (BDM) and 10 μM blebbistatin (Cayman Chemical Company, Ann 
Arbor, Michigan, USA) were added to give a KH-BDM/blebbistatin solution to achieve 
electromechanical uncoupling. The heart was then immediately placed in ice-cold KH-
BDM/blebbistatin solution for dissection of the right ventricle from the rest of the heart. The 
right ventricle was then mounted on Sylgard (Dow Chemical Company, Staines, UK) and placed 
in a temperature monitored experimental chamber filled with filtered KH buffer solution at 
27 oC.  
2.6.2 PIPETTE MANUFACTURE  
 
Pipettes, pulled from borosilicate glass capillaries (GC150-10 Harvard Apparatus, Cambourne, 
Cambridge, UK) using a Brown-Flaming microelectrode puller (model P-97, Sutter Instrument 
Co. Novato, CA, USA) were mounted under a microscope with 250× magnification and a 
calibrated eyepiece graticule for fracturing using a diamond knife. This applied a transverse 
force to the distal tip of the pipette, giving a fracture perpendicular to the pipette shaft. 
Selected pipettes were then fire-polished under visual guidance at 400× magnification using 
an electrically heated nichrome filament. Finally the pipette tips were bent so they made a 
~45o angle with the pipette shaft. When mounted at an angle on the recording amplifier 
headstage they could then be made to approach the membrane vertically. Maximum internal 
pipette tip diameters, measured at 1000× magnification, were 28-32 µm following polishing.   
2.6.2 LOOSE PATCH CLAMP RECORDINGS  
 
The distal ends of the pipette were filled with KH solution, and then mounted onto a pipette 
holder incorporating an Ag/AgCl half-cell connected to the headstage. This lowered the 
pipette onto the membrane surface. Gentle suction was then applied through an air-filled line 
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connecting the pipette holder and a syringe. This resulted in seal formation with a membrane 
patch. Figure 6-1 illustrates (A) the recording layout and (B) the equivalent circuit resulting 
from apposing the loose patch clamp electrode to the membrane surface. Voltage-clamp steps 
were applied under computer control. Owing to its relatively low seal resistances, the loose 
patch clamp results in larger leakage currents compared to those associated with conventional 
patch clamping. Most of the leakage current, series resistance errors and displacement 
currents through the pipette capacitance were compensated for using a custom-built 
amplifier (Stühmer et al., 1983). Residual leakage and capacitative currents were then 
corrected by using reference records obtained from subsequent P/4 control protocols that 
applied voltage steps with amplitudes scaled down by a factor of 4 in a direction opposite to 
those of the test steps as previously described (Almers et al., 1983 a;  b). Each established 
patch was then subject to a complete set of pulse procedures examining either inward or 
outward current activation, which could be accomplished within 30 s making effects arising 
from prolonged changes in the patch such as bleb formation unlikely (Milton and Caldwell, 
1990).  
 
The loose patch clamp controls the voltage at the extracellular surface of the membrane 
within the seal in an intact cardiomyocyte. Accordingly, positive and negative voltage steps 
applied through the pipette respectively hyperpolarise and depolarise the membrane 
potential relative to the cardiomyocyte resting membrane potential (RMP). Voltage steps are 
therefore described in terms of the alterations they produce relative to the RMP, following 
the convention in earlier studies that introduced this technique (Almers et al., 1983 a;  b).  
Current-voltage curves display current densities (pA/μm2)  obtained by normalizing the 
observed currents (nA) to the cross sectional area (πa2) of the pipette tip, radius a. Inactivation 
curves plotted maximum current densities normalized to the maximum current densities 
obtained at the most polarised holding potentials. Curve-fitting was performed using the open 
source R programming language. 
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2.7 STATISTICAL ANALYSIS 
2.7.1 ECG DATA 
 
Statistical analysis used the R programming language. Data sets were first tested for normality 
with the Shapiro-Wilk test before statistical analysis using two way factorial multivariate 
analysis of variance, i.e. MANOVA with Pillai trace. The data sets analysed were the steady 
state heart rates, P wave durations, PR intervals, activation parameters of QR, QS and QR’ 
durations, recovery parameters of RTc, R'Tc and STc durations, as well as the QTc interval. Each 
of these were measured from ECG records of young and aged, WT and Pgc-1β-/- mice 
respectively, both before and following dobutamine challenge. The initial MANOVA tests 
examined each parameter for significant effects of age, genotype or interactive effects of age 
and genotype either prior to or following dobutamine challenge.  Where MANOVA testing 
indicated existence of significant differences prior to dobutamine administration, further 
ANOVA analyses were conducted on pre-drug parameters testing for effects of genotype, age 
of interacting effects of the two. The presence of significant effects then prompted pairwise 
Tukey honest significant difference testing of differences between pairs of individual 
parameters.  Similarly, where significant differences were indicated post-dobutamine, a 
similar procedure of significance testing was performed examining for significant effects post 
drug challenge. Peak heart rates that were obtained following dobutamine challenge, were 
analysed by a two way factorial ANOVA: there was no meaningful peak heart rate pre-
dobutamine. These were then also followed by post hoc Tukey tests for differences between 
individual parameters if prompted by the significance levels. An ANCOVA analysis was also 
performed for correlation of heart rates pre and post dobutamine administration. 
 
A p < 0.05 following Bonferroni correction where appropriate was considered to indicate a 
significant difference. Murine ECGs which demonstrated P wave dissociation in the analysis 
period were discarded for P wave dependent parameter analysis. All diagrams were produced 
with the R-grammar of graphics package. 
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2.7.2 ANALYSIS OF ACTION POTENTIAL DATA  
 
Measures of arrhythmia duration included the number of beats during an episode of non-
sustained (NSVT) or sustained ventricular tachycardia (VT), and the duration in seconds of the 
respective episode. Alternans was defined as beat to beat changes in the value of a parameter 
such that the direction of the change oscillates for at least ten successive action potentials. 
 
The data was analysed with a custom-written programme using the python programming 
language and all statistical analysis performed in the R programming language (R Core Team, 
2015). Data are expressed as means ± standard errors of the mean (SEM). Differences 
between experimental groups in AP parameters and degrees of fibrosis were compared using 
a two-way analysis of variance (ANOVA) testing for significant effects of genotype, ageing, and 
an interaction between the two. Where the F-ratio yielded a significant result, post-hoc Tukey 
honesty significant difference testing was performed. ANCOVA analysis was used to model the 
effect of genotype on heart rate while controlling for co-variate effects of pre-drug heart rates. 
Analysis of the S2 AP parameter curves was confirmed with a linear mixed effects analysis of 
the relationship using R (R Core Team, 2012) and lme4 (Bates et al., 2015). Categorical 
variables describing the incidence of arrhythmia were compared using a chi-squared test. 
 
Both were analysed with a multivariate negative binomial regression model. Risk factors and 
confounders were included in the multivariate analysis based on the regression analysis of 
each variable individually. Each variable could only be added to the multivariate model if it 
showed a significant effect in the simple univariate analysis. In all cases a p < 0.05 was taken 
to be significant, with application of Bonferroni correction where appropriate. 
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2.7.2 ANALYSIS OF LOOSE PATCH CLAMP DATA  
 
Statistical analysis of results applied two-way analysis of variance (ANOVA) to the 
experimental groups of young and aged, WT and Pgc-1β−/− preparations to test for significant 
differences arising from independent or interacting effects of age and/or genotype on fitted 
parameters. The presence of such differences was then explored by pairwise tests for 
differences using Tukey’s honestly significant difference testing.  
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3. AGE DEPENDENT ELECTROCARDIOGRAPHIC CHANGES IN 
Pgc-1β DEFICIENT MURINE HEARTS 
 
3.1 INTRODUCTION 
Murine electrocardiography (ECG) and analysis of ECG waveforms have proven useful in 
investigating electrophysiological changes associated with cardiac disease (Goldbarg et al., 
1968). Murine ECGs differ in their sinus rates and action potential waveforms (Figure 1-4, 
Figure 1-5 and Figure 3-1) (Danik et al., 2002; Boukens et al., 2014) as compared to human 
ECGs, but nevertheless can be used to clarify alterations in heart rate, its variability, and 
timings in the cardiac excitation sequence. Thus, their P waves, and PR, QRS and QT intervals, 
continue to reflect atrial and ventricular, depolarisation and repolarisation whose alterations 
could reflect potentially pro-arrhythmic electrophysiological changes. Alterations in murine 
ECG waveforms have thus proven useful in studying murine models for the Brugada syndrome 
(Jeevaratnam et al., 2010; Martin et al., 2010), long QT syndrome type 3 (Wu et al., 2012) and 
catecholaminergic polymorphic ventricular tachycardia (Zhang et al., 2011). 
 
The present study investigates ECG changes associated with the energetic dysfunction 
occurring with Pgc-1β ablation. As the underlying chronic mitochondrial lesions likely exert 
cumulative phenotypic effects with advancing age, we studied both young and aged, WT and 
genetically modified animals both at baseline and following adrenergic stress. This provided 
additional insights into possible interactions between genotype and ageing. 
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3.2 RESULTS 
 
There were no significant differences in weights between different experimental groups, 
whether stratified by age or genotype. Aged Pgc-1β-/- mice had a mean weight of 35.49 ± 1.44 
g compared to 35.57 ± 1.13 g for aged wild type (WT) mice. Young Pgc-1β-/- and WT mice had 
mean weights of 31.30 ± 1.56 g and 35.31 ± 2.26 g respectively. The complete ECG records 
confirmed sinus rhythm as the predominant rhythm (Figure 3-2A) with ECG complexes 
including clearly identifiable deflections as reported on earlier occasions (Mitchell et al., 1998) 
(Figure 3-1).  Two mice, both aged Pgc-1β-/-, showed multiple ectopic beats (Figure 3-2B) 
(Table 3-1). ST segment depression, defined in mice as the segment of the ECG signal 
representing ventricular repolarisation (Figure 1-5-A) having values abnormally depressed 
below the isoelectric baseline, was also analysed for. This initial analysis confirmed that ST 
segment changes that might signal acute ischaemic change never occurred prior to  
dobutamine challenge.  
   
 
 
 
 
 
 
 
 
 
 
Typical ECG and definition 
of deflections used in 
quantitative analysis (A) 
start of P-wave; (B) End of 
P-wave; (C) Q wave/start of 
QRS complex; (D) R wave 
peak; (E) S wave; (F) peak of 
R' deflection; (G) C wave; 
(H) End of C wave. The 
corrected QT interval, QTc is 
taken as the interval from C 
to H and corrected for RR 
intervals (Mitchell et al., 
1998) 
Figure 3-1: The murine 
ECG. 
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ST segment depression occurred in a small number of both WT and Pgc-1β-/- aged mice 
following such challenge (Figure 3-1D and 3-1E). 
 
Table 3-1: Incidence of particular electrocardiographic features in the 
experimental groups. 
 WT Pgc-1β-/- 
 Young Aged Young Aged  
(A) Ischaemic change 
    
Ischaemic changes present 0 2 0 2 
Ischaemic changes absent 5 6 9 4 
     
(B) Arrhythmic ECG patterns 
    
Sinus Rhythm only 5 4 8 3 
Isorhythmic AV 
dissociation 
0 4 1 3 
Ectopic beats 0 0 0 1 
Electrocardiographic records obtained at baseline prior to pharmacological intervention in young WT (n = 5), aged 
WT (n = 8), young Pgc-1β-/-  (n = 9) and aged Pgc-1β-/- (n = 6) 
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3.2.1 PGC-1Β-/- HEARTS DISPLAY IMPAIRED HEART RATE RESPONSES 
 
Chronotropic incompetence is an established clinical feature of cardiac failure, although it can 
also occur in association with other cardiac pathology. It has been variably defined, but is 
commonly identified as a failure to reach an arbitrary percentage of the predicted maximum 
heart rate following sympathetic challenge, ranging from 70 – 85 % (Brubaker and Kitzman, 
2011). A previous study had reported an impaired chronotropic response in isolated ex-vivo 
Pgc-1β-/- hearts challenged with dobutamine. These findings had not been statistically 
significant at a 10 ng/kg/min infusion rate and depended on single heart rate recordings at 
each, predefined, time point (Lelliott et al., 2006). The present experiments systematically 
analysed steady-state parameters over 5-min recording periods before and following 
dobutamine challenge in intact animals. 
 
Figure 3-3 shows typical heart rate profiles at baseline and in response to dobutamine for each 
experimental group. As there is no algorithm predicting normal murine heart rates at different 
ages as there is with humans, we assessed the chronotropic responses to dobutamine 
challenge using two different parameters: (1) peak heart rate attained after dobutamine 
administration and (2) mean heart rate observed post dobutamine administration. Figure 3-4 
plots mean heart rates observed before dobutamine challenge against results obtained 
following dobutamine challenge for each individual animal. Pgc-1β-/- animals displayed a 
tendency to slower basal heart rates under both conditions. A Pearson product-moment 
correlation coefficient assessing the co-variance between mean heart rates before and 
following dobutamine challenge demonstrated a positive association between variables, 
(r=0.692, p < 0.0001). Lower resting heart rates thus correlated with lower heart rates after 
dobutamine challenge. Further ANCOVA analysis yielded a significant association of the heart 
rate after dobutamine challenge with both the pre-dobutamine heart rate (F = 33.4, p < 0.01) 
and with the experimental group the animal came from, (F = 4.34, p = 0.016), suggesting that 
the relationship of heart rate to dobutamine exposure is significantly affected by genotype, 
with Pgc-1β-/- mice have lower heart rates than their WT counterparts. However there were 
Age dependent electrocardiographic changes in Pgc-1β deficient murine hearts 
 
58 
 
no significant interacting effects of experimental group with the pre-dobutamine heart rate 
(p = 0.36). 
 
 
 
 
 
 
 
Figure 3-3: Heart rate response to dobutamine challenge. Traces plotting heart rate response curves 
before and following dobutamine challenge in a (A) young WT, (B) aged WT; (C) young Pgc-1β−/− and 
(D) aged Pgc-1β−/− mouse 
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Figure 3-4: Correlations between heart rates observed pre- vs post-dobutamine challenge in Pgc-1β−/− 
and WT hearts. Young WT (n = 5), aged WT (n = 8), young Pgc-1β-/-  (n = 9) and aged Pgc-1β-/- (n = 6) 
 
MANOVA demonstrated significant effects of genotype (p = 0.022) and age (p = 0.048) on 
steady state heart rates. Post hoc Tukey tests demonstrated that genotype and age neither 
exerted independent nor interacting effects upon baseline steady state heart rates. In 
contrast, genotype exerted independent effects, with the Pgc-1β-/- mutation reducing heart 
rates observed following dobutamine challenge (Pgc-1β-/- 8.30 ± 0.28 Hz, n=15; WT: 9.11 ± 
0.11 Hz, n = 13; p = 0.021) (Figure 3-5). In contrast, there were no significant effects of either 
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age or interactions between age and genotype. Similarly, ANOVA demonstrated independent 
significant effects of genotype (p = 0.011) but no significant effects of age or interactive effects 
between genotype and age on maximum heart rates attained after dobutamine challenge. 
Thus, post-hoc tests demonstrated lower peak heart rates in Pgc-1β-/- than WT mice (mean 
peak heart rate 8.47 ± 0.28 vs 9.53 ± 0.21 Hz, p = 0.0084, n = 13 vs 15 respectively).  
 
 
Figure 3-5: Mean steady state heart rates in the 5 minute analysis window before and after 
dobutamine administration in WT (n = 13) and Pgc-1β−/− mice (n = 15). Asterix denotes a significant 
difference between the groups with ANOVA testing, p = 0.021. 
 
Heart rate variabilities, reflecting autonomic influences on the heart, are known to be related 
to adverse mortality risk, were expectedly altered within each experimental group following 
dobutamine challenge. However, the respective findings obtained before or following 
dobutamine did not vary between experimental groups. This was reflected in Poincare plots 
constructed for each mouse (Fig. 3-6A, B), exemplified in pre- (A) and post-dobutamine (B), 
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young (a,b) and aged (c,d), WT (a,c) and Pgc-1β-/- mice (b,d). The dispersion of these points 
was quantified by the standard deviation of the ΔRR interval before (Fig. 3-6C) and following 
dobutamine challenge (Fig. 3-6D). 
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ANOVA demonstrated no significant differences in such dispersions before or after 
dobutamine addition between different experimental groups. These results attribute the 
present findings to the existence of a sino-atrial node (SAN) defect as opposed to autonomic 
dysfunction in Pgc-1β-/- mice. 
3.2.3 AGE-RELATED SA NODE DISEASE IN WT AND PGC-1Β-/- MURINE HEARTS 
 
Although sinus rhythm was the prevailing rhythm in all groups, both WT and Pgc-1β-/- mice 
demonstrated intermittent episodes of isorhythmic AV dissociation (Massumi and Ali, 1970) 
during the recording period. Isorhythmic AV dissociation is defined by a cardiac rhythm in 
which there is no fixed association between the P waves and the ventricular complex though 
each still occurs in a 1:1 ratio. These episodes predominantly occurred in aged animals, 
affecting 3/6 aged WT mice and 4/8 aged Pgc-1β-/-  mice, but in only one young Pgc-1β-/-  and 
none of the young WT mice (Table 3-1). They most frequently occurred immediately following 
dobutamine challenge, whilst RR intervals were decreasing from their baseline, pre-treatment 
values.  During these episodes, RR intervals were shorter than their corresponding PP 
intervals, but the ventricular complexes remained identical to those observed during sinus 
rhythm. The latter suggests a supraventricular (likely junctional) pacemaker focus driving such 
activity (Figure 3-2C). 
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3.2.4 PGC-1Β-/- HEARTS DISPLAY PARADOXICAL ATRIOVENTRICULAR NODE FUNCTION 
 
MANOVA analysis indicated that P-wave durations were not affected by either independent 
or interacting effects of age or genotype, whether before or following dobutamine challenge 
(Fig 3-2A). In contrast, two alteration patterns of altered PR interval reflecting atrioventricular 
node (AVN) function were observed with dobutamine administration. These took the form of 
either positive or negative dromotropic effects of dobutamine appearing as increases or 
decreases in PR interval (Figure 3-6C; Figure 3-8),  
 
 
reflecting paradoxical 
AV dysfunction before 
and following 
dobutamine challenge 
in (A) young WT and (B) 
aged Pgc-1β−/− mouse 
Figure 3-8: PR intervals 
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taking place despite unchanged P-wave durations that were similar between experimental 
groups suggesting a continued normal atrial conduction  (Figure 3-6A).  
 
MANOVA indicated that neither age nor genotype affected PR interval whether before or 
following dobutamine challenge (Figure 3-6B). Nevertheless, the alteration in PR interval 
following dobutamine challenge demonstrated differing responses from WT and Pgc-1β−/− 
mice. All young (5 of 5) and aged (6 of 6) WT mice showed decreased PR intervals following 
dobutamine challenge. In contrast, the PR interval decreased in 5 of 9 and increased in the 
remaining four young Pgc-1β−/− mice. In aged Pgc-1β−/− mice the result was even more marked 
with only one mouse showing the expected positive dromotropic effect with dobutamine 
administration and 5 of 6 mice showing a paradoxical negative dromotropic effect in response 
to dobutamine. In addition to the SAN dysfunction seen with the Pgc-1β knockout there was 
compromised AVN conduction in a subset of mutant hearts, an effect exacerbated by 
increasing age. 
 
The presence of AVN dysfunction in mutant mice which also demonstrated impaired heart 
rate responses led us to examine whether paradoxical AV node dysfunction underlies or is 
associated with the blunted chronotropic responses. Such a comparison demonstrated that 
Pgc-1β-/- animals with a normal AVN response showed a mean heart rate of 9.10 ± 0.22 Hz (n 
= 6) following dobutamine challenge. In contrast, Pgc-1β-/- animals with a paradoxical AVN 
response to dobutamine showed a heart rate of 7.77 ± 0.34 Hz (n = 9). A two-tailed student t 
test confirmed that the difference was significant (p = 0.0061). Thus these findings suggest 
that the Pgc-1β-/- mutation is associated only with significantly altered AV nodal function in a 
subset of mutant mice, and that the presence of AV nodal dysfunction itself may be a marker 
for impaired heart rate responses. 
3.2.5 AGED PGC-1Β-/- HEARTS DISPLAY SLOWED VENTRICULAR ACTIVATION 
 
Ventricular activation is a synchronised, sequential process, whose onset is easily detected as 
the beginning of the Q wave deflection (Figure 3-1). Ventricular recovery is considered to 
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begin at a timepoint between the S wave trough, and the beginning of the R’ peak. 
Examination of three independent ECG indicators, of QR, QS and QR’ durations, of ventricular 
activation, suggested interacting effects of age and genotype upon its duration (Figure 3-9).  
 
MANOVA demonstrated that genotype and age, whilst not exerting independent effects, 
showed interacting effects upon all the three parameters of QR (p = 0.032), QS (p = 0.040) and 
QR’ duration (p = 0.039). This was also the case with QR, QS, but not QR’ (QR: p = 0.029; QS: 
p = 0.029; QR’: p = 0.086) prior to dobutamine challenge and with all three parameters 
following (QR: p = 0.016; QS: p = 0.022; QR’: p = 0.026) dobutamine challenge. Post hoc Tukey 
tests then demonstrated that prior to dobutamine administration, QR durations were longer 
in aged Pgc-1β-/- than aged WT (p = 0.030), with indications of such differences in aged 
compared to young Pgc-1β-/- mice (p = 0.059). QS intervals were longer in aged Pgc-1β-/- than 
either young Pgc-1β-/- (p = 0.040) or aged WT mice (p = 0.024). Following dobutamine 
administration, QR durations were longer in aged Pgc-1β-/- than either aged WT (p = 0.035) or 
young Pgc-1β-/- (p = 0.030). QS durations were longer in aged Pgc-1β-/- than either young Pgc-
1β-/- (p = 0.035) or aged WT mice (p = 0.026). QR’ durations were longer in aged Pgc-1β-/- mice 
than either aged WT (p = 0.039) or young Pgc-1β-/- mice (p = 0.017).  
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3.2.6 PGC-1Β-/- HEARTS SHOW SHORTENED VENTRICULAR RECOVERY TIMES AFTER 
ADRENERGIC CHALLENGE 
 
Age and genotype exerted contrasting effects on ventricular recovery times. Genotype 
affected all three measures of recovery (RTc, R'Tc and STc durations; p = 0.0098, p = 0.0014 and 
p = 0.0029 respectively) (Figure 3-10). In contrast, age did not significantly affect any of these 
recovery parameters, nor were there any interactive effects of age and genotype. Post hoc 
testing showed that (for all parameters) the difference lay in findings obtained post 
dobutamine challenge; there were no differences due to age, genotype or their interaction 
prior to dobutamine administration. Following dobutamine administration all three 
parameters showed a marked effect of genotype (p = 0.015, p = 0.021 and p = 0.0067 
respectively) but no other effects. Post hoc Tukey tests showed that Pgc-1β-/- showed 
significantly shorter RTc, R’Tc and STc intervals than WT mice (p = 0.0053, p = 0.018 and p = 
0.0080 respectively). Thus, all three recovery parameters were highly concordant confirming 
that the Pgc-1β ablation significantly shortened ventricular recovery parameters (Figure 3-10). 
3.2.7 EMERGENCE OF A SHORT-QT PHENOTYPE IN PGC-1Β-/- ANIMALS 
 
The QTc interval (QT interval corrected for RR interval) has traditionally been used as a marker 
for repolarisation abnormalities in that the electrocardiographic phenotype is usually caused 
by a defect in ventricular recovery. However, it is more accurate to describe the QTc interval 
as a parameter that describes the combined durations of both activation and recovery i.e. the 
duration of ventricular excitation. The onset of ventricular activation is represented by the Q 
wave deflection; the C wave trough was taken to represent the end of ventricular recovery 
and hence used for calculation of the QT interval in the present study (Figure 3-1). Genotype, 
but neither age (p= 0.083) nor interactions between age and genotype (p = 0.075), significantly 
affected QTc interval (p = 0.0071) (Figure 3-11). ANOVA indicated no differences between 
groups at baseline. Following dobutamine challenge, genotype (p = 0.032), but not age 
affected QTc interval. Post hoc Tukey HSD tests revealed that, following dobutamine 
Age dependent electrocardiographic changes in Pgc-1β deficient murine hearts 
 
70 
 
administration, young Pgc-1β-/- had shorter QTc intervals than both young WT (p = 0.026) and 
aged WT mice (p = 0.041). There was also a trend towards young Pgc-1β-/- mice having shorter 
QTc intervals than aged Pgc-1β-/- mice (p = 0.094). Thus, Pgc-1β-/- mice had shorter QTc 
intervals than their WT counterparts with most of the effect arising from shortening of the 
QTc intervals in young Pgc-1β -/- mice. 
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Electrographic measurements made of QTc durations before and following dobutamine challenge in 
young WT (n = 5), aged WT (n = 8), young Pgc-1β-/- (n = 8) and aged Pgc-1β-/- (n = 5) mice. One young  
and one aged Pgc-1β-/- mouse were excluded as these showed paradoxical dromotropic effects that 
lead to prolonged PR intervals and P waves that interfered with determinations of the end ventricular 
recovery to give the following n values stated.  The asterix denotes a significant difference (p < 0.05) 
between young Pgc-1β-/- post dobutamine and young and aged WT mice in post hoc tukey HSD 
analysis. Please see text for detailed statistical breakdown.  
Figure 3-11: Electrocardiographic measurement of QTc durations 
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3.3 DISCUSSION 
 
The ECG yields much prescient and strategic clinical electrophysiological information as a 
primary investigational tool. Its experimental application has demonstrated valuable insights 
into electrophysiological abnormalities in murine hearts modelling clinical arrhythmic 
conditions. Cellular energetic dysfunction following metabolic disturbances is increasingly 
recognised as an important factor in the aetiology of such atrial and ventricular arrhythmias. 
Destabilisation of inner mitochondrial membrane potentials results in approximately 10-fold 
increases in reactive oxygen species production (Liu et al., 2010 a), in turn affecting maximum 
Na+ (Liu et al., 2010 a) and K+ current (Wang et al., 2004), sarcolemmal KATP channel function, 
Na+ and L-type Ca2+ channel inactivation kinetics and late Na+ current. They also affect 
ryanodine receptor function which in turn affects surface membrane excitability and 
intracellular Ca2+ homeostasis (Terentyev et al., 2008; Brown and O’Rourke, 2010; Bovo et al., 
2012). Mitochondria are also the main cardiomyocyte ATP source and ATP/ADP depletion 
increases sarcolemmal ATP-sensitive K+ channel (sarcKATP) open probabilities affecting action 
potential duration (APD), effective refractory period (ERP) and heterogenous current sinks 
potentially causing current-load mismatch (Akar and O’Rourke, 2011). These cellular 
mechanisms could in turn potentially give rise to potentially pro-arrhythmic effects on cell-
cell coupling (Smyth et al., 2010), AP conduction (Liu et al., 2010 a) and AP repolarisation 
(Wang et al., 2004). There may also be an appearance of alternans and Ca2+ mediated 
triggering phenomena (Terentyev et al., 2008). The Pgc-1β-/- genetic modification has thus 
been associated with altered ion channel function and ventricular arrhythmias in  
Langendorff-perfused heart preparations (Gurung et al., 2011 b). 
 
ECG alterations accompanying the associated mitochondrial dysfunction were therefore 
investigated in intact anaesthetised Pgc-1β-/- mice murine hearts lacking the transcriptional 
coactivator PGC-1β. The present study yielded electrophysiological features associated with 
Pgc-1β  ablation in the in vivo system with intact autonomic innervation and normal cardiac 
mechanical function, building upon earlier reports from the cellular studies (Gurung et al., 
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2011 b) and ex-vivo hearts (Lelliott et al., 2006). The pharmacological manoeuvres involving 
dobutamine challenge in the latter studies would largely involve β1-adrenergic receptor 
activity, whereas the present in vivo studies could potentially further involve β2-adrenergic 
receptor mediated extracardiac changes, which in the clinical setting are also known to 
influence arrhythmic risk. 
 
The present experiments characterised the intervals separating specific ECG waveform 
components more closely than did previous studies. Quantitative statistical analysis of these 
steady state parameters then employed two way factorial MANOVA testing for interacting 
and non-interacting effects of age and genotype before and after dobutamine challenge. The 
presence of significant differences then prompted further, two way factorial ANOVA to 
ascertain whether the difference occurred before or following dobutamine application. 
Finally, appropriate Tukey HSD tests assessed for particular differences between individual 
parameters. Peak heart rates following dobutamine challenge were analysed by themselves 
by a two way factorial ANOVA followed by post hoc Tukey tests. 
 
The ECG analysis demonstrated a range of age-dependent abnormalities associated with the 
Pgc-1β-/- genotype. The predominant ECG pattern in both young and aged, WT and Pgc-1β-/- 
mice was one of sinus rhythm. Any ischaemic ECG changes observed were associated with age 
but were not specific to Pgc-1β-/- or WT genotypes, suggesting that there was no underlying 
difference in vascular (as opposed to primary cardiomyocyte) function between the two 
groups. However, we demonstrated for the first time blunted chronotropic responses to 
dobutamine challenge in an intact Pgc-1β-/- mammalian system despite heart rate variabilities 
suggesting unchanged autonomic backgrounds. Previous reports had hinted at compromised 
heart rate responses in ex-vivo Langendorff perfused Pgc-1β-/- hearts following dobutamine 
challenge (Lelliott et al., 2006). These results together suggest that the impaired heart rate 
response of Pgc-1β-/- hearts does not reflect generalised autonomic dysfunction but rather 
alterations in the intrinsic myocardial response to dobutamine. Ageing did not affect this 
chronotropic response, implicating the mutation as opposed to background deterioration of 
maximal heart rate with age.  
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Aged mice, independent of genotype, also showed episodes of isorhythmic AV dissociation 
with dobutamine challenge. During these episodes regular ventricular responses were seen, 
with normal, narrow QRS complexes despite the absence of a fixed PR interval, even when P 
wave complexes were buried within the ventricular signal. These findings suggest that the 
murine SAN is vulnerable to degenerative changes with age, with appearances of 
supraventricular, most likely junctional, pacemaker foci intermittently dictating the 
ventricular rate. The anatomical level of block that produce the AVN abnormalities seen could 
theoretically be at the level of the AVN, intra-hisian (within the his-purkinje system), or infra-
hisian (distal to the his-purkinje AVN system). A narrow ventricular complex is most 
compatible with an AV nodal or intra-His problem, though a wide QRS complex certainly may 
occur with A-V nodal or intra-His disease in the presence of coexistent bundle branch block or 
conduction delay. Thus the only way to delineate the level of block is through an intracardiac 
multielectrode recording from the SAN, AVN and infra-hisian cardiac sites so that the level of 
block can be determined. This represents a limitation of the current analysis as though a 
relatively narrow complex QRS with a lengthened AV delay is suggestive but not diagnostic of 
an intranodal pathology. 
 
Pgc-1β-/- ablation also appeared to cause a more generalised defect also affecting the AVN. A 
significant proportion of Pgc-1β-/-, particularly aged, mutants, demonstrated an abnormal 
negatively dromotropic response to dobutamine challenge, suggesting progressive 
deterioration in AVN function in Pgc-1β-/- hearts with age. Furthermore, mice showing this 
abnormal AVN function showed more pronounced blunting in their chronotropic response to 
dobutamine, relating an AVN dysfunction to the chronotropic deficit observed here.  
 
Pathological bradycardic rhythms secondary to cardiac conduction system disease are known 
to occur with ageing, often necessitating permanent pacemaker implantation. Progressive 
fibrotic change is a recognised feature of cardiac ageing in both animal (Jeevaratnam et al., 
2012, 2016) and human studies (Gazoti Debessa et al., 2001). Fibrotic change could directly 
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disrupt gap junction function, increasing tissue resistance (Xie et al., 2009), or increase 
fibroblast-cardiomyocyte coupling, increasing effective membrane capacitance (Chilton et al., 
2007). More recent studies indeed implicate abnormal gap junction function in both SAN and 
AVN disease (Jones et al., 2004; Nisbet et al., 2016). Interestingly, oxidative stress, associated 
with mitochondrial impairment increases transforming growth factor (TGF)-β activity (Sullivan 
et al., 2008 a), in turn implicated in such age-related myocardial fibrosis (Davies et al., 2014). 
Conversely augmented mitochondrial anti-oxidant capacity protects against features of 
cardiac ageing including fibrotic change (Dai et al., 2009). Mitochondrial dysfunction could 
also impair gap junction function through elevating intracellular [Ca2+] or altering connexin 
phosphorylation through oxidative stress (Sovari et al., 2013). Finally, the range of ionic 
currents including RyR2 channel function (Bhuiyan et al., 2007) involved in SAN and AVN 
activity, are potentially modifiable by mitochondrial dysfunction. Isolated cardiomyocytes 
from Pgc-1β-/- hearts have previously been reported to display altered diastolic Ca2+ transients 
in keeping with abnormal RyR2 function (Gurung et al., 2011 b). 
 
ECG deflections related to ventricular activation and recovery confirmed previous reports that 
murine ECGs lack well-defined ST segments (Danik et al., 2002; Zhang et al., 2014). The murine 
ECG shows an R’ wave deflection not seen in the human ECG. This is followed by a further but 
variably reported deflection which has not been systematically identified or formally 
correlated with particular action potential components. This variability may be attributed to 
the greater rostro-caudal anatomical alignment of the mouse heart in the thoracic cavity and 
variations in limb positioning during experimental recording between reports, with 
consequent variations in the effective positioning of the centre of the Einthoven triangle 
relative to the heart. Thus, although we also identified C waves, small changes in lead 
positioning could lead to its apparent disappearance in one or both ECG leads. This may 
account for the controversy concerning its inconsistent appearance (Danik et al., 2002). 
 
The onset of ventricular recovery in the murine ECG has been considered to occur from time 
points ranging from the S wave nadir to the R’ peak. A number of authors have suggested that 
the late component of the R’ wave or the R’ wave in totality is in fact part of ventricular 
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repolarisation (Goldbarg et al., 1968; Boukens et al., 2014; Zhang et al., 2014). Others 
suggested that inclusion of the R’ wave may lead to systematic overestimation of ventricular 
activation, while its exclusion in genetically modified mouse models, such as that of the 
Brugada syndrome, which displays slowed conduction, may lead to underestimation of 
ventricular activation times (Boukens et al., 2014). 
 
We accordingly explored a set of related recovery parameters that utilised both the S wave 
nadir and peak of the R’ wave as cut-off separating ventricular activation and recovery phases. 
Each parameter is likely to capture activation and recovery in different areas of myocardium, 
reflecting the non-simultaneous nature of electrical activity in the myocardium. This increased 
the robustness of our analysis and permitted us to assess the possibility of early repolarisation 
in our genetic model. The statistical analysis of the different parameters of recovery and 
activation were highly concordant. Pgc-1β-/- hearts showed a prolongation of all such 
measures of ventricular activation with age whether before or following adrenergic stress, in 
an absence of independent effects of age or genotype. These findings parallel the reduced 
conduction velocities reported in other arrhythmic genetic models. These had accompanied 
either fibrotic change or reduced Na+ currents resulting from Nav1.5 deficiency in Scn5a+/- 
(Jeevaratnam et al., 2011, 2012, 2016) and Scn5a+/ΔKPQ (Wu et al., 2012), or secondary to Ca2+ 
handling abnormalities in RyR2-P2328S hearts (King et al., 2013 b; Zhang et al., 2014; Ning et 
al., 2016 a). These findings are also compatible with reports that mitochondrial abnormalities 
could alter IK and therefore result in current-load mismatch (Akar and O’Rourke, 2011; 
Kabunga et al., 2015). 
 
Pgc-1β−/− hearts also showed shorter recovery parameters than WT after dobutamine 
administration, without effects of age whether acting independently or interacting with 
genotype. Such shortened repolarisation intervals have also been implicated in arrhythmic 
risk. Human short QT syndrome is diagnosed using the J point to T peak interval that may 
represent the interval between the end of the ventricular complex to the peak of the 
repolarisation wave (Gollob et al., 2011). Short QT syndrome has been traced to HERG and 
other K+ channel mutations and more recently, Ca2+ channel function (Antzelevitch et al., 
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2007). The present findings are thus consistent with alterations in K+ conductance properties 
or Ca2+ handling properties in the Pgc-1β-/- system that would also modify current-load 
matching (Gurung et al., 2011 a). These changes appeared to result in shortened QTc intervals 
for mutant mice with adrenergic stress. Although the mechanisms underlying these changes 
remain unclear, increased expression of Kcna5 was reported in the latter study and may 
contribute to the increased K+ conductance.  Additionally, the opening and K+ conductance of 
the sarcKATP is linked to rising cellular ADP levels, therefore correlating its activity to cellular 
metabolic status. Its activity is known to reduce the action potential duration and is thought 
to contribute to increased arrhythmic risk (Billman, 2008). Oxidative stress is also known to 
enhance sarcKATP activity; however the cellular mechanism are yet to be established but may 
occur through depletion of cellular ATP.  Nevertheless, the effects of ROS upon sarcKATP 
activity could be attenuated through inhibition of protein kinase C, protein kinase G and 
calcium-calmodulin kinase II but not protein kinase A, providing some insights into the 
pathways involved (Yan et al., 2009). 
 
Finally, these findings prompted us to measure QTc intervals reflecting the total activation 
times of the ventricular myocardium. Pgc-1β-/- mice showed shorter QTc intervals than their 
WT counterparts. The majority of this effect seemed to be due to young mutant mice, though 
this was not significant. This is in contrast to the shortened repolarisation parameters in both 
young and aged Pgc-1β-/-. This likely reflects the additional, prolonged, depolarisation 
parameters in aged Pgc-1β-/- mice, offsetting to some degree the shortening in the 
repolarisation parameters.  
 
The experiments presented here utilise sample sizes that could be criticised for being too 
small; however, they are consistent with the sample sizes in previous ECG studies of murine 
models (Salama and London, 2007; Jeevaratnam et al., 2010; Boukens et al., 2014; Chadda et 
al., 2017), and were constructed to be adequately powered to detect differences of the order 
of magnitude seen in previous studies of genetically modified mice.  The limited exploration 
of the murine ECG and its analysis in previous studies also limits the interpretation of the 
findings in this study - there is an absence of accepted ‘normal’ or physiological values for the 
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majority of ECG parameters and intervals measured. Thus while the statistical methods 
presented can gauge differences between groups, it is not possible at this time to comment 
on many if not all of the absolute values of the intervals found and whether these are 
concordant with expected WT values or not.  
 
The use of volatile anaesthetic compounds for the study also presents another limitation – it 
is known that many volatile anaesthetic affect the murine ECG and alter ventricular recovery 
parameters, in particular the QTc (Loushin, 2005). However, the study employed a 
standardised protocol for anaesthesia and assessing the depth of anaesthesia to ensure this 
affect was present across all experimental groups equally as much as was feasible. It is not 
however known if volatile anaesthetics would differentially affect ECG parameters in 
mitochondrial dysfunction; this empirically seems unlikely though cannot be absolutely ruled 
out. The choice of anaesthetic, avertin, was also deliberate as it is known to be among the 
anaesthetic agents with the least cardiovascular and in particular electrophysiological effects 
(Hart et al., 2001; Pachon et al., 2015).    
 
An alternative technique using telemetry with surgical implantation of ECG telemetry could 
be used and would avoid the known cardiac effects of volatile anaesthetics. However 
telemetry has its own drawbacks including lower sampling rates, increased noise (which is 
particularly important for the P wave features which have a low signal to noise ratio) and being 
unable to control for activity levels of a mouse which may lead to rapid changes in heart rates 
and ECG intervals making analysis problematic.  
 
With these considerations in mind, the conclusions of this section of the study point to a range 
of electrocardiographic abnormalities associated with the Pgc-1β-/- genotype and those 
features particularly vulnerable to advanced age. Thus, Pgc-1β-/- mice show reduced sino-atrial 
response to dobutamine, paradoxical atrioventricular nodal function increasing in prevalence 
with age, slowed ventricular activation with ageing and shortened recovery parameters after 
dobutamine challenge. 
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4. VENTRICULAR PRO-ARRHYTHMIC PHENOTYPE, 
ARRHYTHMIC SUBSTRATE AND AGEING IN Pgc-1β-/- 
HEARTS 
 
4.1 Introduction 
 
The previous chapter explored the ECG changes associated with chronic mitochondrial 
dysfunction in the Pgc-1β-/- model. However, relatively few studies have investigated the 
electrophysiological consequences of the cellular changes of mitochondrial dysfunction and 
their implications for arrhythmic triggering or arrhythmic substrate at the level of intact Pgc-
1β-/- hearts.  
 
The present experiments characterize the electrophysiological changes underlying arrhythmic 
substrates and how these progress with age in Pgc-1β-/- hearts modelling chronic 
mitochondrial dysfunction. They compared four groups of intact, young and aged, wild type 
(WT) and genetically modified, Langendorff-perfused Pgc-1β-/- hearts. Triggering events 
provoking arrhythmia in the presence of substrate were mimicked by S2 stimuli interposed at 
differing intervals following regular S1 pacing trains similar to protocols established on earlier 
occasions (Thomas et al., 2007 a, 2008). Direct intracellular determinations of resting 
membrane potentials (RMPs), AP amplitudes and latencies, and maximum rates of AP 
depolarization, (dV/dt)max, in cardiomyocytes in situ ensured unperturbed intracellular 
conditions, particularly of Ca2+ homeostasis. Pgc-1β-/- as opposed to WT genotypes were 
implicated in decreased (dV/dt)max and increased AP latencies in the absence and in the 
presence of effects of age respectively. The latter segregation prompted explorations 
demonstrating distinct dependences of AP latency on (dV/dt)max in young and aged WT hearts 
but a single such dependence in both Pgc-1β-/- groups approximating the functions observed 
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in aged WT. The difference could be accounted for effects on AP latency of increases in fibrotic 
change arising from both Pgc-1β-/- genotype and ageing.  Predictions of arrhythmic substrate 
from wavelengths derived from these AP activation and recovery terms, paralleled the relative 
incidences of arrhythmia in Pgc-1β-/- and WT hearts.  
 
4.2 RESULTS 
 
The experiments involved simultaneous ECG recordings in intact hearts and intracellular 
microelectrode recordings from ventricular cardiomyocytes in situ. The intracellular 
recordings employed microelectrode impalement sites confined to the proximal region of the 
left ventricle and consistent stimulating electrode positioning between hearts, minimising 
variabilities in distance between stimulating and recording electrode sites. They explored and 
characterised effects of the Pgc-1β-/- genotype and ageing upon arrhythmic properties at the 
organ level in Langendorff-perfused murine hearts during both regular pacing and 
programmed electrical stimulation (PES). These findings were then correlated with cellular 
electrophysiological quantifications of action potential (AP) activation and propagation, as 
well as recovery characteristics, and morphometric assessments of age-related structural 
change, features previously implicated in arrhythmic substrate.  
 
The intracellular recordings confirmed fully polarised resting membrane potentials (RMPs) in 
all groups studied (young WT (n = 27): -79.0 ± 1.5 mV; aged WT (n = 27): -79.0 ± 1.5 mV; young 
Pgc-1β-/ (n = 37)-: -75.0 ± 1.5 mV; aged Pgc-1β-/- (n = 29): -80.0 ± 1.5 mV; all values rounded to 
the nearest 0.5mV) with slightly more polarized RMPs in young Pgc-1β-/- compared to each of 
the remaining groups (p < 0.05 in each case). AP amplitudes (young WT (n = 27): 83.0 ± 1.0 
mV; aged WT (n = 27): 88.0 ± 1.5 mV; young Pgc-1β-/ (n = 37)-: 80.0 ± 1.0 mV; aged Pgc-1β-/- (n 
= 29): 81.0 ± 1.0 mV; all values rounded to the nearest 0.5mV), were slightly greater in aged 
WT than in each of the remaining experimental groups (p < 0.05 in each case). Nevertheless, 
comparisons of RMPs and AP amplitudes confirmed AP overshoots were positive as expected 
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from recordings from viable ventricular cardiomyocytes. 
4.2.1 PGC-1Β-/- VENTRICLES DEVELOP ARRHYTHMIC PHENOTYPES 
 
The occurrence of spontaneous arrhythmic events were first quantified during regular 8 Hz 
pacing resembling normal resting heart rates. Arrhythmic substrate (i.e an 
electrophysiological state of the myocardium that is pro-arrhythmic) was thereafter assessed 
by applying extrasystolic S2 stimuli in a programmed electrical stimulation (PES) protocol. 
Figure 4-1 shows typical ECG (upper trace in each panel) and intracellular AP recordings (lower 
trace in each panel) obtained during such regular 8 Hz pacing (A) and PES (B) from a young WT 
ventricle. The PES protocol comprised cycles of eight S1 beats at a baseline BCL (basic cycle 
length, i.e the unit of time between two stimuli) of 125 ms followed by an extra stimulus (S2) 
every ninth beat. The initial S1-S2 coupling interval was 89 ms, decrementing by 1 ms with 
each cycle. Differences in arrhythmic propensity were quantified from occurrences or 
otherwise of both spontaneous and provoked arrhythmic events, and the S1-S2 intervals at 
which the latter took place. None of the hearts in any of the experimental groups showed 
spontaneous arrhythmic events during the regular 8 Hz pacing. In contrast, the PES protocols 
elicited a range of abnormal rhythms, exemplified in Figure 4-2 for an aged Pgc-1β-/- ventricle. 
These included single (A) or pairs (couplets) of successive ectopic beats (B), non-sustained (C) 
and sustained ventricular tachycardia (D). 
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Figure 4-1: Typical electrocardiographic and intracellular action potential recordings. Typical 
electrocardiographic (ECG) (upper panel in each) and simultaneous intracellular action potential (AP) 
recordings (lower panel in each) obtained during 8 Hz pacing (A) and programmed electrical stimulation 
(PES) (B), recorded from a young wild type (WT) heart. The timings of stimulus delivery are given in the 
bar beneath the AP recordings, and corresponding stimulation artefacts can be seen on the ECG and 
AP traces, preceding the respective complexes. In panel (B), arrows indicate the imposition of S2 
extrastimuli. The first two S2 stimuli trigger APs, whereas the third S2 stimulus fails to elicit a response, 
thus representing a refractory outcome. 
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Table 4-1 summarises frequencies with which these different categories of abnormal rhythms 
occurred stratified by experimental group. Young Pgc-1β-/- ventricles demonstrated greater 
incidences of rhythm disturbances than other experimental groups, particularly in the form of 
non-sustained ventricular tachycardia (NSVT) (p < 0.001). Young WT ventricles demonstrated 
few abnormal rhythms of any description; all the NSVT episodes observed occurred in the 
same heart.  
 
Aged Pgc-1β-/- displayed fewer individual episodes of abnormal rhythms than young Pgc-1β-/- 
hearts, and a similar number as aged WT hearts. However arrhythmias in the aged Pgc-1β-/- 
group appeared to be associated with the greatest risk of major cardiac events. The durations 
of the VT episodes, whether non-sustained or sustained, were influenced by interacting 
effects of age and genotype with the VT episodes in aged Pgc-1β-/- hearts significantly longer 
in duration than in the other groups (p < 0.05). Aged Pgc-1β-/- hearts were also the only 
experimental group showing sustained VT episodes.  Thus an S2 beat could trigger an episodes 
of a short and self-terminating run of NSVT in a young Pgc-1β-/- heart, with subsequent S2 
beats triggering further short-lived episodes. In contrast, an episode of VT in an aged Pgc-1β-
/- ventricle was more likely to be prolonged thereby precluding subsequent S2 beats from 
triggering further episodes.  
 
Finally, Figure 4-3 compares incidences of NSVT and sustained VT in young (A, C) and aged (B, 
D) WT (A, B) and Pgc-1β-/- hearts (C, D), sorted by the S1S2 coupling interval at which the 
episodes took place. Both young and aged Pgc-1β-/- hearts showed arrhythmic phenomena 
over more extensive ranges of S1-S2 coupling intervals than the young and aged WT hearts. 
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Table 4-1: Summary of arrhythmic events according to experimental group. 
Experimental Group Numbers that developed  
NSVT or VT 
Ectopic Beats  Couplets NSVT  Sustained VT  Duration of VT Episode 
 
 (n / total) Mean number of 
beats (± SEM)  
Mean  number 
of couplets  (± 
SEM) 
Mean number of 
episodes (± 
SEM) 
Mean number of 
episodes (± 
SEM) 
No. of Beats 
(mean ± SEM) 
 
Time (s) 
(mean ± SEM) 
 
 
Young Wild Type  
 
1 / 31 
 
0 
 
0.03 (± 0.03) 
 
0.26 (± 0.26) 
 
0 
 
4.13 ± 0.74 
 
0.022 ± 0.004 
 
Aged Wild Type  
 
4 / 29 
 
0 
 
0.03 (± 0.03) 
 
0.89 (± 0.47) 
 
0 
 
5.96 ± 0.66 
 
0.032 ± 0.004 
 
Young Pgc-1β-/-  
 
 
7 / 37 
 
0.09 (± 0.04) 
 
1 (± 0.48) 
 
1.70 (± 0.80)* 
 
0 
 
6.81 ± 2.00 
 
 
0.041 ± 0.016 
 
Aged Pgc-1β-/-  
 
6 / 29 
 
0.14 (± 0.10) 
 
0.10 (± 0.30) 
 
0.72 (± 0.43) 
 
0.07 (± 0.05) 
 
103.57 ± 64.32* 
 
7.835 ± 3.765* 
 
Symbols denote significant differences of the labelled value from corresponding measurements in the other experimental groups based on post hoc Tukey HSD analysis. These 
post hoc-tests were performed if the F value from two-way ANOVA was significant. Single asterix denotes significance at p < 0.05 comparison made to other groups. Aged Pgc-
1β-/- mice had significantly longer duration of VT episodes both by number of beats (p = 0.016) and by time (p = 0.021) compared to other groups. 
Ventricular pro-arrhythmic phenotype, arrhythmic substrate and ageing in Pgc-1β -/- hearts 
 
86 
 
 
                     
Figure 4-2: Typical AP recordings of different abnormal rhythms observed during programmed 
electrical stimulation (PES) in an aged Pgc-1β-/- heart following an extrasystolic S2 stimulus.  These 
were classified as an individual ectopic beat (A), a couplet of two successive ectopic beats (B), non-
sustained ventricular tachycardia (NSVT) (C) and sustained ventricular tachycardia (D). The timings of 
stimulus delivery are given in the bar beneath the AP recordings and arrows indicate the onset of the 
abnormal rhythm. 
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4.2.2 ALTERED AP PARAMETERS IN PGC-1Β-/- VENTRICLES DURING REGULAR PACING 
 
Parameters corresponding to AP initiation, propagation and recovery were next examined (by 
intracellular cardiomyocyte recordings) under conditions of regular 8 Hz pacing for 
differences between groups, in order to correlate these with the arrhythmic phenotypes 
delineated above (Table 4-2). Pgc-1β ablation independently altered both AP activation and 
recovery properties in directions compatible with pro-arrhythmic defects in an absence of 
effects of ageing whether independently, or interacting with genotype. Thus, maximum AP 
upstroke velocities, (dV/dt)max, were reduced in Pgc-1β-/- compared to WT ventricles (F = 
31.606, p < 0.001), without effects of age (F = 1.973, p > 0.05) or interacting effects of age and 
genotype (F = 0.904, p > 0.05). Post hoc tests confirmed lower (dV/dt)max in both young and 
aged, Pgc-1β-/- group than either WT group. Assessments of AP conduction similarly 
demonstrated longer AP latencies between stimulus delivery and the AP peak, in Pgc-1β-/- 
than WT ventricles (F = 11.458, p < 0.001) without effects of age (F = 0.494, p > 0.05) or 
interactions between age and genotype (F = 0.744, p > 0.05). However, post hoc analysis 
demonstrated shorter AP latencies in young WT than both young (p < 0.05) and aged Pgc-1β-
/- (p < 0.05) ventricles, but no differences between aged WT ventricles and the remaining 
groups. 
 
Of recovery characteristics, AP durations at 90%, 70% and 50% repolarisation, APD90, APD70 
and APD50 respectively, were indistinguishable between groups.  Finally, ventricular effective 
refractory periods (ERPs) were evaluated from the PES protocol as the shortest S1-S2 coupling 
interval at which an S2 stimulus successfully triggered a ventricular beat. Pgc-1β-/- ventricles 
showed shorter ERPs than WT (F = 13.508, p < 0.001) without effects of either age (F = 0.208, 
p > 0.05) or interactions between age and genotype (F = 0.391, p > 0.05). Post hoc Tukey tests 
demonstrated shorter ERPs in both young (p < 0.05) and aged Pgc-1β-/- (p < 0.05) compared 
to aged WT ventricles.   
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Table 4-2: Action potential properties in WT and Pgc-1β-/- hearts during regular 8 Hz pacing. 
Experimental Group 
(n) 
 
(dV/dt)max (V s-1) AP latency (ms) APD90 Duration 
(ms) 
APD70 Duration 
(ms) 
APD50 Duration 
(ms) 
Effective Refractory 
Period (ms) 
 
 
Young Wild Type 
(27) 
 
156.08 (± 6.00)***, † 
 
 
9.70 (± 0.32)*, † 
 
 
51.01 (± 1.47) 
 
27.51 (± 1.29) 
 
7.27 (± 0.64) 
 
57.15 (± 1.92) 
Aged Wild Type (27) 
 
158.14 (± 5.45)‡‡‡, α 
 
10.92 (± 0.35) 
 
51.24 (± 1.68) 
 
26.08 (± 1.57) 7.63 (± 0.63) 59.92 (± 2.20)*, † 
 
Young Pgc-1β-/- (37) 119.23 (± 5.49)***, 
‡‡‡
 
 
12.85 (± 0.77)* 
 
47.31 (± 2.12) 
 
23.58 (± 1.67) 8.69 (± 1.00) 51.54 (± 1.74)* 
 
Aged Pgc-1β-/- (29) 132.21 (± 5.73) †, α 
 
12.79 (± 1.09) † 
 
53.14 (± 1.60) 
 
28.19 (± 1.47) 8.27 (± 0.54) 51.25 (± 2.42) † 
 
 
All values are given as mean (± SEM). Symbols denote significant differences on post hoc analysis between pairs of experimental groups with the same symbol. 
These post-hoc tests were performed if the F value from two-way ANOVA was significant. Single, double and triple symbols denote p < 0.05, p < 0.01 and p < 0.001 
respectively. 
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4.2.3 ALTERED AP PARAMETERS IN PGC-1Β-/- VENTRICLES SUBJECTED TO EXTRASYSTOLIC 
STIMULI 
 
Whereas regular 8 Hz pacing permitted evaluation of electrophysiological properties under 
conditions resembling resting heart rates, a PES protocol explored the presence or absence of 
an arrhythmic substrate. The PES protocol utilised transient perturbations, in the form of 
isolated S2 extra stimuli mimicking ectopic APs, that are thought to act as arrhythmic triggers.  
PES protocols gave APs triggered by S2 stimuli over the range of S1-S2 coupling intervals 
explored. There were variations in (dV/dt)max and of AP latency which showed contrasting 
dependences upon genotype and age, despite invariant dependences of APD90 with coupling 
interval.  
 
Thus, plots of (dV/dt)max against S1-S2 coupling interval (Figure 4-4A(i)) confirmed lower 
(dV/dt)max values in Pgc-1β-/- compared to WT ventricles (F = 30.167, p < 0.001) at the long 
coupling intervals early in the PES protocol. There were no effects of age or interactions of age 
and genotype. A second statistical analysis was also performed to confirm these results. Using 
R and lme4 (R Core Team, 2012) a linear mixed effects regression analysis of the relationship 
between (dV/dt)max and genotype and age was performed. As fixed effects, genotype and age 
(with an interaction term) were entered into the model. As random effects, intercepts for each 
cell impalement and the BCL were set, as well random slopes for the effect. Visual inspection 
of residual plots did not reveal any obvious deviations from homoscedasticity or normality. P 
values were obtained by likelihood ratio tests of the full model with the effect in question 
against the model without the effect in question. Genotype significantly affected (dV/dt)max, 
with the Pgc-1β ablation significantly lowering (dV/dt)max by 24.52 V/s (χ2 6.1082, p = 0.047) 
with no significant effect of age (χ2 0.66, p = 0.72) or significant interaction of age and 
gentoype together (χ2 0.27, p = 0.61).  These statistical tests are concordant with each other 
and in keeping with those from the regular 8 Hz pacing.  
 
Post hoc testing demonstrated lower (dV/dt)max in each individual Pgc-1β-/- group compared 
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to any WT group (Fig. 4-4A(ii)), but no differences between young and aged ventricles within 
either group. (dV/dt)max fell with shortening S1-S2 coupling interval preserving their relative 
magnitudes between experimental groups consistent with progressive reductions in 
conduction velocity and the increased arrhythmic tendency. The (dV/dt)max values then 
converged to indistinguishable values whether stratified by genotype (F = 1.395, p > 0.05) or 
age (F = 0.060, p > 0.05) (Fig. 4-4A(ii)). 
 
The corresponding AP latencies (Fig. 4-4B(i)) were longer in Pgc-1β-/- than WT ventricles at the 
longest S1-S2 coupling intervals (F = 8.633, p < 0.01) without independent effects of age (F = 
0.001, p > 0.05) or interacting effects of age and genotype (F = 2.689, p > 0.05), consistent 
with the (dV/dt)max readings.  The mixed effect analysis was again concordant, with genotype 
significantly affecting latency; the Pgc-1β-/- mice had an increased latency by 1.2ms (χ2 7.6013, 
p = 0.022) with no significant effect of age (χ2 3.1027, p = 0.21) or interaction with age and 
genotype (χ2 2.7854, p = 0.095). However, young Pgc-1β-/- showed longer AP latencies than 
young WT ventricles on post hoc Tukey analysis (p < 0.05) though with no further differences. 
Furthermore, AP latencies increased with falling S1-S2 intervals to varying extents amongst 
groups. AP latencies at the shortest S1-S2 intervals were affected by interactions between 
genotype and age (F = 4.100, p < 0.05). Young WT ventricles here showed shorter AP latencies 
than the remaining groups (post hoc Tukey tests: young WT vs. young Pgc-1β-/- p < 0.01; young 
WT vs. aged Pgc-1β-/-: p < 0.05; no significant differences in the remaining comparisons). AP 
latency did not differ between aged WT and either young or aged Pgc-1β-/- ventricles. Thus at 
the shortest S1-S2 coupling intervals the young WT ventricles, which were the least 
arrhythmic, showed smaller increases in AP latency than any other group including aged WT 
ventricles. 
 
Finally, similar shortenings of APD90 with reductions in S1-S2 coupling intervals (Fig. 4-4C(i)) 
were observed through all groups, with indistinguishable APD90 at both the longest (genotype: 
F = 0.004, p > 0.05; age: F = 0.309, p > 0.05) and shortest S1-S2 intervals (genotype: F = 2.661, 
p > 0.05; age: F = 2.152, p > 0.05) (Fig. 4-4C(ii)). The mixed effects analysis confirmed these 
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results, with no significant effect of genotype (χ2 8.8976, p = 0.064) or age (χ2 7.2975, p = 
0.121) or interactions with age and genotype (χ2 8.3611, p = 0.079) on APD90. Table 4-3 
demonstrates that these similarities in action potential recovery extended to the respective 
values of APD50 and APD70 at the longest and shortest S1-S2 intervals.    
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Figure 4-4: Mean AP parameters for S2 triggered APs. Means ± SEM of maximum action potential 
upstroke rate, (dV/dt)max(A), AP latencies (B) and action potential durations to 90% recovery, APD90 (C) 
for S2 triggered APs in the four experimental groups (young WT (n = 27), aged WT (n = 27), young Pgc-
1β-/- (n = 37) and aged Pgc-1β-/- hearts (n = 29)),  for (i) S1-S2 intervals falling from 89 ms to 50 ms 
during the PES protocols.  Panel (ii) for each provides a comparison of these values at the outset and at 
the end of the pacing protocol, corresponding to a refractory outcome or the onset of sustained 
arrhythmia. The symbols denote significant differences between each pair, obtained from post hoc 
Tukey testing, which was conducted if the ANOVA indicated a significant outcome. Single, double and 
triple symbols denote p < 0.05, p < 0.01 and p < 0.001 respectively. 
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Table 4-3: Action potential duration time in WT and Pgc-1β-/- hearts during programmed stimulation. 
 
Experimental Group (n) 
 
 
APD50 Duration (ms) 
Protocol Start 
 
 
APD50 Duration (ms) 
Protocol End 
 
APD70 Duration (ms) 
Protocol Start 
 
APD70 Duration 
(ms) 
Protocol End 
 
APD90 Duration (ms) 
Protocol Start 
 
APD90 Duration 
(ms) 
Protocol End  
       
Young Wild Type (27) 6.51 (± 0.50) 9.98 (± 0.63) 22.56 (± 1.03) 20.63 (± 0.50) 42.11 (± 1.48) 
 
34.86 (± 0.54) 
 
Aged Wild Type (27) 
 
6.78 (± 0.58) 8.98 (± 0.75) 
 
20.00 (± 1.13) 
 
20.42 (± 1.02) 39.38 (± 1.33) 
 
34.95 (± 1.19) 
 
Young Pgc-1β-/- (37) 8.73 (± 0.92) 8.15 (± 0.86) 
 
20.19 (± 1.30) 
 
16.93 (± 1.20) 38.67 (± 1.73) 
 
30.60 (± 1.48) 
 
Aged Pgc-1β-/- (29) 7.74 (± 0.61) 9.12 (± 0.61) 
 
22.85 (± 0.99) 
 
19.69 (± 0.75) 42.84 (± 1.34) 
 
34.46 (± 1.06) 
 
 
All values are given as mean (± SEM). Post-hoc tests were performed if the F value from two-way ANOVA was significant. There were no significant differences between 
groups. 
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4.2.4 DISTINCT DEPENDENCES OF AP LATENCY UPON (DV/DT)MAX IN WT AND PGC-1Β-/- 
VENTRICLES 
 
These detailed differences in the effects of genotype and age upon the dependences of AP 
latency and (dV/dt)max upon S1-S2 coupling interval prompted investigations of the 
relationship between these two parameters. Figure 4-5 plots mean (±SEM) latencies of the 
extrasystolic S2 APs against their corresponding (dV/dt)max values for each experimental 
group. Both WT and Pgc-1β-/- showed AP latencies increasing with falling (dV/dt)max and 
shortening S1-S2 coupling intervals, consistent with much of this increased AP latency being 
related to falls in (dV/dt)max. However, young and aged WT ventricles generated two separable 
plots of AP latency against (dV/dt)max (Fig. 4-5A), with aged showed greater AP latencies than 
young WT ventricles at any given (dV/dt)max. In contrast, both young and aged Pgc-1β-/- 
ventricles gave similar AP latency - (dV/dt)max plots (Fig. 4-5B), whose values closely resembled 
those of aged as opposed to  young WT.  
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4.2.5 INCREASED FIBROTIC CHANGE WITH PGC-1Β ABLATION 
 
Young and aged WT ventricles thus showed distinct dependences of AP latency upon 
(dV/dt)max whereas both young and aged Pgc-1β-/- ventricles showed a single dependence 
resembling that shown by the aged as opposed to the young WT. (dV/dt)max classically reflects 
cardiomyocyte membrane depolarisation driven by regenerative inward Na+ current 
important in AP conduction (King et al., 2013 c; Zhang et al., 2013). However, AP conduction 
additionally varies with tissue conductivity properties reflecting gap junction resistances 
separating successive coupled cardiomyocytes, and their cell membrane capacitances 
influenced by fibroblast-myocyte fusion (King et al., 2013 a; Davies et al., 2014). Previous 
reports in murine Scn5a+/- hearts had implicated age-dependent fibrotic change and such 
effects on tissue conductivity in similar pro-arrhythmic alterations in AP conduction (Royer et 
al., 2005; Jeevaratnam et al., 2011, 2012). The final experiments accordingly made 
morphometric assessments for fibrotic change amongst the four experimental groups. This 
was conducted blindly by two independent investigators achieving a high measure of 
consistency (ICC = 0.94). Figure 4-6 illustrates typical histological sections from young and 
aged WT and Pgc-1β-/- hearts (A), higher power representations of normal and fibrotic tissue 
(B) and quantifications of this fibrotic change (C). Age and genotype independently increased 
levels of fibrosis in ventricular tissue (p < 0.05 for both), with no evidence of interaction 
between variables. The differing fibrotic levels in aged vs. young WT ventricles paralleled their 
differing AP latency - (dV/dt)max association, whereas the similar fibrotic levels in young Pgc-
1β-/- and aged WT ventricles paralleled their similar AP latency - (dV/dt)max plots.  
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 (A) Representative examples of histological samples from young ((i) and (iiii)) and old ((ii) and (iv)), WT 
((i) and (ii)) and Pgc1β-/- hearts ((iii) and (iv)) used for morphological assessment of fibrotic change 
(scale bar 1 mm), with (B) typical higher power appearances to illustrate (i) normal tissue architecture 
in young WT and (ii)  tissue structure showing fibrotic change in aged Pgc-1β-/- ventricles (scale bar 100 
μm). (C) The degree of fibrotic change was assessed as the proportion of morphometric squares 
covering tissue that showed positive evidence of fibrotic change as detected by picrosirius red staining. 
Numbers of hearts examined: young WT (n = 8), aged WT (n = 8), young Pgc-1β-/- (n = 9), aged Pgc-1β-
/- (n = 10).  Symbols denote pairs of points showing significant differences from post hoc Tukey testing, 
where single, double and triple symbols denote p < 0.05, p < 0.01 and p < 0.001 respectively. 
Figure 4-6: Morphological assessment of fibrotic change. 
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4.2.6 ACTION POTENTIAL WAVELENGTHS AND PRO-ARRHYTHMIC PHENOTYPES IN PGC-1Β-
/- VENTRICLES  
 
Wavelengths made up of AP activation and ERP terms have provided indications of arrhythmic 
substrate arising from slowed conduction and/or shortened ERP, in earlier experimental 
analyses of cardiac arrhythmia (Weiss et al., 2005; Matthews et al., 2013 b; Huang, 2017 a). 
Figure 4-7 summarises such an analysis for the experimental groups studied during the regular 
pacing (A) and with the extrasystolic S2 stimuli imposed through the different S1-S2 coupling 
intervals during PES pacing (B). With (dV/dt)max as the activation term (Fig. 4-7A(i) and 4-7B(i)), 
ANOVA demonstrated shorter wavelengths in Pgc-1β-/- compared to WT ventricles (F = 38.591, 
p < 0.001) without effects of either age (F = 1.943, p > 0.05) or interactions between age and 
genotype (F = 0.016, p > 0.05). Post hoc analysis revealed significant differences between each 
WT group compared to either Pgc-1β-/- group (young WT vs. young Pgc-1β-/- p < 0.001, young 
WT vs. aged Pgc-1β-/- p < 0.01, aged WT vs. young Pgc-1β-/- p < 0.001, aged WT vs. aged Pgc-
1β-/- p < 0.001). However, there were no significant differences between young or aged groups 
of the same genotype. This thus accounts for the more marked arrhythmic substrate in both 
young and aged Pgc-1β-/-. 
 
With 1/(AP latency) as the activation term, representing wavelength by the ratio ERP/(AP 
latency) thereby including tissue conductivity changes produced by fibrotic change (Figure 4-
7A(ii) and B(ii)), ANOVA similarly associated Pgc-1β ablation with shortened wavelengths 
compared to WT ventricles (F = 22.766, p < 0.001) with no effect of age (F = 0.36, p > 0.05) or 
interaction between age and genotype (F = 1.872, p > 0.05). However, the post hoc testing 
revealed longer wavelengths in young WT than either young Pgc-1β-/- (p < 0.001) or aged Pgc-
1β-/- (p < 0.01) ventricles.  However, wavelengths in aged WT, although higher than in young 
Pgc-1β-/- ventricles (p < 0.05), were similar to those shown by aged Pgc-1β-/- ventricles (p > 
0.05). Similarly, dependences of wavelength on S1-S2 coupling intervals showed greater 
wavelengths in young WT ventricles, shortened values in Pgc-1β-/- and intermediate measures 
in aged WT ventricles. Both these findings parallel further findings in Table 4-1 showing that 
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aged Pgc-1β-/- hearts displayed fewer individual episodes of abnormal rhythms compared to 
young Pgc-1β-/- hearts, and a similar number to the aged WT group. 
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4.3 DISCUSSION 
 
PGC-1β expression is restricted to tissues with high oxidative capacity such as the heart and 
plays a key role in modulating cellular mitochondrial biogenesis, energy substrate uptake and 
utilisation (Arany et al., 2005; Lin et al., 2005; Finck and Kelly, 2006).  Mice lacking both Pgc-
1β and the related Pgc-1α have significantly reduced mitochondrial content and die at birth 
due to heart failure (Lai et al., 2008).  In contrast isolated deficiency of Pgc-1β is not associated 
with cardiac contractile dysfunction (Lelliott et al., 2006). However cellular studies indicate an 
increased vulnerability to arrhythmia (Gurung et al., 2011 a).  The latter report demonstrated 
that murine Pgc-1β-/- cardiomyocytes also showed irregular and extrasystolic Ca2+ signalling 
patterns and spontaneous Ca2+ propagating waves associated with arrhythmic phenotypes in 
other situations (Balasubramaniam et al., 2004; Goddard et al., 2008 a; Hothi et al., 2008; 
Gurung et al., 2011 a).  The Pgc-1β system thus provides a suitable model to investigate the 
electrophysiological alterations secondary to metabolic impairment.  
 
The present study is the first report investigating the electrophysiological phenotype and 
associated arrhythmic tendency associated with Pgc-1β knockout at the organ as opposed to 
the cellular level.  Sustained arrhythmia likely depends upon interactions between 
contributions from triggering events and arrhythmic substrate (Huang, 2017 a). We employed 
a modified Langendorff preparation, enabling simultaneous intracellular recordings from the 
left ventricular epicardium and volume conducted electrocardiograph monitoring surveying 
whole heart activity. The arrhythmic vulnerability could therefore be correlated with cellular 
electrical properties in young and aged WT and Pgc-1β-/- hearts during regular 8 Hz pacing and 
PES protocols.  The measurements provided effective refractory periods (ERPs), and 
parameters related to action potential (AP) initiation, propagation, and recovery. Adoption of 
intracellular recording methods permitted closer estimates of the activation parameters, 
(dV/dt)max and AP latency (King et al., 2013 c) than did the monophasic AP recordings, primarily 
used to determine AP recovery parameters as APD90 and ERP measurements, on previous 
occasions (Thomas et al., 2007 a;  b, 2008). 
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The resulting measurements could also be compared with those obtained by previous 
electrophysiological studies employing similar methods in other, monogenic, murine systems 
that characterised arrhythmic phenotypes associated with specific genetic ion channel 
modifications. These had previously implicated distinct electrophysiological features in 
arrhythmic substrate and triggering. Reduced maximum rates of depolarisation, (dV/dt)max, 
attributed directly to a loss of Na+ channel function, were implicated as pro-arrhythmic factors 
in Scn5a+/- hearts through their effects upon AP conduction and therefore latency (Martin et 
al., 2010, 2012 b). Alterations in cardiomyocyte coupling further limiting AP propagation could 
arise from connexin Cx40 or Cx43 deficiency (Simon et al., 1998; Royer et al., 2005; Verheule 
and Kaese, 2013), or tissue morphological changes in the form of fibrosis (Jeevaratnam et al., 
2011, 2012). These potentially alter intracellular electrical resistances between 
cardiomyocytes, with the latter additionally increasing cardiomyocyte-fibroblast fusion (Xie et 
al., 2009; Davies et al., 2014; Mahoney et al., 2016). Alternatively, compromised AP recovery 
altering APD90 and/or ERP, as might arise from late inward Na+ current or deficient outward 
K+ current, were demonstrated in the pro-arrhythmic Scn5a+/∆kpq and Kcne5-/- systems 
respectively, particularly where the relative APD90 and ERP durations gave rise to potential 
windows for a generation of re-entrant excitation (Thomas et al., 2007 a;  b, 2008). Altered 
intracellular Ca2+ homeostasis was associated with both membrane instabilities in the form of 
early or delayed after depolarising triggering phenomena (Balasubramaniam et al., 2004; 
Goddard et al., 2008 a; Hothi et al., 2008), and altered AP (dV/dt)max and conduction attributed 
to indirect effects upon Na+ channel function (Zhang et al., 2013; Salvage et al., 2015; Huang, 
2017 b). 
 
We here report an arrhythmic phenotype associated with chronic mitochondrial dysfunction 
that evolves with age, extending earlier cellular studies linking Pgc-1β ablation to increased 
arrhythmic risk (Gurung et al., 2011 a).  No arrhythmias were observed in any group during 
regular pacing at a frequency of 8 Hz.  Regular pacing at this rate falls within the murine resting 
heart range and so would not be expected to trigger arrhythmias.  The Pgc-1β deficient hearts 
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are known to have a mild cardiac phenotype in the non-stressed state in keeping with these 
findings.  In contrast, several arrhythmias were observed in Pgc-1β-/- hearts during 
programmed electrical stimulation.  Exceptionally few arrhythmias occurred in young WT 
hearts and the incidence was greater in aged WT hearts reflecting patterns seen in the clinical 
setting and underlining the impact of age on arrhythmic risk.  Mitochondrial dysfunction 
progresses with age through the accumulation of mutations in mitochondrial DNA and 
impaired autophagy (Michikawa et al., 1999; Pyo et al., 2013), with this shift in arrhythmic risk 
possibly being its sequelae.  This effect was further emphasised by the even higher incidence 
of arrhythmia seen in Pgc-1β deficient hearts that possess a more pronounced mitochondrial 
deficit.  Here, young Pgc-1β-/- hearts had the greatest incidence of arrhythmia of any group.  
The absolute incidence in aged Pgc-1β-/- hearts was lower; however these hearts displayed 
alterations in the nature of the arrhythmias that would be expected to have the most 
deleterious features.  That is, the duration of arrhythmias occurring in aged Pgc-1β-/- hearts 
were far greater than that in any other group including the young Pgc-1β-/- hearts.  Thus 
although the incidence was higher in young Pgc-1β-/- hearts, the proportion of time spent in 
arrhythmia was greatest in aged Pgc-1β-/- hearts. 
 
Characterisation of the electrophysiological parameters suggested that the increased 
vulnerability to arrhythmia in Pgc-1β-/- hearts arise primarily through abnormalities in AP 
initiation and conduction.  Both young and aged Pgc-1β-/- hearts showed reduced (dV/dt)max 
values compared to WT hearts during regular pacing. However no difference was observed 
between young and aged hearts of the same genotype.  APs in response to S2 stimuli during 
the PES protocol displayed a similar segregation between genotypes in terms of (dV/dt)max 
values at longer S1-S2 intervals.  The values of (dV/dt)max fell in all experimental groups whilst 
preserving their relative magnitudes between groups with shortening S1-S2 coupling interval. 
However (dV/dt)max values converged at the shortest intervals that represented the greatest 
electrophysiological stress. Thus Pgc-1β-/- hearts displayed compromised (dV/dt)max at modest 
levels of stress, underpinning their greater vulnerability to arrhythmia through longer periods 
of the protocol.  Values of (dV/dt)max have been shown to correlate with both peak sodium 
current and conduction velocity in skeletal and cardiac muscle (Hondeghem and Katzung, 
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1977; Jack et al., 1983; Usher-Smith et al., 2006; Fraser et al., 2011).   
 
Metabolic stress has been previously reported to reduce peak sodium currents in 
cardiomyocytes (Liu et al., 2009) and this could be reversed with the mitochondrial specific 
ROS scavenger mitoTEMPO (Liu et al., 2010 b). Additionally, activity of the mammalian 
voltage-gated Na+ channel is influenced by cytosolic [Ca2+] through C-terminal IQ- and EF-
hand-like motifs sensitive to calmodulin/calmodulin kinase II (Mori et al., 2000).  Elevated 
intracellular [Ca2+] caused reductions in INa density and (dV/dt)max in cardiomyocytes in vitro 
(Casini et al., 2009), and in whole hearts either through application of caffeine (Zhang et al., 
2009), previously shown to increase diastolic Ca2+ release, or mutations associated with 
diastolic Ca2+ release (Glukhov et al., 2013; King et al., 2013 b; Li et al., 2014; Ning et al., 2016 
a).  Diastolic Ca2+ transients have been demonstrated in myocytes from Pgc-1β-/- hearts 
(Gurung et al., 2011 a), thus presenting a further mechanism through which (dV/dt)max may 
be reduced. 
 
Additionally, slow AP conduction in Pgc-1β-/- hearts was also reflected in measurements of AP 
latencies. These increased with ageing in WT hearts despite similar values of (dV/dt)max in 
young and aged hearts.  In contrast, AP latency times were prolonged in Pgc-1β-/- hearts to an 
even greater degree, with no difference in young and aged hearts. Pgc-1β-/- hearts showed 
longer latencies than WT hearts during both regular pacing and at the longest S1-S2 coupling 
intervals without effects of age or its interactions with genotype. AP latencies increased with 
falling S1-S2 intervals preserving their relative magnitudes between groups. However, at the 
shortest S1-S2 intervals interactive effects of genotype and age appeared to result in 
significantly shorter AP latencies in young WT hearts than the remaining groups. The latter 
differences between (dV/dt)max and AP latency properties with PES were explored by 
comparing dependences of AP latency upon (dV/dt)max between groups. AP latencies 
consistently increased with falling (dV/dt)max values in APs obtained in response to the 
extrasystolic S2 stimuli during PES as expected from established relationships between Na+ 
currents, (dV/dt)max and conduction velocity (Hunter et al., 1975). However, young and aged 
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WT hearts displayed two separate plots reflecting consistently greater AP latencies at any 
given (dV/dt)max, in aged compared to young WT. In contrast, both young and aged Pgc-1β-/- 
fell on similar functions that resembled those obtained in aged as opposed to young WT 
hearts. 
 
The latter differences were tested in terms of suggestions that whereas (dV/dt)max primarily 
reflects discharge of the cardiomyocyte membrane capacitance by sodium current, AP 
conduction velocity is further influenced by increases or decreases in tissue resistance and 
capacitance (Jeevaratnam et al., 2011; King et al., 2013 a). Previous reports had associated 
such conduction changes with progressive myocardial fibrosis with age in various animal 
(Eghbali et al., 1989; Orlandi et al., 2004; Lin et al., 2008; Jeevaratnam et al., 2012, 2016) and 
human studies (Gazoti Debessa et al., 2001). Histological results at least partly confirmed such 
a hypothesis. Age and genotype then independently resulted in increased ventricular fibrosis 
(p < 0.05 for both), with no evidence of effects of age-genotype interaction. There was thus 
increased fibrotic change in aged compared to young WT hearts, but also increased fibrotic 
change in Pgc-1β-/- hearts in which fibrotic levels in young Pgc-1β-/- hearts reached those 
shown by aged WT hearts.  
 
These findings at the tissue level fulfil predictions from previous evidence for cellular roles for 
mitochondrial ROS in fibrotic change (Weiss et al., 1989; Wang et al., 2004; Terentyev et al., 
2008; Brown and O’Rourke, 2010; Liu et al., 2010 b; Bovo et al., 2012). Mitochondrial targeted 
catalase overexpression protected transgenic mice from features of cardiac ageing including 
myocardial fibrosis (Dai et al., 2009). Conversely, mice lacking mitochondrial sirtuin SIRT3 
demonstrated increased mitochondrial ROS production and cardiac fibrosis (Hafner et al., 
2010). Finally, TGF-β activity, thought involved in age-related myocardial fibrosis (Brooks and 
Conrad, 2000; Rosenkranz et al., 2002; Guzadhur et al., 2010; Hao et al., 2011; Davies et al., 
2014) is enhanced by oxidative stress (Barcellos-Hoff and Dix, 1996; Sullivan et al., 2008 b). 
Such fibrotic change could disrupt gap junction function increasing tissue resistance (Xie et al., 
2009). It could also increase fibroblast-cardiomyocyte coupling through Cx43 and Cx45, and 
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the consequent effective membrane capacitances (Camelliti et al., 2004; van Veen et al., 2005; 
Chilton et al., 2007).  The mitochondrial dysfunction in Pgc-1β-/- hearts could also potentially 
directly impair gap junction function through elevating intracellular [Ca2+] (De Mello, 1983) or 
cause oxidative stress induced alterations in connexion phosphorylation (Sovari et al., 2013). 
 
No differences in APD90, APD70, APD50 or APD30 were observed between groups. These 
parameters are in turn surrogates of APD, which is difficult to measure as it approaches the 
baseline RMP asymptotically. Thus all these parameters may be taken as measuring a corollary 
of APD, though as the percentage of repolarisation measured shortens, the relative 
contribution of the various channels in the murine action potential (Figure 1-1) varies, with a 
greater contribution of the plateau period, Ca2+ and Ito currents at shorter APD percentages.  
 
Although both young and aged Pgc-1β-/- hearts showed shorter effective refractory periods 
(ERPs) than WT, particularly aged WT hearts. Although ERP shortening is often accompanied 
by corresponding reductions in APD (Davidenko and Antzelevitch, 1986; Lee et al., 1992), this 
need not be the case in all circumstances and indeed discordant alterations in APD and ERP 
have been reported previously (Martin et al., 2011 a).  At all events, this ERP shortening would 
be consistent with increased likelihoods of re-entry in the Pgc-1β-/- hearts. 
 
Finally the AP wavelength, expressed as a product of AP activation and recovery terms, has 
been used as a criterion for pro-arrhythmic tendency. Wavelength has been postulated to be 
an important parameter in arrhythmic theory.  Longer and shorter wavelengths respectively 
correspond to reduced or increased likelihood of re-entry (Davidenko et al., 1995; Zaitsev et 
al., 2000; Weiss et al., 2005; Matthews et al., 2013 a; Pandit and Jalife, 2013; Spector, 2013). 
Shorter wavelengths are presumed to have more pro-arrhythmic potential, as it allows for re-
entry of excitation in a circuitous manner; circus movement re-entry occurs when an 
activation wavefront propagates around an anatomic or functional (e.g. refractory 
myocardium) obstacle or core, and re-excites the site of origin (Antzelevitch and Burashnikov, 
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2011). In this type of re-entry, all cells take turns in recovering from excitation so that they are 
ready to be excited again when the next wavefront arrives. The stability of this kind of re-
entrant arrhythmia is determined by the fact that the circuit is longer than the wavelength of 
the electrical impulse, leaving an excitable gap between head and tail of the circulating wave 
to allow re-excitation. Shorter wavelengths are thus more pro-arrhythmic as they allow for a 
longer excitable gap. Cardiac fibrosis may can exacerbate this excitable gap between the head 
and tail of a circulating wave in a number of ways. Firstly, if the fibrosis is local and dense it 
can be an anatomical block for a re-entrant circuit to propagate around. Secondly, it may slow 
conduction velocity by increasing tissue resistivity, disrupt gap junction function and therefore 
shorten wavelength.  
 
The experimental configuration employed to determine wavelength entailed uncertainty in 
measuring conduction velocity owing to corresponding uncertainty concerning the path taken 
by the depolarising wave. The experimental technology to map multiple areas of myocardium 
simultaneously exists to a limited degree for the surface myocardium/epicardium – however 
there is no method in existence to map the conduction path in an intra-mural course and this 
yields a degree of uncertainty over the true conduction path and conduction length between 
hearts if they contain anatomic heterogeneities which may impact upon the conduction path. 
Similarly, ERP measurements reflect AP recovery from refractoriness over the entire line of 
tissue between stimulus and recording sites, and any heterogeneities in either ERP or of 
effective AP conduction along this pathway (Martin et al., 2011 a). Furthermore, in contrast 
to the absolute refractory period, ERP depends upon the value of the effective stimulus 
intensity at the site of membrane excitation (Duehmke et al., 2012). Nevertheless, the present 
estimates employed two separate conduction velocity measures of (dV/dt)max and the 
reciprocal of AP latency and ERPs were obtained under conditions of applied stimuli 
amplitudes consistently scaled relative to the observed AP thresholds. Wavelengths derived 
from (dV/dt)max would incorporate electrophysiological properties at the single cell level 
whereas wavelengths derived from AP latency would further include contributions from 
cardiomyocyte coupling resulting from tissue fibrosis. Both measures demonstrated lower 
values in Pgc-1β-/- compared to WT hearts but no effects of either age or interactions between 
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age and genotype.  However, in post hoc analysis of wavelengths derived from AP latencies, 
aged WT hearts showed significantly higher values than young Pgc-1β-/- hearts but not aged 
Pgc-1β-/- hearts, accounting for the observed differences in the arrhythmic incidences.  
 
However despite the initial elegance of such a wavelength based theory of arrhythmia, there 
are a number of gaps that should be highlighted. Firstly, the theory should mean that there is 
a minimal myocardial volume necessary for arrhythmia – yet structures such as murine atria 
were long thought not to have sufficient volume for sustained arrhythmia as the wavelength 
of excitation is in the same order of magnitude as the size of the entire atria. It was thus 
proposed that there needed to be a critical cardiac mass for sustained arrhythmias (Janse and 
Rosen, 2006) but this has also been demonstrated to be insufficient to explain 
arrhythmogenesis (Vaidya et al., 1999). Many studies have shown that murine atria can 
sustain arrhythmia rendering such analyses oversimplified at best or incorrect at worst (Riley 
et al., 2012; Huang, 2017 b). Thus it is evident that while wavelength may be part of arrhythmic 
theory it is not sufficient to explain arrhythmia, not least in small mammals. 
 
Further limitations of the study centre around the use of Langendorff perfused heart studies, 
which are routinely used in the domain of cardiac electrophysiology. However, it must be 
borne in mind that despite its widespread adoption, the Langendorff heart has a number of 
important limitations which do impact upon the study. The Langendorff preparation is 
designed to emulate a physiological state as far as possible, with a whole intact organ perfused 
by its natural vasculature through retrograde filling of the coronary arteries. However, the 
perfusion is not completely physiological – firstly the perfusate is typically a crystalloid 
solution such as Krebs-Henseleit or Tyrode’s solution.  Thus the oxygen carrying capacity of 
such a perfusate is limited compared to blood. The perfusate requires continuous gasification 
(typically with 95% O2/5% CO2 carbogen) to increase oxygen concentration to a point which 
allows a stable, non-hypoxic, preparation. Despite this, the oxygen carrying capacity is limited, 
and could potentially compound experiments in which mitochondrial function (which in turn 
impacts upon oxidative phosphorylation) is being examined. This is mitigated somewhat by 
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ensuring all experimental hearts are exposed to the same conditions, though does not rule 
out hearts with mitochondrial dysfunction being more sensitive to such experimental 
conditions and thus over-estimating the effect of electrophysiological changes attributed to 
mitochondrial dysfunction . 
 
Conversely, the use of blebbistatin in our experiments reduces the energetic requirements of 
the heart and in turn oxygen requirements. Again, as the experimental protocol is 
standardised, the magnitude of the effect could be postulated to be identical across all groups 
– and would in fact tend to underestimate the magnitude of any arrhythmic effect in 
mitochondrial dysfunction (i.e Pgc-1β-/- mice) in any statistical analysis. The use of blebbistatin 
itself is widespread in cardiac electrophysiology optical mapping studies with suggestions of 
minimal electrophysiological effect, importantly having no effect on calcium transients unlike 
other electromechanical uncouplers (Fedorov et al., 2007; Physiology et al., 2010). However, 
it cannot be assumed to be completely inert in term of its electrophysiological effect, as a 
number of studies have postulated that electromechanical feedback is an important factor in 
arrhythmogenesis (ter Keurs, 2011; Wall et al., 2012). Further, a single study has found that 
there are electrophysiological changes associated with its use in rabbit hearts (though making 
it more difficult to provoke arrhythmia) (Brack et al., 2013). 
 
Overall these findings extend initial studies on the Pgc-1β-/- model at the cellular level to 
obtain electrophysiological evidence for increased arrhythmic substrate under conditions of 
chronic mitochondrial deficiencies. They then attribute this predominantly to decrements in 
measures of AP conduction, as reflected in (dV/dt)max and AP latency, and demonstrate this is 
accompanied by increased fibrotic change with age in Pgc-1β-/- mice. 
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5. EFFECTS OF AGEING ON PRO-ARRHYTHMIC 
VENTRICULAR PHENOTYPES IN INCREMENTALLY PACED 
MURINE Pgc-1β-/- HEARTS 
 
5.1 INTRODUCTION 
 
Previous studies on models of monogenic ion channel disorders have studied action potential 
(AP) waveforms and their stability in isolated Langendorff-perfused hearts subjected to 
episodes of regular pacing at progressively decremented basic cycle lengths (BCLs) (Sabir et 
al., 2007 b; Matthews et al., 2013 c). Monophasic action potential (MAP) recordings provided 
indications of AP latencies, durations (APDs) and refractory periods. They also provided 
evidence as to whether alternans in AP characteristics, occurred with decreasing BCLs (Ning 
et al., 2016 a). Alternans is defined by the alternation of an AP characteristic between 
successively lower and higher values (for at least ten successive beats in this study – see 
methods) and has been established as presaging arrhythmia in clinical and experimental 
situations (Rosenbaum et al., 1994; Gold et al., 2000). These instabilities could be analysed in 
terms of restitution analyses (Nolasco and Dahlen, 1968), a theoretical construct to assess AP 
recovery properties through dependences on APDs and diastolic intervals (DI) (Sabir et al., 
2008 a, 2010; Matthews et al., 2012). Similarly, AP activation or propagation properties have 
been assessed through an adaptation of restitution analysis (Martin et al., 2012 a; Huang, 2017 
b), by calculation of an AP wavelength parameter and through construction and comparisons 
of active and resting AP wavelengths (Matthews et al., 2013 c). Together, these separated 
arrhythmic phenotypes arising from alterations in recovery properties in Scn5a+/∆KPQ and 
hypokalaemic hearts (Killeen et al., 2007; Sabir et al., 2007 c) from those attributed to 
compromised AP activation and conduction in Scn5a+/- hearts (Martin et al., 2011 a;  b).  
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The present study extends these analyses to the Pgc-1 model of mitochondrial dysfunction in 
an exploration of the electrophysiological consequences of energetic dysfunction. It explores 
whether the various wavelength characteristics of Pgc-1β-/- mice offer further insight into the 
arrhythmic characteristics seen in earlier chapters, as well as calculation of active and resting 
wavelength parameters to explore the concordance of these arrhythmic models with the 
present findings. 
 
5.2 RESULTS 
 
We performed simultaneous electrocardiographic (ECG) whole heart recordings and action 
potential (AP) measurements from single cardiomyocytes in intact ex-vivo Langendorff-
perfused hearts. Each procedure began with a programmed electrical stimulation protocol 
interposing extrasystolic (S2) stimuli at successively decremented intervals following trains of 
8 regular (S1) stimuli applied at a 125 ms basic cycle length (BCL). Overall ventricular electrical 
activity through the S1S2 protocol was monitored by the ECG recordings. Analysis of these 
initial recordings yielded ventricular effective refractory periods (VERPs) that indicated the 
extent to which BCLs could be decreased in the succeeding experiments. A comparison of 
VERPs in young and aged, WT (57.36 ± 2.06 and 56.3 ± 1.96 ms , (n = 23) and (n = 19) 
respectively) and Pgc-1β-/- hearts (53.99 ± 2.2 and 47.64 ± 1.84 ms (n = 21) and (n = 25) 
respectively), demonstrated that Pgc-1β-/- hearts showed shorter VERPs than WT hearts 
(56.88 ± 1.42 vs 50.54 ± 1.48 ms; (n = 42 vs 46); p < 0.01), without effects of either age or 
interactions between age and genotype.  
 
Intracellular microelectrode recordings of cardiomyocyte APs within left ventricular epicardia 
were then obtained in parallel with ECG recordings of isolated Langendorff hearts during an 
incremental pacing protocol. Trains of 100 regular stimuli were imposed at BCLs progressively 
shortened by 5 ms with each successive stimulus train. These examined for the presence of 
arrhythmic activity and alternans in AP parameters related to their activation or recovery. 
Figure 5-1 tracks the progress of the experiments through the incremental pacing protocol in 
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all four groups, using Kaplan-Meier plots of the probability of hearts showing regular 1:1 
evoked activity with decreasing BCL. Quantitative analysis was performed for BCLs up to 55 
ms, after which insufficient hearts showed regular 1:1 capture for analysis. The BCL at which 
hearts failed to follow the repetitive pacing and entered 2:1 block reflect their VERP at that 
particular pacing rate. A log rank test demonstrated that the Kaplan-Meier curves from the 
different experimental groups (Figure 5-1) showed significant differences from each other (p 
< 0.01). VERPs at the termination of the protocol (young WT: 64.35 ± 2.16 ms, (n = 23); aged 
WT: 61.84 ± 2.33 ms (n = 19); young Pgc-1β-/-: 68.33 ± 1.26 ms (n = 21); aged Pgc-1β-/- hearts: 
61.0 ± 1.83 ms (n = 25)) were obtained from the BCLs achieved just prior to the onset of 2:1 
atrioventricular conduction block.  
 
 
Figure 5-1: Kaplan-Meier plot of 1:1 capture. Kaplan-Meier plot of the proportion of young and aged 
WT and Pgc-1β−/− hearts showing regular activity with increasing pacing frequency with the progressive 
fall off at higher pacing frequencies resulting in hearts losing capture and entering either 2:1 conduction 
block or arrhythmia. Total sample size: young WT (n = 23), aged WT (n = 19), young Pgc-1β-/- (n = 21) 
aged Pgc-1β-/- (n = 25). 
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5.2.1 AGE-DEPENDENT ARRHYTHMIC PHENOTYPES IN PGC-1Β-/- HEARTS 
 
Figure 5-2 exemplifies traces of normal, arrhythmic and pro-arrhythmic activity from all four 
experimental groups obtained in the course of the incremental pacing protocol. Under these 
experimental conditions, there were no observations of spontaneous early or delayed after-
depolarizations. The latter have been reported in other pro-arrhythmic murine systems where 
they have been implicated in arrhythmic triggering (Balasubramaniam et al., 2004, 2005; 
Goddard et al., 2008 b). Figure 5-2 compares parallel ECG (i) and intracellular AP recordings 
(ii) of regular activity at a BCL of 130 ms in ventricles from a young WT mouse (A). Similar 
simultaneous ECG (i) and intracellular AP recordings (ii) recordings made it possible to detect 
ectopic beats (B), monomorphic ventricular tachycardia (VT) (C) and torsades de pointes (TdP 
- an uncommon and distinctive form of polymorphic VT characterized by a gradual change in 
the amplitude of the ventricular complexes and their twisting around the isoelectric 
baseline)  (D) in aged Pgc-1β-/- hearts. The intracellular recordings at expanded time bases 
made it possible to discern alternans in APD (E) and both maximal AP upstroke rate, (dV/dt)max 
and APD (F) in Pgc-1β-/-  hearts. 
 
Table 5-1 quantifies the occurrence of arrhythmic phenomena in cardiomyocytes from which 
the intracellular records were obtained. Aged Pgc-1β-/- hearts showed the highest arrhythmic 
incidences compared to the remaining groups (p < 0.05). The latter groups showed similar, 
reduced, arrhythmic frequencies. Aged Pgc-1β-/- hearts were also the only experimental group 
that showed ectopic activity, monomorphic VT and polymorphic VT (Fig. 2B, C, D). The 
incidence of arrhythmias in hearts from young Pgc-1β-/- hearts was not distinguishable from 
their WT counterparts. 
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Table 5-1: Frequency of arrhythmia in the various experimental groups. 
 Arrhythmic  Non Arrhythmic  Total (n) Percentage Arrhythmic 
Young WT 4 19 23 17.4 
Aged WT 3 16 19 15.8 
Young Pgc-1β-/- 4 17 21 19.0 
Aged Pgc-1β-/- 12* 13 25 48* 
* denotes a significance level of p < 0.05 using a fisher exact test 
 
 
Figure 5-3 exemplifies the different forms of alternans in AP characteristics observed in a 
typical aged Pgc-1β-/- heart. Each panel displays (from top to bottom) AP waveforms, AP 
latencies, the first derivative, dV/dt, of the AP waveform, APD90 and RMP respectively. This 
makes it possible to directly visualize alternans in one or more electrophysiological 
parameters. The panels demonstrate the possible combinations of alternans involving 
activation or recovery parameters. Thus, the alternans in (A) involves the recovery variable of 
APD90 alone while (B) demonstrates alternans in the activation variables of AP latency and 
(dV/dt)max alone. In contrast, (C) and (D) exemplify simultaneous alternans involving both 
activation and recovery variables. They include the extreme situations resulting in alternate 
high/low latencies (and therefore low/high (dV/dt)max) simultaneously associated with 
high/low APD90 (C) or low/high APD90 (D). The second case (D) would correspond to the most 
pro-arrhythmic situation.  The bottom control trace shows the (relatively constant) resting 
potentials through the alternans phenomena. 
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Figure 5-3: Alternans phenomena. Examples of alternans phenomena comparing records of AP 
waveform, AP latency, (dV/dt), APD90 and RMP respectively in each panel. In (A), alternans exclusively 
involves the recovery variable APD90 while in (B), it involves the activation variables of AP latency and 
(dV/dt) alone. In (C) and (D), there is simultaneous alternans involving both activation and recovery 
variables. These include situations in which the alternating action potentials with higher/lower 
latencies and therefore lower/higher (dV/dt)max show either higher/lower (C) or lower/higher (D) APD90, 
respectively 
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5.2.2 INCREASED FREQUENCIES OF ALTERNANS IN PGC-1Β-/- HEARTS 
 
The presence of alternans in one or more AP characteristics with variations in BCL is an 
established marker for the instability presaging development of arrhythmia. We first 
compared the number of beats showing alternans in maximum AP upstroke rate (dV/dt)max 
(Fig. 5-4A), AP latency (Fig. 5-4B), AP duration to 90% recovery (APD90) (Fig. 5-4C) and resting 
membrane potential (RMP) (Fig. 5-4D) in young and aged, WT  and Pgc-1β-/- hearts through 
the incremental pacing protocol described above.  
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Overall incidences of alternans were obtained for each heart by summing the number of beats 
of alternans at each BCL examined. The results were then compared between experimental 
groups. Pgc-1β-/- hearts showed greater overall incidences of alternans compared to WT 
hearts in all the parameters (dV/dt)max, AP latency, APD90  and RMP. Thus, both young and 
aged Pgc-1β-/- hearts displayed an increased tendency to display alternans (Table 5-2).  
 
 
Table 5-2: Results of ANOVA comparisons of alternans features in Pgc-1β-/- 
and WT hearts. Values represent number of beats out of 1600 beats. 
 AP parameter Pgc-1β-/- WT p-value 
Overall 
incidences of 
alternans 
(beats) 
(dV/dt)max 872 ± 42    659 ± 41   p < 0.0001 
AP latency 928 ± 49    672 ± 35  ;  p < 0.001 
APD90  1089 ± 40    868 ± 46   p < 0.001 
RMP
 
 852 ± 42    694 ± 44    p = 0.01 
Maximum 
duration of 
alternans 
episodes 
(beats) 
(dV/dt)max 535 ± 41   404 ± 36   p < 0.05 
AP latency  611 ± 46   456 ± 34   p < 0.01 
APD90  682 ± 57    509 ± 44   p < 0.05 
RMP 417 ± 35  312 ± 32   p < 0.05 
 
 
Secondly, in addition to the above effects of genotype alone, genotype and age exerted 
interacting effects on the incidence of AP latency alternans (p < 0.05) and APD90 alternans (p 
< 0.05). Young WT hearts had the lowest incidences of AP latency alternans (575 ± 51 beats) 
with progressive increases in this incidence through the series: young Pgc-1β-/- hearts (785 ± 
78 beats), aged WT hearts (790 ± 33 beats) and aged Pgc-1β-/- hearts (923 ± 81 beats), with 
the last group showing the greatest amount of AP latency alternans. Post hoc testing 
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demonstrated significantly more AP latency alternans in young Pgc-1β-/- hearts compared to 
young WT hearts (p < 0.01) and aged Pgc-1β-/- hearts compared to young WT hearts (p < 
0.001). A similar pattern emerged in post hoc testing for APD90  alternans: all remaining groups 
showed significantly more alternans than young WT hearts (young WT vs young Pgc-1β-/- :726 
± 65 beats vs 1068 ± 53 beats, p < 0.001; young WT vs aged WT: 726 ± 65 beats vs 1040 ± 37 
beats, p = 0.001; young WT vs aged Pgc-1β-/:- 726 ± 65 beats vs 1107 ± 60 beats; p < 0.0001). 
 
5.2.3 ALTERNANS AT LONGER BCLS, WITH LONGER EPISODES, AND INVOLVING 
MULTIPLE AP PARAMETERS IN PGC-1Β-/- HEARTS 
 
Fig. 5-4 also displays the distribution of alternans in each parameter across different BCLs for 
each experimental group. It is apparent that there are greater incidences of alternans at 
longer BCLs in Pgc-1β-/- hearts than WT hearts. This suggests that they have a greater tendency 
to instability even at lower heart rates. In addition to the absolute burden of alternans 
described previously, we quantified the number of discrete sequences of alternans per 
protocol, the maximum duration of alternans as well as the amount of simultaneous alternans 
between multiple parameters. 
 
First, there were no distinguishable differences in the number of discrete episodes of 
alternans in (dV/dt)max, APD90 or RMP between young and aged, Pgc-1β-/- and WT hearts. In 
contrast, aged Pgc-1β-/- hearts showed a higher number of discrete runs of AP latency 
alternans than young WT hearts (11.0 ± 1.24 vs 7.43 ± 0.58 runs of alternans; p < 0.05).  
 
Secondly, the maximum duration of individual alternans episodes, whether involving 
(dV/dt)max, AP latency, APD90 or RMP, were significantly longer in Pgc-1β-/- hearts than in WT 
hearts. The maximum duration of alternans episodes involving AP latency also showed 
significant interactive effects of age and genotype (p < 0.05). Post hoc testing demonstrated 
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that young Pgc-1β-/- hearts showed longer durations of AP latency alternans than young WT 
hearts (683 ± 62 beats vs 406 ± 50 beats p < 0.01). 
 
Thirdly, alternans simultaneously involving different AP characteristics were observed within 
the same heart. This could involve situations in which the alternating high/low AP latencies or 
reduced/increased (dV/dt)max coincided with higher/lower APD90 values (Fig. 5-3C), or in the 
more pro-arrhythmic pattern, occurred out of phase with higher/lower APD90 values (Fig. 5-
3D). Pgc-1β-/- hearts showed more frequent simultaneous (dV/dt)max and APD90 alternans 
compared to WT hearts (72.15 ± 2.22% vs 64.97 ± 3.03% of beats respectively; p = 0.05), with 
similar occurrences of both patterns of alternans. Pgc-1β-/- hearts also showed more frequent 
simultaneous APD90 and AP latency alternans (74.03 ± 2.92% vs 65.11 ± 2.61% of beats; p < 
0.05). In this case a greater number of beats assumed the more pro-arrhythmic pattern (697 
± 58 beats vs 537 ± 43 beats; p < 0.05). The incidence of the more pro-arrhythmic pattern of 
alternans was also significantly affected by interactions between age and genotype (p < 0.05). 
Post-hoc Tukey tests demonstrated that young Pgc-1β-/- hearts showed higher incidences of 
simultaneous alternans than young WT hearts (p = 0.01). 
 
Finally, we quantified the amplitude of alternans where this occurred, by calculating the mean 
differences between successive peak and trough values in each parameter. These findings 
contrastingly demonstrated no significant variations between groups. 
5.2.4 ALTERED ACTION POTENTIAL CHARACTERISTICS IN YOUNG AND AGED PGC-1Β-/- 
HEARTS 
 
These differences in electrophysiological stability and pro-arrhythmic tendency were then 
correlated with differences in AP activation and recovery characteristics over the range of 
BCLs explored. Fig. 5-5 plots the activation variables of (dV/dt)max (A) and AP latency (B) as well 
as the recovery variables of APD90, (C) RMP (D), as well as diastolic interval, DI, (given by the 
time between the action potential peak and the preceding APD90) (E) against BCL in young and 
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aged, Pgc-1β-/- and WT hearts. All data varied monotonically with BCL and so their overall 
magnitudes could be compared by the areas beneath their curves. Table 5-3 demonstrates 
that hearts with the Pgc-1β-/- genotype have lower (dV/dt)max values and increased AP 
latencies relative to WT (both p < 0.001). However, there were no detectable effects of either 
ageing or any interaction between genotype and ageing on (dV/dt)max. In contrast, neither 
APD90 nor RMPs were influenced by genotype alone. However, APD90 was longer in aged Pgc-
1β-/- hearts than young Pgc-1β-/- hearts (p < 0.05), and RMP greater in aged than young hearts.  
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Figure 5-5: Variation of AP parameters with basic cycle length. Dependence of maximum rate of AP 
depolarization, (dV/dt)max (a), AP latency (b), APD90 (c), RMP (d) and DI (e) on BCL in young and aged, 
WT and Pgc-1β hearts (n = 23; n = 19; n = 21; n= 25 respectively).
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Table 5-3: Areas under the curves (AUC) of AP parameter with respect to BCL. 
Parameter All WT Young WT Aged WT 
All Pgc-1β-
/-
 
Young 
Pgc-1β-/- 
Aged Pgc-
1β-/- All Young All Aged 
(dVdt)max (mV) 
8719.17 ± 
241.3*** 
8644.38 ± 
315.86 
8809.71 ± 
380.44 
7202.22 ± 
323.25*** 
7118.87 ± 
429.06 
7272.23 ± 
480.81 
7916.3 ± 
284.69 
7936.14 ± 
336.1 
APD90 (ms2) 
3025.52 ± 
77.85 
3049.12 ± 
111.58 
2996.97 ± 
109.6 
2938.67 ± 
101.34 
2658.59 ± 
153.61† 
3173.94 ± 
117.74† 
2862.73 ± 
97.22 
3097.52 ± 
82.14 
DI90 (ms2) 
3425.62 ± 
86.84 
3432.78 ± 
85.07 
3416.96 ± 
165.08 
3470.24 ± 
110.69 
3608.28 ± 
174.96 
3354.29 ± 
140.05 
3516.54 ± 
94.39 
3381.35 ± 
105.68 
AP Latency (ms2) 
815.11 ± 
29.12*** 
797.85 ± 
38.96 
836.02 ± 
44.48 
994.64 ± 
54.38*** 970.68 ± 80.8 
1014.77 ± 
74.79 
880.33 ± 
45.04 937.58 ± 48.1 
RMP (mV) 
-5214.08 ± 
114.15 
-5148.33 ± 
149.22 
-5293.68 ± 
178.95 
-5144.06 ± 
133.21 
-4768.19 ± 
91.03 
-5459.8 ± 
215.23 
-4966.9 ± 
92.91‡ 
-5388.06 ± 
143.66‡ 
Table represents the overall magnitude of each parameter across the different experimental categories. Values were obtained by calculating the area under the 
curves for each parameter in each heart and then means and standard errors calculated. Results of statistical tests are shown. Each symbol represents statistical 
results from ANOVA; *** denote p < 0.001 for independent effects of genotype; ‡ denote p < 0.05 for independent effects of age; † denote p < 0.05 for interacting 
effects of genotype and age 
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5.2.5 WAVELENGTH AS THE BASIS FOR ARRHYTHMIC SUBSTRATE 
 
The findings above demonstrate pro-arrhythmic features in aged Pgc-1β-/- hearts. Further 
quantification demonstrated increased alternans in both young and aged Pgc-1β-/- hearts. This 
in turn correlated with altered AP activation characteristics as reflected in (dV/dt)max and AP 
latency, as opposed to the recovery characteristics, APD90 and RMP. The following analyses 
further tested the hypothesis that activation and not recovery parameters are the primary 
determinant of arrhythmia in this system. 
 
First, hearts were stratified by arrhythmic and non-arrhythmic phenotypes, regardless of 
genotype or age. AP parameters observed prior to the onset of either arrhythmia or entry into 
2:1 block were then compared. Arrhythmic hearts (n = 20) showed lower (dV/dt)max and longer 
AP latencies than non-arrhythmic hearts (n = 68) ((dV/dt)max: 67.29 ± 6.85 V s-1 vs 87.66 ± 3.28 
V s-1, p < 0.05;  AP latencies: 22.25 ± 1.50 ms vs 18.64 ± 0.88 ms, p < 0.05  respectively). Diastolic 
interval (DI90) durations were calculated from the APD90 time to the next action potential peak, 
thus they were consequently altered as expected from the altered AP rise times (27.43 ± 1.53 
ms vs. 31.54 ± 1.09 ms; p < 0.05). There were no significant differences between their APD90 
(32.75 ± 1.22 ms and 34.79 ± 0.92 ms) and RMPs (-73.81 ± 1.16 mV vs. -73.60 ± 0.72 mV). 
These findings implicate AP activation rather than recovery parameters in the initiation of 
arrhythmia. 
 
Secondly, previous reports have correlated alternans characteristics to arrhythmic tendency 
in both monogenic murine models as well as in clinical situations. Arrhythmic syndromes 
primarily attributed to repolarisation abnormalities, exemplified by the murine Scn5a+/∆KPQ 
model, were associated with alterations in the relationship between APD90 and VERP with 
varying DI (Sabir et al., 2008 a; Matthews et al., 2010, 2012). In contrast, arrhythmia attributed 
to altered conduction in Scn5a+/- hearts was associated with altered relationships between 
active AP wavelengths, λ, and BCL (Ning et al., 2016 a) or resting wavelength λ0 (Matthews et 
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al., 2013 c). Figure 5-6 illustrates the outcome of analyses testing both assumptions. These 
demonstrated indistinguishable limiting slopes in restitution plots of APD90 against DI90 in all 
four experimental groups (Fig. 5-6A), in opposition to the prediction from the first hypothesis. 
We then proceeded to determine λ, calculated as the product of conduction velocity 
represented by 1/(AP latency) and the corresponding VERP at each BCL. This was derived by 
interpolating values from the VERP obtained during the S1S2 protocol at a BCL of 125 ms and 
from the VERP obtained from the BCL during incremental pacing prior to loss of 1:1 stimulus 
capture. Young and aged WT hearts showed similar λ-BCL and λ-λ0 plots (Fig. 5-6B, C). 
However, Pgc-1β-/- hearts showed lower plateau λ values compared to WT hearts, particular 
with ageing. This would be consistent with the relative arrhythmic tendencies in the four 
experimental groups reported here. Further strengthening this hypothesis, the mean 
wavelengths immediately prior to termination of the protocol into either arrhythmia or 2:1 
block were significantly different (p = 0.01) at 4.4 ± 0.31 (n = 20) for arrhythmic vs 5.4 ± 0.20 
(n = 68) for non-arrhythmic hearts.  
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Restitution plots of APD90 
against DI90 (a) and of 
active AP wavelength (b) 
and passive wavelengths (c) 
observed at different BCLs 
through the incremental 
pacing procedure in young 
and aged WT and Pgc-1β −/− 
hearts (n = 23; n = 19; n = 
21; n= 25 respectively) 
 
 
Figure 5-6: Restitution and 
wavelength functions. 
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5.3 DISCUSSION 
 
The present studies explored arrhythmic and pro-arrhythmic phenotypes and their evolution 
with age in murine hearts deficient in peroxisome proliferator activated receptor-γ 
coactivator-1β. PGC-1β upregulates cardiac mitochondrial mass and function, cellular 
metabolism (Lin et al., 2005; Finck and Kelly, 2006; Zamiri et al., 2014), and expression of 
nuclear and mitochondrial genes key to the tricarboxylic acid cycle, fatty acid β–oxidation and 
oxidative phosphorylation (Arany et al., 2005). Pgc-1β-/- hearts thus provided models to study 
effects of mitochondrial impairment on cardiac arrhythmia (Gurung et al., 2011 a). Such 
energetic dysfunction occurs in a number of common, age-dependent, acute and chronic, 
clinical situations (Vianna et al., 2006; Sato et al., 2009; Kucharska-Newton et al., 2010; Akar 
and O’Rourke, 2011) themselves constituting independent risk factors for major ventricular 
arrhythmias (Yeung et al., 2012; Adabag et al., 2015). 
 
Previous studies had characterized arrhythmic phenotypes in murine models of specific 
human monogenic channelopathies. These analyses had attributed arrhythmic substrate 
variously to triggering events resulting in triggered AP firing (Balasubramaniam et al., 2004; 
Goddard et al., 2008 b), altered recovery from excitation (Killeen et al., 2007; Thomas et al., 
2008) or to altered AP activation and propagation (Martin et al., 2012 a; Huang, 2017 b). 
Protocols imposing regular pacing at progressively incremented steady state heart rates 
determined the corresponding stability or instability of action potential (AP) characteristics 
and the onset of alternans (Sabir et al., 2008 a; Matthews et al., 2010, 2012). Alternans, 
whether involving electrocardiographic T-wave deflections or QT intervals, clinically correlates 
with eventual breakdown of the stable, normal pattern of electrical activity leading to major 
arrhythmias (Rosenbaum et al., 1994; Euler, 1999). 
 
The particular experiments described here were prompted by reports that murine Pgc-1β-/- 
cardiomyocytes showed irregular and extrasystolic Ca2+ signalling patterns and spontaneous 
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Ca2+ propagating waves but normal APDs (Gurung et al., 2011 a). They thus shared phenotypic 
similarities with RyR2-P2328S/P2328S myocytes modelling the similarly arrhythmic 
catecholaminergic polymorphic ventricular tachycardia (Goddard et al., 2008 b; Zhang et al., 
2013). Recent work had attributed arrhythmic substrate in RyR2-P2328S/P2328S hearts 
following adrenergic challenge to slowed AP conduction reflecting reduced (dV/dt)max (Hunter 
et al., 1975; Zhang et al., 2013), in turn attributable to reduced Na+ current (King et al., 2013 
b;  d). The resulting arrhythmic substrate would have similarities with that shown by Nav1.5-
haploinsufficient Scn5a+/- hearts (Sheikh et al., 2001; Martin et al., 2012 a; King et al., 2013 a) 
despite it arising from a primary genetic defect not directly involving Nav1.5 (King et al., 2013 
d). Certainly, acute manipulations of Ca2+ homeostasis alter membrane excitability in WT 
skeletal (Usher-Smith et al., 2006) and cardiac muscle (King et al., 2013 b; Li et al., 2017), and 
murine hearts carrying a primary RyR2-P2328S/P2328S genetic modification (Salvage et al., 
2015, 2017; Ning et al., 2016 a). Altered cytosolic Ca2+ handling thus proved a potential 
mechanism modifying Nav1.5 function (Tan et al., 2002; Aiba et al., 2010; Ashpole et al., 2012) 
or expression (Taouis et al., 1991; Duff et al., 1992; Chiamvimonvat et al., 1995) in RyR2-
P2328S/P2328S hearts. This could potentially take place through direct Ca2+- Nav1.5 binding 
at an EF hand motif close to the Nav1.5 carboxy-terminal (Wingo et al., 2004) or indirect Ca2+ 
binding involving an additional ‘IQ’ domain binding site for Ca2+/CaM in the Nav1.5 C-terminal 
region (Mori et al., 2000; Wagner et al., 2011; Grandi and Herren, 2014). At the cellular level 
patch-clamped myocytes show reduced INa and (dV/dt)max with increased pipette [Ca2+] 
(Chiamvimonvat et al., 1995; Casini et al., 2009).  
 
We used intact Langendorff-perfused hearts to permit electrophysiological exploration of the 
arrhythmic and pro-arrhythmic phenotype of Pgc-1β-/- hearts at physiological and varied 
steady-state heart rates. Previous studies in this preparation had employed monophasic 
action potential recordings (Killeen et al., 2007; Thomas et al., 2008). The present study 
introduced a combination of intracellular recordings from individual epicardial left ventricular 
cardiomyocytes and ECG recordings of isolated Langendorff perfused hearts. This permitted 
determinations of absolute resting membrane potentials (RMPs), AP amplitudes, AP latencies 
and action potential durations (APD90), and sufficient bandwidth to follow maximum rates of 
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AP depolarisation (dV/dt)max, determinations that are not possible with monophasic action 
potential recording. The simultaneous ECG recordings made it possible to distinguish 
arrhythmic and non arrhythmic events at the whole organ or chamber levels. As chronic 
mitochondrial lesions likely exert cumulative and time-varying phenotypic effects with 
advancing age, the experiments compared young and aged, Pgc-1β-/- and WT animals.  
 
This use of the Langendorrf preparation is therefore subject to a similar set of limitations as 
discussed previously in Chapter 4. Notably, the use of a crystalloid perfusate and the use of an 
electromechanical uncoupler is something to be borne in mind when interpreting the results. 
The Krebs-Henseleit solution used contains glucose and pyruvate as the primary substrate for 
ATP generation. The heart relies almost entirely on the oxidation of fatty acids as its primary 
fuel source (Jafri et al., 2001) not glucose or pyruvate. This is potentially problematic as it 
reflects non-physiological conditions in an experiment designed to explore mitochondrial 
dysfunction – an organelle intimately involved in fatty acid oxidation. However in an 
aggressive pacing protocol such as used here the energetic demands of the heart are raised 
and even in physiological conditions there would be the expectation of glucose utilisation as 
a metabolic fuel. 
 
The initial experiments applying extrasystolic S2 stimulation following trains of regular 8 Hz 
stimuli at successively decremented S1S2 intervals revealed significantly shorter effective 
refractory periods in Pgc-1β-/- hearts compared to WT hearts, without effects of age or 
interactions of age and genotype. The resulting ERPs informed the subsequent incremental 
protocols, applying sequences of steady stimulation at progressively shortened BCLs. These 
yielded Kaplan Meir curves following the progress of each experimental group into either 2:1 
block or arrhythmia and the corresponding ERP from the BCL beyond which this disruption 
from 1:1 stimulation took place.  
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Incremental pacing proved an effective method of assessing for the presence of pro-
arrhythmic phenotypes in energetically compromised Pgc-1β-/- hearts. The demonstration of 
a pro-arrhythmic phenotype in aged Pgc-1β-/- hearts aligned with epidemiological clinical data 
suggesting age-dependent arrhythmic risks with metabolic disease. Thus, these incremental 
protocols first demonstrated that aged, but not young, Pgc-1β-/- hearts showed increased 
incidences of arrhythmic events. These took the form of both sustained and non-sustained 
monomorphic and polymorphic tachycardias. Early or delayed afterdepolarisation 
phenomena, previously implicated in arrhythmic triggering processes (Balasubramaniam et 
al., 2004; Thomas et al., 2007 a) were not observed, making an arrhythmic phenotype 
dependent on such events less likely.  
 
Secondly, the incremental pacing protocol demonstrated an increased incidence of alternans 
phenomena in Pgc-1β-/- hearts irrespective of age, as compared to WT hearts. These 
alternations concerned both AP activation ((dV/dt)max and AP latency) and recovery (APD90 
and RMP) features. These instabilities appeared at lower pacing frequencies in Pgc-1β-/- hearts 
compared to WT hearts. All four groups of mice showed episodes of simultaneous (dV/dt)max 
and APD90 alternans, that were less frequent in young WT compared to aged WT, and young 
and aged Pgc-1β-/- hearts.  
 
APD alternans has been described as occurring due to the instability of voltage kinetics at the 
tissue level or Ca2+ handling dynamics at the cellular level. However, the exact mechanism of 
cardiac alternans has been difficult to elucidate due to the two-way coupling between voltage 
and Ca2+ handling kinetics. There are two main cellular mechanisms of APD alternans that have 
been postulated from the experimental evidence and simulation studies. At high pacing rates 
or under pathological conditions alternans can originate from the kinetics of the membrane 
voltage, which subsequently causes alternated intracellular Ca2+ mainly through voltage-
related L-type Ca2+ channel (LCC) current (I CaL) (Merchant and Armoundas, 2012; Nivala and 
Qu, 2012). Secondly, the instability of Ca2+ handling dynamics leads to alternated intracellular 
Effects of ageing on pro-arrhythmic ventricular phenotypes in incrementally paced murine Pgc-1β-/- hearts 
 
133 
 
Ca2+, which then causes voltage alternans mainly by ICaL and Na+-Ca2+ exchange current (I NCX) 
(Kanaporis and Blatter, 2015) . 
 
As can be seen there is a great deal of uncertainty regarding the primary instigating 
abnormality that triggers APD alternans. Alternans in activation parameters has never been 
described before in the literature and this study represents the first to do so. This stems from 
the difficulty in recording intracellular action potentials from a moving beating preparation 
and nearly all studies have focused on optical mapping which cannot be used for 
determination of parameters such as (dV/dt)max. Thus the determination of the mechanism of 
such alternans is currently unknown. Empirically, a number of feedback mechanisms could be 
involved including Ca2+ transients (which are involved in APD alternans) to modulate Na+ 
channel function.  
 
Experimental protocols to dissect the contribution of activation parameter alternans from 
recovery parameter alternans would likely necessitate a multi-pronged experimental 
approach, with pharmacological manipulation to abolish Ca2+ transients, in conjunction with 
a voltage clamp method in different experimental pairings to determine if one form of 
alternans is a bigger contributor to arrhythmogenesis than the other. This approach would be 
strengthened by the simultaneous use of a computer modelling approach to probe fruitful 
avenues of exploration and to feed the gathered experimental data into to verify and generate 
new hypotheses.   
 
Incremental pacing together with quantification of findings from micro-electrode recording 
methods permitted discrimination of the role of activation variables, measured as (dV/dt)max 
and AP latency, and the recovery variables of APD90 and RMP and their dependence upon BCL 
in these pro-arrhythmic phenomena. This associated the Pgc-1β-/-genotype with reduced 
(dV/dt)max and increased AP, but with no further effects of either ageing or interactions 
between genotype and ageing. Genotype alone did not influence either APD90 or RMP, 
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although aged Pgc-1β-/- hearts showed longer APD90 than young Pgc-1β-/- hearts, and RMP was 
greater in aged than young hearts. Finally, stratifications by arrhythmic or non-arrhythmic 
phenotype (regardless of age or genotype) demonstrated that (dV/dt)max and AP latencies in 
APs obtained prior to arrhythmia were significantly lower than (dV/dt)max and AP latencies in 
APs prior to entry into 2:1 block in non-arrhythmic hearts. However, there were no significant 
differences in APD90 and RMP values when stratified by arrhythmic phenotype. These findings 
therefore attribute the greater frequency of alternans in Pgc-1β-/-  hearts to alterations in AP 
activation characteristics.  
 
Fourthly, previous reports have demonstrated that arrhythmic substrate resulting from 
repolarisation abnormalities as reported in the Scn5a+/∆KPQ model and hypokalaemic hearts 
for long QT syndrome give restitution plots of APD90 against DI90 with distinct gradient 
properties from those of WT hearts (Sabir et al., 2008 a). However, the present analysis 
applied to Pgc-1β-/- and WT hearts gave loci with indistinguishable limiting slopes.  
 
Finally, a contrasting form of arrhythmic substrate has been attributed to the altered AP 
conduction occurring in Scn5a+/- and RyR2-P2328S/P2328S hearts modelling the Brugada 
Syndrome and catecholaminergic polymorphic ventricular tachycardia respectively. This has 
been associated with alterations in action potential wavelength, λ, reflected by the product of 
conduction velocity and effective refractory period (Sabir et al., 2008 a, 2010, Matthews et al., 
2010, 2012, 2013 c; Ning et al., 2016 a). The present experiments demonstrated that whereas 
young and aged WT hearts showed similar λ-BCL and λ-λ0 plots, young and aged Pgc-1β-/-  
hearts showed progressively reduced maximum λ, an effect more marked in the aged Pgc-1β-
/- hearts. This finding is an exact parallel of the demonstrations of the presence of arrhythmic 
phenotypes and of pro-arrhythmic alternans phenomena. It should be remembered however 
that the wavelength calculations rest upon a number of presumptions not least a reproducible 
conduction path from the stimulating electrode to the recording microelectrode; this may not 
be the case and certainly it may be that different hearts have variant anatomical courses of 
the conduction pathways over different distances. Effort was made to ensure consistent 
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placement of the stimulating electrode and the recording microelectrode though it is not 
possible to ensure that the conduction path between the two is identical in all hearts. Further, 
it is possible that the conduction path changes during the course of an experiment as the BCL 
is decremented; i.e. some conduction paths might become refractory necessitating an 
alternate path. The VERP for each pacing frequency have been interpolated between the two 
measured VERPs at 8hz and at loss of 1:1 capture; there simply exists no data in the literature 
as to how VERP may be altered with pacing frequency. A linear relationship is the simplest 
mathematical model to explain the relationship though definitive experimental evidence 
would be needed to prove this. 
 
However, overall the experimental evidence attributes arrhythmogenesis in Pgc-1β-/- hearts 
to altered (dV/dt)max and activation latency. The present findings thereby also throw light on 
possible more widespread effects of altered intracellular homeostasis on AP propagation in 
addition to suggesting electrophysiological mechanisms for the increased arrhythmic risk 
associated with metabolic disturbance.
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6. REDUCED CARDIOMYOCYTE NA+ CURRENT IN THE AGE 
DEPENDENT MURINE Pgc-1β-/- MODEL OF VENTRICULAR 
ARRHYTHMIA. 
 
6.1 INTRODUCTION 
 
The present experiments were designed to explore a hypothesis implicating alterations in Na+ 
channel function in the age-dependent ventricular pro-arrhythmic Pgc-1β-/- phenotype. 
Application of the loose patch technique (Figure 6-1) permitted a comparison of Na+ against 
K+ currents in ventricular preparations from young and aged, WT and Pgc-1β-/- hearts. The 
loose patch clamp technique apposes an extracellular solution filled electrode against an 
intact, in situ, cardiomyocyte membrane patch without perturbing its intracellular space 
thereby preserving in vivo extracellular [Na+] and intracellular Ca2+ homeostatic conditions 
(Almers et al., 1983 b; Stühmer et al., 1983; King et al., 2013 b). This contrasts with the 
cardiomyocyte isolation and intracellular Ca2+ chelation entailed in conventional whole-cell 
patch clamp (Lei et al., 2005; Gurung et al., 2011 a; Martin et al., 2012 b). Previous loose patch 
clamp experiments reversibly manipulating extracellular [Na+] had identified early inward 
currents elicited by depolarising steps with Na+ currents determining the maximum cardiac AP 
upstroke rate, (dV/dt)max, (King et al., 2013 b). The present experiments could thus assess and 
quantify the activation, inactivation, and recovery from inactivation of inward Na+ currents 
attributable to Nav1.5. They then compared these to the corresponding activation and 
rectification properties of voltage-dependent K+ currents in the same preparations.  
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Figure 6-1: Loose patch clamp configuration. Loose patch clamping of murine ventricular myocytes. 
(a) Experimental loose patch configuration: (a) mounted muscle preparation under Krebs–Henseleit 
solution within (b) experimental chamber. (c) Loose patch pipette mounted at 45° to the preparation 
but bent to permit right-angled contact of pipette tip with the myocyte surface. Pipette held within (d) 
half-cell chamber in turn connected to (e) air line and suction syringe, and mounted on (f) headstage 
moved under micromanipulator and upright microscope guidance. (b) Equivalent circuit of loose patch 
clamp electrode on membrane. Pipette clamped at voltage Vpip. Compensation for the voltage error 
arising from currents flowing through the series combination of the pipette resistance (Rpip) and the 
seal resistance (Rseal) achieved using a bridge circuit in the custom-designed loose patch clamp 
amplifier. As the loose patch technique alters the extracellular potential within the patch relative to 
RMP, negative and positive voltage excursions in Vpip, respectively, produce hyperpolarising and 
depolarising voltage steps relative to RMP.RMP: resting membrane potential; Rpatch: patch membrane 
resistance; Rcell: overall cell membrane resistance 
 
6.2 RESULTS 
6.2.1 CURRENTS REFLECTING VENTRICULAR NA+ CHANNEL ACTIVATION  
 
Isolated ventricular preparations were used for loose patch clamp recordings. Typical results 
of Na+ current activation are shown in Figure 6-2. Comparisons were made between 
experimental groups that consisted of preparations from young (panels A, C; E, G) and aged 
(B, D, F, H), wild-type  (A, B, E, F) and Pgc-1β-/- hearts (C, D, G, H). Displays of the resulting 
current traces are shown at slow (A-D) timebases illustrating the full time course of the current 
records. Those at rapid (E-H) timebases show the detailed kinetics of the transient 
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components of the observed currents. The pulse protocol (Figure 6-2I) used first held the 
patches at the resting membrane potential (RMP) for 5 ms from the beginning of the 80 ms 
recording period. A 5 ms prepulse step to V0 = (RMP - 40 mV) was then applied to remove any 
residual Na+ current inactivation and ensure a consistent initial state of activation of Na+ 
channels within the patch. This was then followed by the depolarising test steps that extended 
to the end of the 80 ms record length; these were of successively larger amplitudes through 
the 13 successive sweeps that were applied, and were made to voltages ranging from V1 = 
RMP to V1 = (RMP + 120 mV), in successive +10 mV increments. The observed currents were 
corrected for residual leakage by the P/4 protocol to give a family of traces reflecting the 
voltage dependence of Na+ channel activation, with inward currents shown as downward, 
negative deflections.  
 
The resulting current traces typically began with a small consistent upward deflection in 
response to the -40 mV prepulse (A-D). The inward currents obtained in response to the 
subsequent test voltage steps to level V1 illustrate the typical Na+ current activation 
characteristics expected. The recorded currents initially increased with time to a peak value 
that became greater with greater voltage excursion and varied nonlinearly with voltage V1. 
Each peak was then followed by an inactivation decay whose characteristics were similarly 
determined by the voltage V1 (E-H). The records demonstrated that ventricular preparations 
from young and aged mice showed similar Na+ current amplitudes. However, Pgc-1β-/- 
ventricular preparations showed consistently smaller Na+ currents than did WT preparations.  
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6.2.2 CURRENTS REFLECTING VENTRICULAR NA+ CHANNEL INACTIVATION  
 
Results from experiments exploring ventricular Na+ current inactivation properties are 
illustrated in Figure 6-3. Again, the experimental groups consisted of preparations from young 
(panels A, C; E, G) and aged (B, D, F, H) wild-type (WT; A, B, E, F) and Pgc-1β-/- mice (C, D, G, 
H).  In the pulse protocols (Fig. 6-3I), patches were first held at the RMP for 5 ms.  This was 
followed by a prepulse of 5-ms duration to V0 = (RMP - 40 mV). Next, depolarising conditioning 
steps were applied to voltages that were altered in 10 mV increments between V1 = RMP to 
(RMP + 120 mV) through the 13 successive sweeps. This conditioning step elicited a Na+ 
current reflecting the process of activation followed by inactivation, with the extent of the 
latter determined by the voltage V1. The extent of inactivation was assessed by imposition of 
the test step 5 ms later to a fixed voltage V2 = (RMP + 100 mV). This voltage was maintained 
to the end of the record length. The resulting traces (Fig. 6-3A-H) reflect Na+ currents which 
would become reduced in amplitude to an extent dependent upon the channel inactivation 
brought about by the prior voltage prepulse to V1.  This combined pulse protocol thus gave 
families of currents in response to the step to voltage V2, the peak currents of which vary 
nonlinearly and decrease in amplitude as voltage V1 is varied. These also demonstrated that 
the magnitudes of the observed currents in preparations from young and aged mice were 
similar, but currents were consistently reduced in Pgc-1β-/- relative to WT ventricular 
preparations.  
6.2.3 VOLTAGE DEPENDENCE OF VENTRICULAR NA+ CURRENT ACTIVATION  
 
Figure 6-2J plots current-voltage curves quantifying the activation of peak ventricular Na+ 
current (means ± standard error of the mean (SEM)) with excursion to the test voltage V1. It 
compares results from preparations from young (circles) and aged (triangles), WT (open 
symbols) and Pgc-1β-/- mice (filled symbols). In such activation plots, the peak inward Na+ 
current, INa, increased with the amplitudes of the depolarising steps beyond +10 mV, reaching 
a maximum value at a voltage excursion at around +80 mV. Their amplitudes then decreased 
with larger voltage excursions as these reached voltages V1 successively closer to the Na+ 
Nernst potential.  
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The activation of such peak Na+ currents, I, was empirically related to the activating voltage V 
= V1 by a Boltzmann function expressed in terms of the maximum value of the peak current, 
Imax, voltage at half maximal peak current, V*, and a steepness factor describing the voltage 
sensitivity of the current, k: I = Imax{1-1/{1 + exp [(V - V*)/k]}}. The maximum values of the peak 
ventricular inward Na+ currents were similar in young WT (-36.63 ± 2.14 (n = 20) pA/μm2) and 
aged WT (-35.43 ± 1.96 (n = 18) pA/μm2) mice. They were reduced to similar extents in young 
(-29.06 ± 1.65 (n = 23) pA/μm2) and aged Pgc-1β-/- mice (-27.93 ± 1.63 (n = 20) pA/μm2). These 
changes reflected independent effects of genotype (F= 16.57; p = 0.0001), but not of age (F= 
0.40; p = 0.53), or of interacting effects of age and genotype (F< 0.001; p = 0.99) on two-way 
ANOVA. Post hoc Tukey tests demonstrated pairwise differences between aged WT and aged 
Pgc-1β-/- hearts (p = 0.033), young WT and young Pgc-1β-/- hearts (p = 0.019), as well as young 
WT and aged Pgc-1β-/- hearts (p = 0.0075). 
 
In contrast, V* values were similar amongst ventricular preparations from young (34.28 ± 1.10 
(n = 20) mV) and aged WT (34.49 ± 0.85 (n = 18) mV), and young (34.49 ± 1.80 (n = 23) mV) 
and aged Pgc-1β-/- hearts (32.22 ± 1.87 (n = 20) mV). Accordingly, 2-way ANOVA demonstrated 
that there were no independent effects of either genotype (F = 0.37; p = 0.54) or age (F = 0.52; 
p = 0.47). Nor were there interacting effects of age and genotype (F = 0.65; p = 0.42). Values 
of k were also similar amongst ventricular preparations from young (3.24 ± 0.25 (n = 20) mV) 
and aged WT (4.06 ± 0.18 (n = 18) mV), and young (4.04 ± 0.28 (n = 23) mV) and aged Pgc-1β-
/- hearts (4.11 ± 0.24 (n = 20) mV). 2-way ANOVA indicated no independent effects of either 
genotype (F = 3.23; p = 0.072) or age (F = 2.96; p = 0.089). Nor were there interacting effects 
of age and genotype (F = 2.34; p = 0.13). 
6.2.4 VOLTAGE DEPENDENCE OF VENTRICULAR NA+ CURRENT INACTIVATION  
 
Figure 6-3J plots the voltage dependences of Na+ current inactivation of preparations from 
young (circles) and aged (triangles), WT (open symbols) and Pgc-1β-/- mice (filled symbols). 
The peak inward Na+ currents observed in response to a depolarising step to a constant test 
voltage decreased as the preceding prepulse voltages, V1, became progressively positive. This 
reflects an inactivation process increasing in extent with progressive depolarisation. The peak 
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currents were related to an inactivation function in the inactivating voltage V = V1 through a 
Boltzmann function of the form: I = Imax /{1 + exp[(V-V*)/k]}.  
 
Values of V* were similar amongst young (39.33 ± 1.32 (n = 20) mV)  and aged WT (37.41 ± 
2.20 (n = 18) mV), and young (36.10 ± 1.26 (n = 23) mV) and aged Pgc-1β-/- preparations (40.39 
± 1.72 (n = 20) mV) with an absence of independent effects of either genotype (F = 0.040; p = 
0.84) or age (F = 0.714; p = 0.401), or interacting effects of age and genotype (F = 3.66; p = 
0.059) on two-way ANOVA. Values of k were also similar amongst young (8.11 ± 0.53 (n = 20) 
mV) and aged WT (7.48 ± 0.68 (n = 18) mV), and young (7.85 ± 0.58 (n = 23) mV) and aged Pgc-
1β-/- preparations (9.36 ± 0.42 (n = 20) mV), with an absence of independent effects of either 
genotype (F = 1.75; p = 0.19) or age (F = 0.81; p = 0.37), or interacting effects of age and 
genotype (F = 3.66; p = 0.060). 
 
Thus, in contrast to the genotype dependant effect upon the maximum peak Na+ currents Imax,  
neither age or genotype influenced the voltages at half maximal current V*, or the steepness 
factors, k, of Boltzmann functions describing current activation or current  inactivation.  
6.2.5 TIME COURSE OF NA+ CHANNEL RECOVERY FROM INACTIVATION 
 
Fig. 6-4 shows typical experimental results of the time course of recovery from inactivation. 
This was explored by restoration of the baseline voltage after an initial conditioning 
depolarising step to a fixed voltage. Results are compared for preparations from young (A, C) 
and aged (B, C), WT (A, B) and Pgc-1β-/- hearts (C, D). The pulse protocol (Fig. 6-4F) held the 
membrane potential at the RMP for 1 ms from the beginning of the recording period. This was 
followed by a hyperpolarising prepulse to voltage V0 = (RMP - 40 mV) for 4 ms to establish 
consistent baseline levels of Na+ current inactivation as in the previous protocols.  
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A 5 ms P1 conditioning step was then imposed between V0 and V1 = (RMP + 80 mV). This 
elicited Na+ current activation followed by its inactivation decay, before restoration of the 
baseline voltage V0. The depolarising 5 ms duration P2 steps to voltage V3 = (RMP + 80) mV 
were then imposed after different time intervals, ∆T. This time interval varied between 2 ms 
to 75 ms, altered in 2 ms increments for the first 5 recordings and 5 ms increments thereafter, 
through the 16 successive sweeps making up the protocol. These P2 steps elicited a Na+ 
current activation whose peak amplitude, normalised to corresponding values in the P1 step, 
reflected the Na+ current recovery from inactivation with time ∆T. Time constants, τ, were 
fitted to the exponential function I = Imax(1 - exp(-∆T/τ)) describing this recovery (Fig. 4G). 
Values of τ were similar amongst young (4.69 ± 0.47 (n = 20) ms) and aged WT (5.31 ± 0.58 (n 
= 18) ms), and young (4.58 ± 0.27 (n = 23) ms) and aged Pgc-1β-/- hearts (4.45 ± 0.29 (n = 20) 
ms). There was an absence of any effects of genotype (F= 1.31; p = 0.26), age (F=0.30; p = 
0.59), or interacting effects of age and genotype (F = 0.88; p = 0.35) on τ with 2-way ANOVA. 
6.2.6 VOLTAGE DEPENDENCES OF VENTRICULAR K+ CURRENT ACTIVATION 
 
The loose-patch clamp technique was used to investigate voltage-dependent total outward, 
K+, currents and their rectification properties in murine ventricular preparations for the first 
time. They demonstrated that, in contrast to the differences in maximum Na+ current, these 
outward current properties were similar amongst groups.  
 
Figure 6-5 illustrates the results of experiments investigating K+ current activation in 
preparations from young (Fig. 6-5A, C, E, G) and aged (Fig. 6-5B, D, F, H), WT (A, B, E, F) and 
Pgc-1β-/- (C, D, G, H) mice. The pulse procedure (Fig. 6-5I) initially imposed a voltage step 
between 1-10 ms from the start of the recording period from RMP to (RMP – 20 mV). It then 
imposed a 10 ms duration test step to voltages between (RMP – 60 mV) to (RMP + 170 mV), 
varied in increments of 10 mV through the 24 sweeps that were investigated. The traces 
shown at slow (A-D) sweep speeds encompassing the entire record demonstrate that such 
test steps initially elicited Na+ channel activation, followed by its inactivation. This was 
succeeded in some traces by a gradual outward current reflecting activation of a rectified 
voltage-dependent K+ current. This was followed by a 10 ms hyperpolarising step to a fixed  
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voltage of (RMP – 120 mV), before final restoration of the membrane potential to (RMP - 20 
mV). The traces shown at the rapid timebases (E-H) demonstrate that this resulted in K+ tail 
currents. This reflects the instantaneous conductance resulting from K+ channel activation 
induced by and existing at the end of the preceding depolarising step. The amplitudes of these 
families of tail currents were similar between experimental groups.  
 
Figure 6-5J plots typical activation K+ current-voltage curves for the young (circles) and aged 
(triangles) WT (open symbols) and Pgc-1β-/- ventricular preparations (filled symbols). The plots 
were close to superimposable, their areas with the abscissa showing neither independent (F 
= 0.02; P = 0.89 and F = 0.19; P = 0.67 respectively) nor interacting (F = 0.42; P = 0.52) effects 
of genotype or age.    
6.2.7 RECTIFICATION PROPERTIES OF VENTRICULAR K+ CURRENTS 
 
Figure 6-6 illustrates results from investigations of K+ current rectification properties in 
ventricular preparations from young (Fig. 6-6A, C, E, G) and aged (Fig. 6-6B, D, F, H), WT (A, B, 
E, F) and Pgc-1β-/- (C, D, G, H) hearts. The pulse procedure (Fig. 6-6I) initially imposed a voltage 
step between 1-10 ms from the start of the recording period from RMP to (RMP – 20 mV). It 
then imposed a 10 ms test step to a fixed voltage of (RMP + 140) mV. As indicated in the traces 
displayed at a compressed timebase illustrating the entire record (A-D), such test steps initially 
elicited an inward, Na+ current, activation, followed by its inactivation, and this was followed 
by a specific level of a rectified K+ current activation. Further test steps to a range of voltages 
between (RMP - 120 mV) to (RMP + 50 mV) altered in 10 mV increments through successive 
sweeps then elicited tail currents, shown at low (A-D) and high sweep speeds (E-H), that reflect 
the instantaneous current-voltage relationship and the rectification properties of the 
activated channel (Fig. 6-6J). Plots of such currents against voltage (Fig. 6-6J) showed the 
typical concave downward form of K+ channel rectification. These were similar amongst the 
young (circles) and aged (triangles) WT (open symbols) and Pgc-1β-/- ventricular preparations 
(filled symbols), demonstrating close to superimposable plots  and enclosing areas with the 
abscissa in which there were neither independent (F = 0.18; P = 0.67 and F = 0.004; P = 0.95 
respectively) nor interacting (F = 0.013; P = 0.91) effects of genotype or age.    
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6.3 DISCUSSION 
 
Ventricular arrhythmic risk is known to increase with age (Kucharska-Newton et al., 2010; 
Hookana et al., 2011; Adabag et al., 2015) through accumulation of mitochondrial genomic 
mutations and impaired autophagy (Michikawa et al., 1999; Pyo et al., 2013). It also increases 
with clinically common age-related metabolic conditions arising from obesity, metabolic 
syndrome, diabetes mellitus and heart failure, which constitute independent risk factors for 
such outcomes. Biochemical effects of the latter conditions were previously replicated in 
murine Pgc-1β-/- hearts which demonstrated deficiencies in key mitochondrial energetic 
tricarboxylic acid cycle, fatty acid β–oxidative and oxidative phosphorylative processes (Arany 
et al., 2005; Lin et al., 2005; Finck and Kelly, 2006).  
 
More recent reports on Pgc-1β-/- hearts have also demonstrated age-dependent ventricular 
pro-arrhythmic phenotypes (Gurung et al., 2011 a) accompanying slowed propagation of the 
action potential (AP) mediating cardiomyocyte excitation (Ahmad et al., 2018 a). This was 
accompanied by compromised maximum AP depolarization rates, (dV/dt)max and an age-
dependent accentuation of fibrotic change accentuated by the Pgc-1β-/- genotype (Ahmad et 
al., 2017, 2018 b). Pro-arrhythmic reductions in conduction velocity have been attributed to 
compromised cardiac Na+ channel function in genetically modified Scn5a+/- murine models 
modelling the Brugada Syndrome (Sabir et al., 2008 b; Kalin et al., 2010; Martin et al., 2011 a;  
b; Huang, 2017 b). They may also arise from fibrotic change altering cardiomyocyte 
capacitance following cardiomyocyte-fibroblast fusion (Xie et al., 2009; Davies et al., 2014; 
Mahoney et al., 2016), or increased intercellular gap junction resistance with connexin Cx40 
or Cx43 deficiency accompanying or resulting from tissue fibrosis (Jeevaratnam et al., 2011, 
2012).  
 
The present experiments accordingly test a hypothesis implicating compromised Na+ channel 
function as a contributor to such arrhythmic substrate. Previous reports had suggested that 
metabolic stress of the kind occurring with the Pgc-1β-/- genotype could potentially alter Na+ 
channel activity through increased reactive oxygen species (ROS) production (Liu et al., 2010 
Reduced cardiomyocyte Na+ current in the age dependent murine Pgc-1β-/- model of ventricular arrhythmia 
 
150 
 
a), or compromised NAD+/NADH ratios (Pugh et al., 2013), effects which are reversed by the 
mitochondrial ROS scavenger mitoTEMPO (Liu et al., 2010 b) and NAD+ restoration (Gomes et 
al., 2013) respectively. Pgc-1β-/-cardiomyocytes also show altered Ca2+ homeostasis (Gurung 
et al., 2011 a) accompanied by increased frequency of pro-arrhythmic delayed 
afterdepolarisation activity in common with murine RyR2-P2328S ventricular cardiomyocytes 
(Goddard et al., 2008 b).  
 
However, RyR2-P2328S ventricles also showed parallel reductions in AP conduction velocity 
and maximum depolarization rates (Zhang et al., 2013). These were subsequently correlated 
with reduced Na+ current (King et al., 2013 b), itself attributed to both chronically 
downregulated NaV1.5 expression (King et al., 2013 b; Ning et al., 2016 a) and acute (King et 
al., 2013 b;  d; Zhang et al., 2013) but potentially reversible loss of NaV1.5 function (Knollmann 
et al., 2001 b; Salvage et al., 2015, 2017). Previous studies have reported that increasing or 
sequestrating intracellular [Ca2+] reduced or restored Na+ currents and (dV/dt)max respectively 
in in vitro WT cardiomyocytes (Casini et al., 2009). Altered cellular Ca2+ homeostasis could 
potentially acutely affect Nav1.5 function (Tan et al., 2002; Aiba et al., 2010; Ashpole et al., 
2012) through its C-terminal region, either directly at an EF hand motif (Wingo et al., 2004) or 
indirectly through an IQ domain sensitive to calmodulin/calmodulin kinase II (Mori et al., 
2000). Nav1.5 also shows multiple phosphorylatable, serine 516 and 571, and threonine 594 
sites in its DI-II linker that are targetable by calmodulin kinase II (CaMKII) action (Mori et al., 
2000; Wagner et al., 2011; Grandi and Herren, 2014).  
 
The loose patch clamp method measures transmembrane current flow into an extracellular 
electrode apposed to the cardiomyocyte surface membrane forming the patch. It further can 
be applied to intact ventricular tissue preparations (King et al., 2013 b; Salvage et al., 2015; 
Ning et al., 2016 a). It thereby avoided the tissue disruption, cell isolation and intracellular 
Ca2+ chelation required by conventional whole-cell patch-clamp studies (Lei et al., 2005; 
Martin et al., 2012 b). The latter may account for differences between some of the present 
findings and previous observations using conventional patch clamping of isolated cells  
(Gurung et al., 2011 a). The present studies further employed in vivo rather than reduced 
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extracellular [Na+] levels thereby sparing effects on Na+-Ca2+ exchange. Previous reports had 
identified early inward currents obtained in loose patches with Na+ currents mediating AP 
upstroke and its conduction (King et al., 2013 b).  
 
Depolarising test steps elicited inward currents which activated to a peak value then showed 
an inactivating decline to baseline in a pattern characteristic of voltage-dependent Na+ 
currents. These features were observed in all the young and aged, WT and Pgc-1β-/- ventricular 
cardiomyocytes studied. The resulting current-voltage relationships gave values that 
increased with depolarisation up to voltage excursions of (RMP + 80 mV) beyond which they 
declined as expected towards the Na+ reversal potential. In contrast, imposition of voltage 
steps exploring inactivation characteristics began with prepulse voltages to varying levels of 
depolarisation which similarly elicited currents rising to a peak followed by an inactivation-
mediated decay. These were followed by steps to a fixed depolarised membrane potential. 
The latter elicited currents whose peaks declined in amplitude with the depolarising prepulse 
as expected from the voltage dependent inactivation this would produce. Inactivation curves 
were constructed from plotting such peak currents against the prepulse level. These gave 
currents that fell with depolarisation. A two-way ANOVA, followed where indicated by post-
hoc pairwise testing, then examined for significant independent and interacting effects of the 
Pgc-1β-/- (as opposed to WT) genotype and of age on the quantitative parameters emerging 
from fitting Boltzmann relationships to both the activation and inactivation data. This 
demonstrated independent effects of genotype, but not of age, or of interactions between 
these factors, in reducing maximum values of the peak Na+ currents. However, there were 
neither independent nor interacting effects on consequently similar values of voltage at half 
maximum current, V*, and the steepness k of both activation and inactivation characteristics. 
Nor were there differences in the time constants describing the timecourses for recovery from 
inactivation following restoration of the background voltage, which were consequently similar 
between experimental groups. These findings suggested that the altered availability of 
functional Na+ channels accompanied otherwise normal voltage dependences. 
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These differences specifically in maximum Na+ current contrasted with indistinguishable 
outward K+ current characteristics between groups. Pulse protocols investigating the voltage 
dependences of K+ current activation applied voltage steps to a range of test potentials, and 
followed these with hyperpolarising steps that would elicit a tail current whose amplitude 
reflected the preceding K+ channel activation. Conversely K+ current rectification properties 
were investigated by first imposing a conditioning step to a fixed membrane voltage step to 
produce a constant level of activation. This was followed by voltage steps to varying 
membrane potentials. The latter would result in tail currents flowing through similarly 
activated channels, in response to different driving forces, which would vary with the voltage 
dependence of the resulting open channel rectification properties. Both experiments yielded 
similar ventricular cardiomyocyte currents suggesting similar activation and rectification 
characteristics in all the four experimental groups explored. These thus yielded closely 
concordant activation and instantaneous current-voltage curves. Thus, two-way ANOVA 
demonstrated that there were neither independent nor interacting effects of genotype or age 
on areas made between observed values representing either plots of K+ current activation, or 
of rectification properties and their voltage abscissae. 
 
The loose-patch clamp technique as used in this study does not directly visualize the cells that 
are patched; it is thus a possibility that some patches are not of cardiomyocytes but of cardiac 
fibroblasts. Cardiac fibroblasts make up 75% of the total number of cardiac cells (Banerjee et 
al., 2007) but only around 5-10% of its volume (Shiraishi et al., 1992) and an even smaller 
percentage of endocardial surface area owing to their spherical shape – this in of itself makes 
it likely that the majority of the data is derived from cardiomyocytes on a probabilistic basis. 
It does not eliminate the possibility entirely however. Cardiac fibroblasts were once thought 
to be electrical bystanders, but more recent data suggests that they are in fact part of a 
complex electrophysiological milieu in the heart. They have a RMP of -50 to -60mV, slightly 
less negative than cardiomyocytes (Li et al., 2009). They express voltage gated potassium 
channels across a number of species (Shibukawa et al., 2005; Li et al., 2009) and human cardiac 
fibroblasts express TTX sensitive voltage gated sodium channels (Li et al., 2009; Yue et al., 
2011); the situation in other species has not yet been determined. 
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Thus the final electrophysiological effect is determined by the electrophysiological properties 
of the two cell populations, as well as electrotonic effects between the two. However, there 
is scant evidence for any active electrical excitability of fibroblasts despite studies looking 
extensively for them (Kohl and Gourdie, 2014) or heterecellular coupling between them (Kohl 
and Gourdie, 2014). Ockham’s razor would suggest that as cardiac excitability is adequately 
explained without invoking heterocellular coupling and complex fibroblast-cardiomyocyte 
interaction, this should be the working hypothesis. In this context, the electrotonic coupling 
would mean that any patch of mixed patch containing both cardiomyocyte/fibroblast would 
simply manifest as a reduced charge density per unit area and increased cell membrane 
capacitance. It may reasonably be questioned whether the lower current density of sodium 
current in Pgc-1β-/- patches thus simply represents the lower current density per unit area due 
to increased fibrosis (seen in chapter 4) rather than a reduction in cardiomyocyte sodium 
current density. However, this is not an adequate explanation for the findings – the fibrosis 
pattern seen in chapter 4 was graded, with differential fibrosis in young vs aged Pgc-1β-/- mice 
and young vs aged WT mice – the same pattern of sodium current density was not seen, with 
an equal reduction in sodium current density in young and aged Pgc-1β-/- mice. This suggest 
that fibroblasts were not patched to any significant degree as would be expected from their 
small contribution to cardiac volume and even smaller contribution to cardiac surface area. 
Any patch that was predominantly fibroblast was unlikely to have yielded experimentally 
viable patches and data would not have been likely collected from them. It is still however 
conceivable that small patches of fibroblast were encapsulated in the patch and as such 
current densities have been expressed as pA/μm2 to reflect the measurement of current 
density per unit area of myocardium. The histology of the patches were not directly examined, 
but this could be a further avenue for exploration in the future.  
 
The loose patch clamp technique also differs from conventional tight patch clamping in the 
potential sources of error in its current measurements; while it does not suffer the drawbacks 
of artificially manipulated ion concentrations (including of the ion currents to be measured) 
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the loose nature of the seal introduces rim current errors. This is due to the membrane directly 
under the rim of the pipette being subjected to deformation causing activation (of the ionic 
channels in the membrane) at an uncontrolled voltage under the rim of the pipette. This 
results in a graded voltage clamp underneath the rim, with the patch being subjected to the 
command voltage, the outside of the patch at Vm and the rim underneath displaying an 
intermediate voltage between the two. Rim current errors can be minimised by increasing 
pipette size and thus reducing the ratio of the rim area to the patch area. A previous paper 
has demonstrated that it can be eliminated completely with the construction of concentric, 
double-barrelled pipettes (Roberts and Almers, 1984).  
 
Despite these limitations, there is robust evidence for the present findings. The present 
current-voltage analyses of both activation and inactivation properties thus associate the Pgc-
1β-/- genotype, but not ageing, with alterations in maximum Na+ conductance. This took place 
in an absence of alterations in Na+ channel activation and inactivation properties reflected in 
their voltages at half maximum current, V* and the steepnesses k, of their voltage 
dependences, their timecourses of recovery from inactivation, and in the voltage 
dependences of K+ current activation and rectification. The resulting reduction specifically in 
maximum Na+ current constitutes a mechanism for the observed pro-arrhythmic reductions 
in AP conduction velocity accompanied by reduced peak AP upstroke rates (dV/dt)max in the 
presence of the Pgc-1β-/- genotype (Ahmad et al., 2017).  
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7. SUMMARY, GENERAL DISCUSSION AND FUTURE WORK 
 
7.1 OBJECTIVES AND BACKGROUND OF PRESENT STUDY. 
 
This project sought to design, complete and interpret a robust set of experiments investigating 
the characteristics and mechanisms of arrhythmogenesis in the setting of mitochondrial 
dysfunction and the cumulative changes that occur with advancing age. The present findings 
develop and complement initial reports that were largely preoccupied with properties of 
isolated Pgc-1β-/- cardiomyocytes (Gurung et al., 2011 b). The latter similarly reported 
arrhythmic phenotypes at the level of whole hearts. Studies in isolated cardiac myocytes 
associated the peroxisome proliferator-activated receptor-γ coactivator-1β knockout (Pgc-1β-
/-) genotype with alterations in Ca2+ homeostasis reflected in diastolic Ca2+ transients.  Use of 
conventional (tight) patch clamp recordings suggested alterations in Ca2+ channel activation. 
These findings together implicated altered Ca2+ homeostasis, in the form of DADs/EADs and 
other recovery abnormalities, in the observed increased frequency of diastolic depolarisation 
events in the arrhythmic phenotype. They also suggested an enhanced Na+ channel function 
in the form of increased maximum rates of action potential upstroke. However, the latter 
findings were obtained under recording conditions involving intracellular Ca2+ chelation. 
These conditions are unlikely to be replicated in cardiomyocytes in vivo. The effect of such 
dramatic changes in ionic composition on ionic channel function have only been reported 
recently. Thus major effects on Na+ current densities followed either genetic or 
pharmacological manipulations of intracellular Ca2+(King et al., 2013 d; Ning et al., 2016 b; Valli 
et al., 2018). It was therefore important to follow studies performed in isolated cardiomyocyte 
with explorations of the electrophysiological properties of intact cardiomyocytes in intact 
working hearts minimizing perturbations in their intracellular homeostasis.  
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7.2 ELECTROCARDIOGRAPHIC STUDIES AT THE WHOLE HEART LEVEL 
 
The series of experiments outlined here studied electrophysiological characteristics through 
measurements of cardiomyocyte electrophysiological properties in multiple physiological 
preparations. Importantly this included experiments on intact working hearts under 
conditions in which arrhythmia could be observed. These included ECG studies in intact 
organisms, microelectrode studies of ventricular cardiomyocyte activity in isolated, perfused, 
hearts, and studies of ion currents using a loose patch clamp technique in a novel ventricular 
preparation. These studies were performed in groups of young (12-16 week) and aged (>52 
week) Pgc-1β-/- and WT mice.  
 
First, electrocardiographic (ECG) studies examined overall cardiac electrophysiological 
phenotypes at the whole animal level. This demonstrated that the mitochondrial dysfunction 
produced by Pgc-1β knockout generates distinct electrocardiographic features that differed 
between anaesthetised young and aged, WT and Pgc-1β-/- mice. Following dobutamine 
challenge, the Pgc-1β-/- hearts displayed compromised sino-atrial node function, and an 
atrioventricular conduction defect.  The latter defect was most frequent in the aged Pgc-1β-/- 
mice. In addition, Pgc-1β-/- mice displayed prolonged ventricular activation times consistent 
with the existence of a ventricular pro-arrhythmic substrate. ECG analysis thus yielded 
electrophysiological findings bearing on potential arrhythmogenicity in intact Pgc-1β-/- mice, 
and suggested detailed features for subsequent testing. These findings demonstrate that 
ventricular activation was prolonged in Pgc-1β-/- mice consistent with slowed action potential 
conduction.  
 
7.3 ELECTROPHYSIOLOGICAL STUDIES OF CARDIOMYOCYTES IN INTACT 
PERFUSED HEARTS 
 
The ECG findings prompted investigations for the importance of slowed ventricular activation 
in the arrhythmic phenotype. Single cell action potential characteristics in intact Langendorff-
perfused hearts were studied using simultaneous microelectrode and ECG recordings. The 
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first set of these microelectrode experiments studied the effects of programmed electrical 
stimulation (PES) protocols.  
 
Young and aged Pgc-1β-/- mice showed higher frequencies and durations of arrhythmic 
episodes. These episodes took place over a wider range of S1S2 intervals when compared to 
WT. Both young and aged, regularly-paced, Pgc-1β-/-  hearts showed slowed maximum action 
potential (AP) upstroke rates, (dV/dt)max (~157 vs. 120-130 V s-1), prolonged AP latencies (by 
~20%) and shortened refractory periods (~58 vs. 51 ms) but similar AP durations (~50 ms at 
90% recovery) compared to WT. However, the Pgc-1β-/- genotype and age each influenced 
extrasystolic AP latencies during PES. Furthermore, young and aged WT ventricles displayed 
distinct dependences of AP latency upon (dV/dt)max, but Pgc-1β-/- ventricles displayed a 
relationship of AP latency upon (dV/dt)max that resembled aged WT mice. They also showed 
independently increased levels of myocardial fibrotic change. Finally, AP wavelengths 
combining activation and recovery terms paralleled the contrasting arrhythmic incidences in 
Pgc-1β-/- and WT hearts.  
 
The second set of microelectrode investigations employed an incremental pacing protocol 
used previously to explore action potential restitution.  Hearts were subjected to successive 
trains of 100 regular stimuli at progressively decremented BCLs. Aged Pgc-1β-/- hearts again 
displayed an increased incidence of arrhythmia compared to other groups. In addition both 
the young and aged Pgc-1β-/- hearts showed higher incidences of alternans, reflecting 
instabilities known to presage the onset of arrhythmia in both AP activation and recovery 
characteristics compared to WT hearts. Such differences were particularly apparent at the 
lower pacing frequencies. They accompanied reduced (dV/dt)max and increased AP latency 
values in the Pgc-1β-/- hearts. In particular, APs observed prior to termination of the protocol 
showed lower (dV/dt)max and longer AP latencies, but indistinguishable APD90 and RMPs in 
those Pgc-1β-/- in which the stimulation protocol culminated in arrhythmia. Restitution curves 
of AP wavelengths were shorter in Pgc-1β-/- than WT hearts, this being particularly the case in 
aged Pgc-1β-/- hearts. These experiments demonstrated that Pgc-1β-/- hearts show pro-
arrhythmic instabilities, and attributed these to altered AP conduction and activation 
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characteristics. The study confirms the important findings of decreased (dV/dt)max and 
importantly the unique wavelength characteristics associated with Pgc-1β-/- hearts.  
 
7.4 LOOSE PATCH CLAMP STUDIES OF IONIC CURRENTS IN CARDIOMYOCYTES 
IN SITU 
 
These findings together suggested a hypothesis that associates mitochondrial dysfunction 
with arrhythmic phenotypes through shortened AP wavelength produced by slowed AP 
conduction and age-dependent fibrotic change. Such findings parallel earlier reports that 
implicated a deficiency of Nav1.5 in arrhythmic tendency, similar alterations in action 
potential characteristics and fibrotic tendency in arrhythmic models (Jeevaratnam et al., 
2016).  
 
The final group of experiments accordingly proceeded to test a hypothesis implicating 
compromised Na+ channel function. Loose patch-clamp techniques were applied in intact  
ventricular cardiomyocyte preparations for the first time. This technique permitted studies of 
cardiomyocytes in situ, conserving their in-vivo extracellular and intracellular conditions. Both 
young and aged Pgc-1β-/- mice showed reductions in the maximum peak Na+ currents. The 
remaining Na+ current activation and inactivation characteristics remained indistinguishable 
through all experimental groups. These differences were observed despite indistinguishable 
activation and rectification properties of delayed outward (K+) currents. These findings directly 
implicate a reduction in maximum available Na+ current with unchanged voltage dependences 
in the pro-arrhythmic reductions in AP conduction velocity in Pgc-1β-/- ventricles. 
 
7.5 DISCUSSION OF THE EXPERIMENTAL APPROACH AND FUTURE STUDIES 
 
The work presented here represents a strong experimental approach to describing the 
electrophysiological characteristics of a model for energetic dysfunction and the changes in 
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ion channel conductance that may be associated with it. It does not however describe a 
mechanistic link between the two and the causative biochemical cascade of events that result 
in the final electrophysiological changes. Such a causative explanation would need evidence 
from DNA and RNA, transcription factor analyses, intracellular second messenger changes and 
finally in-depth ionic channel assays. The study does however suggest a number of avenues 
for future experiments that would be productive in developing this link.  
 
Future studies should therefore aim to further this causative link in a number of ways.  Firstly, 
a direct correlation between energetic dysfunction and the electrophysiological changes such 
as sodium channel conductance and (dV/dt)max should be made to strengthen the link 
between the two. This would entail direct measurement of ATP, ADP, AMP concentrations as 
well as the redox potential of the mitochondria in all experimental hearts. This would clearly 
establish whether there is a direct relationship and correlation between cellular biochemical 
markers of energetic sufficiency and the electrophysiological changes in AP characteristics, or 
whether there is a threshold level below which no changes are induced.  Examining the 
expression of mitochondrial and nuclear gene profiles in genes of interest would also be a 
useful step in examining the detailed cellular level changes that Pgc-1β ablation causes.  
 
Secondly, western blot analysis of ion channel and important mitochondrial proteins would 
confirm the gene level changes with evidence for functional ion channel expression changes 
and ascertain whether there are any significant changes in protein expression levels between 
the experimental groups. With this information, it would then be possible to devise a 
hypothesis as to what cellular signalling changes may be affecting the biochemical milieu. 
There is a strong suspicion of altered Ca2+ homeostasis which could be an intermediator 
between the ultimate ion channel level changes seen and the base genetic level changes and 
this would likely need to be explored regardless – not least because Ca2+ homeostasis is known 
to have a significant impact on arrhythmogenicity in of itself, being important in triggering 
arrhythmias and being a strong candidate for study from the experiments of this study and 
allied experiments not presented here. 
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Finally another promising approach would be to try and integrate the changes in sodium 
channel properties and AP characteristics to the tissue level fibrosis seen. The relative 
contribution of fibrotic change to arrhythmias needs to be examined further. Fibrosis alters 
the structural properties of the tissue and this likely has electrophysiological effects. How this 
impacts upon tissue resistivity gap junction conductance and the relative importance of this 
versus changes in sodium channel changes in conduction velocity changes are yet to be 
determined. A number of different diseases involving the sodium channel seem to have 
abnormal fibrosis, including the Brugada syndrome. This may lead to investigation as to the 
importance of Nav1.5 subunit as a macromolecular anchor at the surface membrane that 
integrates structural as well as signalling components that mediate the normal composition 
of the extracellular matrix and fibrosis and the cell to cell connections that are important in a 
syncytium. Experiments to directly measure tissue resistivity and pulldown experiments to 
isolate the Nav1.5 macromolecular complex would be an initial approach to this question. 
 
The striking SAN and AVN abnormalities seen in the aged Pgc-1β deficient mice is a tangential 
finding that may allow insights into the senile degeneration of the conduction system seen in 
human populations. It is known that AVN disease is a frequent and important cause of 
conduction disease in humans, though the age-related mechanism of how nodal tissues are 
affected by age is mostly unknown. Experimental strategies here would require the ability to 
isolated the nodal tissue and study their AP characteristics. The small size of the mouse system 
would make this challenging as cell yield in cardiomyocyte isolation would be low. An initial 
strategy may instead focus on the structural changes in conduction system with assessment 
of fibrotic changes and immunohistochemistry allowing further information to be gained as 
to the likely cellular abnormalities before investing the significant time needed to isolate nodal 
tissues and cells for in depth electrophysioloical investigation. Pharmacological approaches to 
target the specific molecules of interests and to reduce free radical burden in mitochondria 
may also be potential avenues for exploration.  
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7.8 LIMITATIONS 
 
The main limitations of this study have been discussed previously in the introduction and 
chapter discussions. The differences in murine and human physiology are a key limitation. 
Mice are far smaller mammals than humans and have higher basal heart rates. There are clear 
differences in the cardiac action potential between the two species. Most differences are in 
the repolarisation and plateau phase of the AP, with the depolarising phase conserved – 
human APs display rapid K (IKr) and slow K (IKs) currents, whilst mice show fast K (Ito,f) and slow 
K (Ito,s) currents. Mouse hearts also use less L-type Ca channel current ICa-L. This means that 
the mouse cardiac AP does not have a prolonged plateau phase and has shorter APD values. 
Thus changes in the depolarising phase of the AP are likely to be more translatable to human 
findings. This furthers the importance of future Ca2+ handling work (which would relate to the 
plateau phase of the AP) to use human as well as murine tissue as the experimental base.  
 
Secondly, the Langendorff preparation has drawbacks including a non-physiological perfusate 
and the use of blebbistatin which may have cardio-protective effects and reduce energetic 
demand of the heart (see chapter 4 and 5 discussion). Finally, the lack of previous normal 
physiological values for murine ECG data and human work relating to ventricular tissue and 
PGC-1 (which has invariably looked at the question of heart failure) means there are no studies 
on the effect of the electrophysiological milieu to compare our findings against. This applies 
to murine as well as human studies, with no other literature being available to my knowledge 
on the subject matter of this thesis other than that presented here. The loose patch clamp 
technique allows measurement of current voltage relationships of important cellular currents, 
though in the apparatus used here direct visualisation of the patch was not possible and thus 
there may be additional electrotonic effects of fibroblasts. For this reason, currents were 
expressed as current densities per unit area. Further, rim current error could not be 
completely eliminated in the experiments performed here and thus estimated of the Nernst 
reversal potentials were not made. Despite these caveats, my work offers an important insight 
into the effect complex energetic and mitochondrial pathologies can have on 
electrophysiology, though further work is needed to offer mechanistic insight.
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